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Abstract 
 
The last fifty years has seen an increase in the production of synthetic or artificial enzyme 
substrates used to identify and quantify enzymes.  These substrates have found applications in 
a range of biomedical science disciplines.  Used in biochemistry and clinical chemistry to 
identify and measure enzymes, some of these substrates have been adapted for use in 
microbiology, particularly bacterial diagnosis and, in more recent years, molecular biology. 
The use of artificial chromogenic and fluorogenic enzyme substrates to identify certain 
bacteria is now common place in medical laboratories worldwide.  Not all bacteria can be 
identified with existing and commercially available artificial substrates.  Some of these can 
be slow to yield results, imprecise, expensive or require a technical method too complicated 
to provide a viable laboratory test.  Therefore, the search for new, more efficient, biochemical 
tests has progressed, with novel substrates and inventive applications being developed 
continually. 
In this study, core compounds were synthesised by various condensation reactions and their 
characteristics evaluated with respect to colouration/fluorescence and possible enhancement 
of these properties by metal chelation.  Promising candidates were selected for glycosidation, 
via modified Koenigs-Knorr reactions, in an attempt to synthesise artificial substrates.  
Several commercially available core molecules were also subjected to glycosidation.  The 
more successful substrates included glycosides of alizarin, nitrosalicylaldehyde and 3-
hydroxyflavone. 
The galactoside of nitrosalicylaldehyde was evaluated in solid agar media and found to be 
selective for certain Gram-negative bacteria.  When similarly investigated, the 3-
hydroxyflavone-β-D-glucoside showed the possibility of being used in a procedure for the 
isolation of the clinically significant pathogens including Listeria monocytogenes.  The 
enzyme kinetics of β-glucosidase with this substrate were also determined in a novel 
fluorescence assay and compared favourably to the well documented 4-methylumbelliferyl-β-
D-glucopyranoside.  Alizarin-2-yl-β-D-galactoside and p-naphtholbenzein-β-D-galactoside 
were successfully utilized for the screening of recombinant and non-recombinant Escherichia 
coli transformants produced routinely in molecular biology. 
Aminopeptidase substrates have been shown to be useful for the detection of enzymes which 
hydrolyse peptides that are specific to certain bacteria.  To allow the evaluation of novel 
aminopeptidase substrates, that were to be subsequently synthesised, a cost effective, large 
scale source of recombinant leucyl aminopeptidase enzyme was developed via gene cloning 
techniques. 
Consequently, the products of this study may serve a beneficial purpose in future enzymatic 
investigations, medical diagnosis and molecular biology. 
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1.1 Preface 
 
Over the last fifty years the production of synthetic or artificial enzyme substrates to 
identify and quantify enzymes has increased (Manafi et al., 1991; Dealler, 1993). 
Used primarily in biochemistry to study enzyme kinetics, clinical chemistry to 
quantify enzymes and to a lesser extent cellular pathology to mark the locality of 
enzymes in tissue.  Some of these substrates have been adapted for use in 
microbiology, particularly bacterial diagnosis. 
In other areas such as in industry and research the ability to detect and quantify 
enzyme activity is also of interest (Pettipher et al., 1980; Ley et al., 1988). 
In the field of medical diagnostics the need to identify bacteria rapidly and precisely 
is of the utmost importance.  This can be achieved by a variety of methods including 
the utilization of the sometimes highly specific enzymes produced by bacteria during 
their normal existence (Goodfellow et al., 1987; Bascomb and Manafi, 1998). 
Traditional methods of identifying bacteria in pathological laboratories can be time 
consuming.  They can involve many sequential tests that require handling time to set 
up and long incubations (Hugh and Leifson, 1953; Edberg et al., 1988).  Procedures 
were revolutionised by the development of biochemical methodologies for the 
detection of specific bacterial enzymes (Le Minor, 1962),  since the ‘natural’ enzyme 
substrates that are sometimes employed in these tests can be less than perfect as they 
have a low enzyme affinity or are not easily detected (MacFaddin, 2000). 
These flaws have led to the creation of artificial substrates, the properties of which, 
ideally, include high enzyme reactivity and sensitivity (James and Yeoman, 1988; 
Perry et al., 1999). 
The use of artificial chromogenic and fluorogenic enzyme substrates to identify 
certain bacteria is now common place in medical laboratories worldwide (Manafi, 
1996).  By incorporating a colour producing (chromogenic) or fluorescence 
producing (fluorogenic) agent into a specific substrate a ‘novel’ enzyme substrate is 
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produced.  When acted upon by the relevant enzyme the substrate is cleaved, the 
agent is released and can then be detected. 
Not all bacteria can be identified with existing and commercially available artificial 
substrates and even some of these can be slow to yield results, imprecise, expensive 
or require a technical method too complicated to provide a viable laboratory test.  
Therefore, the search for new, more ideal, biochemical tests has progressed with 
novel substrates and inventive applications being developed continually. 
 
 
1.2 Nature of Enzymes 
 
All proteins are composed of linked amino acids to create polypeptide chains. These 
usually show secondary and tertiary structure (folding and three dimensional 
arrangement) and often exhibit high levels of organisation (quaternary) with 
association of subunits, e.g. lactose dehydrogenase.  Frequently, other groups are 
present to create conjugated proteins by post-translational modification to give, for 
example, glycoproteins, haemoproteins, etc.  Nevertheless, they are all 
fundamentally formed from 20 amino acids, but are arranged in totally different 
sequences. 
The biological activity of enzymes depends on their catalytic function.  They 
effectively lower the activation energy for the reaction which they catalyse.  This 
requires an intimate association of the enzyme with its substrate.  This association is 
not random, but occurs at specific points of the enzyme’s structure known as active 
sites, e.g. acetyl cholinesterase operating on its normal substrate acetylcholine, where 
histidine and serine residues have been implicated. 
In addition to the catalytic nature of enzymes, the specific nature of the enzyme-
substrate interaction needs consideration.  For example, D-amino acid oxidase 
accepts and transforms D-alanine, D-valine, etc., but not the corresponding L-amino 
acids.  In contrast, the L-amino acid oxidase of snake venom converts only L-amino 
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acids into the corresponding ketoacids and not into their D-series counterparts.  
Likewise, Escherichia coli β-galactosidase catalyses the hydrolysis of β-galactosides, 
e.g. lactose methyl-β-galactoside, etc., but not the corresponding α-galactosides. 
The majority of enzyme catalysed reactions can be described by the Michaelis-
Menten equation (Figure 1.1). 
V0 = Vmax [S]
 Km + [S]
 
where: 
V0 is the initial rate of reaction 
Vmax is the maximum rate 
[S] is the substrate concentration 
and KM the Michaelis constant (substrate concentration at half the maximum rate i.e. 
Vmax ÷ 2) 
Figure 1.1:  Michaelis-Menten equation. 
 
This equation relates to: 
S + E          ES             EP           E + P 
Where: 
S is the substrate 
E is the enzyme 
and P is the product 
 
Michaelis-Menten kinetics (Michaelis, 1913) are used in the description of the rate of 
enzyme mediated reactions.  These kinetics parameters are only valid if the substrate 
concentration is higher than than that of the enzyme,  
To determine the maximum rate of an enzyme catalysed reaction, the substrate 
concentration ([S]) is increased until a constant rate of product formation is achieved. 
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This is the maximum velocity (Vmax) of the enzyme. In this state, all enzyme active 
sites are saturated with substrate.  
With increasing substrate concentration [S], the enzyme is approaching its maximum 
speed Vmax, but never actually reaching it. Because of that, no substrate concentration 
for Vmax can be given. Instead, the characteristic value for the enzyme is defined by 
the substrate concentration at its half-maximum speed (Vmax/2). This KM value is also 
called the Michaelis-Menten constant. KM is a good measure of the binding strength 
within the ES complex or a measure of the affinity between the enzyme and 
substrate. A high KM would indicate a weak affinity, whilst a low KM would indicate 
a strong affinity. 
 
 
1.3 Enzyme based detection, identification and quantification 
 
Several methods exist for the above processes:- 
In microbiology, visualisation of potential or actual pathogens frequently involves 
growing the organism on a nutrient agar plate to produce discrete colonies.  A 
specific enzyme substrate is incorporated into the agar and is enzymatically 
transformed to yield a coloured product which, ideally, is localised on the colonies 
possessing the correct enzyme.  This is frequently in contrast to negative or ‘self-
coloured’ colonies.  Alternatively, a large number of enzymatic substrates each 
defining a single reaction are incorporated into a plastic card in discrete microwells.  
Microorganisms introduced into the wells produce a characteristic and individual 
pattern of reactivity evidenced by coloured products.  The wells are interrogated by a 
light beam of appropriate wavelength and results recorded as positive or negative 
signals leading to a computerised identification of the organism. 
In cell pathology, the use of specific substrates for the detection/visualisation of sites 
of enzymatic activity has great value in distinguishing normal cells and tissues from 
abnormal forms.  This forms the basis of enzyme histochemistry and cytochemistry.  
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There are numerous examples and the subject is discussed throughout this 
introduction.  It is important to state however that it was in this area (histochemistry) 
that the application of chemistry to the detection of localised regions of specific 
enzyme activity in cells and tissues was first demonstrated.  This led to the much 
wider use of localising enzyme substrates in other areas of cell biology.  In 
histochemistry/cytochemistry, microscopes are commonly used with a U.V. light 
source (fluorescence), e.g. molecular probes. 
In the field of immunology, detection of the specific antigen-antibody reaction does 
not necessarily require an enzymatic involvement.  Older procedures involved 
eliciting a precipitation reaction, haemolysis or other effects.  The technique of 
enzyme labelling however changed this dramatically.  A specific antibody labelled 
with an enzyme is used to determine the presence or concentration of a particular 
antigen.  The method requires a substrate which is transformed, usually by 
hydrolysis, to give a coloured or fluorescent product, the concentration of which may 
then be determined by, for example, Enzyme-Linked ImmunoSorbent Assay 
(ELISA) (Lequin, 2005).  
Many other examples can be drawn from the field of genetics and molecular biology 
e.g. lac Z  gene in bacterial transformation, hybridisation, blotting techniques, etc 
(Brown, 2006).  
In clinical chemistry visual and spectrophotometric methods are employed.  In its 
simplest sense, the colour of the product of the enzymatic process is observed or, for 
quantification, the colour intensity is measured either by a colorimeter, U.V./visible 
spectrophotometer or spectrofluorimeter.  Such instruments either utilise diffraction 
grating monochromators or interference filters where specific wavelengths are 
required.  The applications of colour observation or measurement are numerous in 
biomedical science 
Types of Spectrophotometric Methodologies: 
a) U.V./Visible Spectrophotometry.  Techniques may vary from simple 
colorimeters to dual beam spectrophotometry and highly automated optical 
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systems such as the automatic analysers found in clinical chemistry 
laboratories. 
 
b) Fluorescence Spectrophotometry.  An atom or molecule fluoresces when it 
has been electrically excited by the absorption of a photon then returned to 
it’s ground state by the emission of a photon with a longer (less energetic) 
wavelength (Figure 1.2). 
 
Excitation: S0 + hνex → S1  
Emission: S1 → S0 + hνem 
Where:-  hv is photon energy (h = Planck’s constant, ν = frequency of light),                   
S0 = ground state and S1 = 1
st
 excited state. 
Figure 1.2:  Fluorescence excitation and emission. 
 
Fluorescence was a term first used by George Gabriel Stokes in 1852 when 
studying the mineral Fluorite which he discovered will emit light in the 
visible region of the electromagnetic spectrum when excited by ultraviolet 
light.   
The processes involved during fluorescence can be shown with the Jablonski 
diagram (Figure 1.3), first devised by Professor Alexander Jablonski in 1933 
to describe absorption and emission of light.   
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Figure 1.3:  Simplified Jablonski diagram. 
 
During fluorescence, electrons are elevated to a higher energy state by the 
absorption of electromagnetic radiation (usually light).  This higher state is 
unstable and some of the energy is lost to the surroundings as heat (non-
radiant energy).  The remaining energy is emitted as light as the electrons 
return to their stable ground state.  As there is a loss of energy during the 
relaxation step, the light emitted is lower in energy (of a longer wavelength) 
than the light absorbed.  As demonstrated by the Einstein-Planck equation 
e=hc/λ.  Therefore, a fluorescent molecule has an absorption and emission 
spectrum.  The distance between the λmax of these two spectra can be 
measured in nanometres and is known as ‘Stokes Shift’. (Figure 1.4) 
A large Stokes Shift is desirable because less of the two spectra overlap 
meaning less interference and a greater area can be used to make a 
measurement.  This also has the benefit of increasing the sensitivity of the 
measurement resulting in detection at lower concentrations or in a smaller 
time frame. 
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resorufin spectra (Ex 560nm, Em 590nm) 
 
 
7-amino-4-methylcoumarin spectra (Ex 350nm, Em 440nm) 
Figure 1.4:  Stokes Shift.  Examples of large and small Stokes Shift. 
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Where fluorometric substrates are used in an enzyme assay, the fluorescent 
molecule (fluorophore) released can be measured using a fluorimeter.  Here 
again, there is a considerable variation in the type of instrumentation 
available.  In the simplest case direct observation under a U.V. source can 
demonstrate areas or zones of fluorescence colour.  This is common practice 
in diagnostic microbiology, e.g. substrates based on 4-methylumbelliferone 
(4-MU) or the more recently developed cyclohexenoesculetin (CHE) to locate 
specific organisms.  4-MU glucuronide has been used to differentiate E. coli 
from other enterobacteria (Szabo et al., 1986) and CHE-β-glucoside to 
visualise Listeria spp. (James, 2001; Smith et al., 2001).  As 4-MU 
glucuronide colonies of organisms possessing the relevant enzyme show as 
bright sky-blue areas on a weakly purple agar back ground (Figure 1.5). 
 
 
Figure 1.5:  4-Methylumbelliferyl-β-D-glucuronide.  Used in agar to differentiate E. coli 
(fluorescent blue) from other enterobacteria.  Picture courtesy of Merck. 
 
Fluorometric measurement can be made using a spectrofluorimeter.  Design 
and construction may vary, but essentially a source of U.V. radiation is 
generated (mercury, deuterium, xenon lamp, etc.).  Monochromation is 
achieved by use of a diffraction grating or interference filter.  The latter is 
used when a broader bandwidth is acceptable.  Sophistication of this 
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technique can be extensive as illustrated by the Fluorescence Activated Cell 
Sorter (FACS) a device which can identify and measure specific fluorophores 
on a cell’s surface and then separate cells based on their charge (Herzenberg 
et al., 2002). 
 
c) Luminescence Spectrophotometry.  This includes chemiluminescence and 
bioluminescence.  The latter is more commonly employed as it is, in theory, 
applicable to all reactions involving adenosine triphosphate (ATP) and 
nicotinamide dinucleotides (NAD and NADH).  Visible light is generated 
through the activation of the luciferin/luciferase system (firefly enzyme) 
(Figure 1.6) or other light generating system, e.g. Green Fluorescent Protein.  
 
luciferin + ATP + O2 oxyluciferin + AMP + CO2 + light
luciferase
 
Figure 1.6:  Luciferin/ luciferase system. 
 
One of the significant advantages of the system is its extreme sensitivity 
since, in contrast to other spectrophotometric procedures; no prior light 
interaction is needed.  As a result there is no extraneous light and the 
luminescence generated can be greatly amplified and detected using 
photodiodes or photomultiplier devices.  An interesting example of an 
application of luminometry is the use of the bioluminescence photoprotein 
aequorin (Aequorea victoria jellyfish) to measure very low levels of calcium 
ions (Shimomura et al., 1990).  Non-fluorescent aequorin interacts with Ca
2+
 
ions undergoing a structural change.  This new form is in an excited state 
which then emits a blue light when returning to its ground state. 
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Other methods of enzyme assay:- 
d) Electrometric.  The enzyme catalysed reaction may be associated with 
changes in electrical/ionic variables, e.g. pH, conductivity, redox potential 
etc.  All have been used to monitor enzymatic reactions and to determine 
activity.  A specific example would be the assay of an esterase enzyme 
(Figure 1.7).  In its simplest form the substrate, ethyl acetate, when 
hydrolysed in the presence of acetyl esterase (from wheat germ) produces 
acetic acid and ethanol. 
 
CH3
O
O
CH3
ethyl acetate
+ OH2
OH
O
CH3
acetic acid
+
ethanol
OH
CH3
But
OH
O
CH3
O
-
O
CH3 + H
+
acetateacetic acid
acetyl esterase
 
Figure 1.7:  Assay of an esterase enzyme. 
 
As hydrogen ions are generated in the reaction there is a decrease in pH which can be 
monitored using a pH meter.  A disadvantage of this is the possible variation in 
enzyme activity caused by this change in pH (pH optimum effect).  Therefore, it is 
common practice to use a pH-stat device which ensures the constancy of pH during 
the reaction in absence of buffers by the addition of alkali.  The rate of alkali 
consumption becomes a measure of enzyme activity.  In the example above, ethyl 
acetate is not an ideal substrate due to its volatility.  Consequently, other substrates, 
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such as glyceryl triacetate (triacetin), can be used.  Alternatively, if the esterase has a 
broad enough specificity then ethyl butyrate could be used. For the lipase assay, 
esters of even longer carbon chains, e.g. palmitate are used, but a surfactant is 
required to cause emulsification and hence give a greater surface area.  This type of 
approach is also applicable to urease and other enzyme systems where the pH 
increases due to release of a base, e.g. amino and decarboxylases, but is usually 
reserved for assays where no satisfactory spectrophotometric alternative exists.   
 
e) Conductimetric.  These methods are usually employed in a similar manner to 
electrometric, since released hydrogen and hydroxide ions have a much 
higher ionic mobility than other ions and contribute strongly to the observed 
conductivity and signal generated.  Another case in point is that of polymer 
hydrolysis, e.g. peptidase or nuclease hydrolysis, where the released amino 
acids or nucleotides give a much higher conductimetric signal than the initial 
polymeric substrate (Besson et al., 1994). 
 
f) Redox Potential.  Changes in redox potential are accompanied by a change in 
observed electromagnetic field (EMF) and, while this could be measured, it is 
more common to link the change to a spectrophotometric method using a 
chromogenic redox indicator, such as triphenyl tetrazolium chloride (TTC) or 
another member of the tetrazolium family (Bieniarz et al., 1992). 
 
g) Radiometric.  Although not commonly used nowadays, radiometric methods 
have played a significant part in enzyme assays, as well as in immunological 
assay (RIA), and in the understanding of the mechanisms of enzyme action 
and metabolic sequences (Yalow and Berson, 1995).  In general, the substrate 
is synthesised in a radiolabelled form (
14
C, 
3
H, 
15
N, etc.) and preferably of 
high specific activity.  During the reaction, the substrate is transformed into 
its products, one of which will contain the radioactive label.  In many cases 
this product must then be separated before they can be measured, e.g. by a 
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scintillation counter.  Problems concerning availability of labelled substrates, 
difficultly of synthesis and the need for a separation stage led to alternative 
methods being used where possible. Also, the inherent risks associated with 
the use of radioisotopes compounded this. 
 
h) Calorimetric.  Isothermal titration calorimetry (ITC) is becoming a popular 
method to investigate enzyme kinetics as it can be employed with enzyme 
types that have no traditional direct assays. The thermal energy produced or 
taken up when an enzyme converts substrate to product is proportional to the 
rate of reaction and can be measured using ITC.  Measurements are based on 
the amount of power needed to maintain equal temperatures between two 
cells, reference and sample.  The reference cell can be considered to be a 
‘blank’, as generally it will only contain buffer or reaction medium, while 
enzyme and substrate are injected in known amounts into the sample cell.  If 
the reaction is exothermic the temperature will increase in the sample cell, 
therefore less power will have to be applied to maintain equilibrium.  If, on 
the other hand, the reaction is endothermic, then more power is needed to 
keep the temperature of the two cells balanced (Todd and Gomez, 2001). 
 
 
1.4 Substrates employed in enzymology and enzyme assays 
 
In the determination of enzyme activity, it is better in the great majority of cases to 
measure the rate of formation of product rather than the rate of disappearance of the 
substrate.  There are many reasons for this but mainly, at the early stage of the 
process, the substrate concentration is changing only slightly, whereas that of the 
product goes from zero to progressively higher and higher values, thus permitting 
more sensitive and accurate determination. 
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Several general procedures for determination of enzyme activity may be identified; 
a) Natural substrates 
b) Coenzymes or other cofactors  
c) Coupled systems  
d) Artificial substrates 
 
 
a) Natural substrates 
In many cases, it is fairly obvious what the principle compound (or sometimes the 
only compound) being transformed by a particular enzyme is, e.g. urea and urease 
(Figure 1.8). 
(NH2)2CO + H2O NH2COO .NH4urease
ammonium carbamate
2NH3 + CO2
 
Figure 1.8:  Urease catalyses the hydrolysis of urea (NH2)2CO to NH3 and CO2. 
 
 
Urea is a very simple molecule and few, if any other, molecules are capable of being 
hydrolysed by the enzyme urease.  The term absolute specificity is often used for this 
effect.  Thus, related compounds, such as thiourea, hydrazine and semicarbazide, are 
inert; however, there is evidence that they bind to the active site of the urease 
enzyme and act as competitive inhibitors.  Urea is therefore used as the substrate for 
urease assay, utilising the change in pH or conductivity or alternatively determining 
the amount of ammonia formed colorimetrically, e.g. by reaction with phenol 
hypochlorite or diacetyl monoxime. Other examples of situations where the natural 
substrate is preferred or necessary include:- 
Creatine phosphokinase (CPK) – the natural substrate of which is creatine phosphate. 
Aminotransferases – although many such enzymes exist, two are of prime 
importance in the area of clinical chemistry:   
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Aspartate aminotransferase (AST), synonym glutamic oxalacetic transaminase 
(GOT), and alanine aminotransferase (ALT), synonym glutamic pyruvic 
transaminase (GPT).  Both enzymes individually catalyse the transfer of the amino 
group from L-aspartate and L-alanine respectively to the acceptor keto acid α-
ketoglutarate (Figure 1.9). 
 
L-aspartate
O
-
O
O
O
-
O
-ketoglutarate oxaloacetate
NH3
+
O
-
O
-
O
O
L-glutamate
O
-
O
-
O
O
NH3
+ + +
aspartate 
aminotransferase
O
-
O
-
O
O
O
 
Figure 1.9:  Action of aspartate aminotransferase. 
 
In both reactions there is an absolute requirement for α-ketoglutarate (1.5) and for 
either of the two amino acids individually. In the equilibrium, there are two amino 
acids and two -α-keto acids, so that following the progress of reaction is not straight 
forward.  In practice, advantage may be taken of the technique of enzyme coupling, 
where a second enzyme specific to one of the products is added.  This is usually an 
NAD
+
 or NADP
+
 dependent dehydrogenase.  Enzyme coupled reactions are dealt 
with later in this section.   
 
b) Coenzymes/cofactors 
By far the most widely used coenzymes for determination of enzyme activity are 
NADH and the related NADPH.  These are the reduced forms of the nicotinamide 
nucleotides NAD
+
 and NADP
+
.  Together with the reduced forms, they constitute 
redox pairs and are obligatory participants in many dehydrogenase reactions.  They 
include:-  
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i. Alcohol dehydrogenase 
ii. Lactate dehydrogenase 
iii. Pyruvate dehydrogenase 
iv. Malate dehydrogenase 
v. Isocitrate dehydrogenase 
vi. α-Ketoglutarate dehydrogenase 
Many of these reactions are central to the metabolism of the cell.  Others are more 
central to amino acid metabolism and include:- 
vii. Glutamate dehydrogenase 
viii. Glutathione reductase 
 
For example, alcohol dehydrogenase enzyme (ADH) catalyses the reversible 
oxidoreduction of ethanol and certain other alcohols/hydroxyl compounds to the 
corresponding aldehydes (Figure 1.10). 
ethanol + NAD
+
 ethanal + NADH + H
+
CH3CH2OH + NAD
+
CH3CHO + NADH + H
+
i.e. ADH
 
Figure 1.10:  The reversible oxidoreduction of ethanol. 
 
There are at least two possibilities for monitoring this reaction.  One is to determine 
the ethanal (acetaldehyde) formed by a specific chemical reaction e.g. with 2,4-
dinitrophenylydrazine (DNPH);  however this would require addition of an auxiliary 
reagent post-incubation, i.e. a fixed time assay. 
Alternatively, the rate of formation of NADH may be monitored kinetically due to its 
spectroscopic characteristics, which are different to the oxidised forms.  Only the 
reduced forms, e.g. NADH, exhibit emitted fluorescence at λF = 450 nm, when 
excited at λx = 340 nm.   
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It follows that dehydrognase reactions involving the formation of NADH or NADPH 
can be followed kinetically either by absorption at 340 nm or by the appearance of 
fluorescence at λF max. 
Since most dehydrogenase reactions are reversible, it is often possible to measure the 
decrease in A340 and use this as a measure of the consumption of NADH.  In certain 
cases, the position of equilibrium can be adjusted in order to ‘drive’ the reaction in 
one direction.  This may involve the addition of a carbonyl trapping reagent such as 
semicarbazide or adjustment of the buffer pH, since hydrogen ions are involved in 
the reaction (Figure 1.11) 
 
NADH + H
+
 + XXH2 + NAD
+
 
 
Figure 1.11:  Equilibrium of NAD/NADH. 
 
While the U.V. absorbing and fluorescing properties of NADH/NADPH are very 
useful in measuring enzyme activity, it is often desirable to have a coloured product 
produced and measured by the dehydrogenase system.  This can be illustrated by the 
use of tetrazolium salts, which may be regarded as dye precursors since they are 
readily reduced to highly coloured derivatives called formazans.  Many tetrazolium 
salts have been synthesised and are commercially available (Altman, 1976).  The 
general formula for the simpler salts is shown in Figure 1.12 
 
R
RR
NN
N
+
N  
Fig 1.12  General formula for a tetrazolium salt. 
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The simplest example still used in diagnostic microbiology to detect growth of living 
cells is the reduction of 2,3,5-triphenyltetrazolium chloride.  This is somewhat 
inhibitory to many enzymes, so that others, e.g. iodonitrotetrazolium chloride (INT) 
(Figure 1.13) or neotetrazolium chloride, are more widely used in a ‘linked’ assay 
(Gong, 1996). 
 
I
NN
N
+
N
N
+
O
-
O
Cl
-
 
 
Figure 1.13:  Iodonitrotetrazolium chloride (INT). 
 
The reduction of such a tetrazolium salt by NADH can be represented as shown in 
Figure 1.14. 
 
R
RR
NN
N
+
N
H
H
R
R
R
NN
N
N
+
H
+
 + NADH NAD
+
Tetrazolium salt Formazan
 
Figure 1.14:  Reduction of a tetrazolium salt by NADH. 
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Tetrazolium salts have a number of advantages, including a very substantial increase 
in colour and at longer λ on reduction. 
Monotetrazolium compounds become deep red while ditetrazolium salts become 
deep purple or blue.  The reduction is irreversible and the products are non-
autoxisable unlike, for example, methylene blue.  Additionally, the molar 
absorptivities of tetrazolium products (formazans) are about 3 or 4 times higher than 
that of NADH and at longer and, therefore more accessible wavelengths.  This 
commonly lowers the detection limits for dehydrogenase enzyme by several fold and 
makes the system more applicable to the automated methodologies, e.g. centrifugal 
analysers. 
 
c) Coupled systems 
The coupling of NADH or NADPH production to the reduction of a tetrazolium salt 
to produce a coloured formazan is one example of a coupled system.  However, it is 
also possible to employ a second enzyme to cause one of the products to be further 
transformed.  If the second reaction is catalysed by an NAD dependent 
dehydrogenase, then the NADH formed will be related to the overall enzymatic 
activity.  Provided that the second enzyme is in considerable excess over the initial 
enzyme to be measured, then this former enzymatic activity will be rate limiting.  A 
good example of the use of a dehydrogenase as the second enzyme is in the assay of 
the clinically important enzyme alanine aminotransferase (ALT) shown in Figure 
1.15.  In this reaction, the product, pyruvate, can be used to form NAD
+ 
via NADH 
using lactate dehydrogenase (LDH). 
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Figure 1.15:  Transanimation of L-alanine coupled to an LDH reaction. 
 
The decrease in absorbance at 340 nm, as NADH is oxidised, reflects the amount of 
pyruvate available to the enzyme lactate dehydrogenase (LDH), which in turn 
depends on the activity of the ALT in the original reaction.  In practice, the 
experimental reagent contains α-ketoglutaric acid, L-alanine, NADH and LDH so that 
the first and second reactions can proceed.  Sometimes, the enzymatic coupling can 
be more complex, e.g. in the assay of creatine kinase (CK) there are two sequentially 
linked derivatising reactions (Figure 1.16). 
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creatine phosphate creatine
CK
glucoseglucose-6-phosphate
HK
glucose-6-phosphate 6-phosphogluconate 
G6PD
ADP ATP
NADP
+  NADPH
 
CK = creatine kinase 
HK = hexokinase 
G6PD = glucose-6-phosphate dehydrogenase 
Figure 1.16:  Creatine kinase assay. 
 
In this case there will be an increase in absorbance at 340 nm, reflecting the activity 
of CK, provided that this is rate limiting.  For this reason, it is general practice to 
make the activity of the derivatising enzymes ten times the activity of the first 
enzyme.  It is also possible to link the production of NADPH to the reduction of a 
tetrazolium salt, as previously discussed.   
 
d) Artificial substrates 
Perhaps the greatest advance in diagnostic enzymology over the last 50 years has 
been the synthesis of derivatives of biomolecules, e.g. sugars, fatty acids, amino 
acids, peptides, to give substrates which are transformable, usually by hydrolysis, to 
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release highly coloured or fluorescent molecules.  The terms chromogenic and 
fluorogenic substrate, repectively, are used to describe these.  Even where natural 
substrates are available, it is often preferable to use a synthetic analogue, provided 
that the enzyme in question exhibits group specificity.  This term is used to denote 
enzymes which will accept a range of related compounds.  The feature is commonly 
shown by hydrolases (where H2O is the hydrolytic agent and is always present in 
excess), a very large group of enzymes which include glycosidases, lipases, 
peptidases, nucleases and phosphatises, etc. (James, 1993).  It is often found that a 
very considerable increase in sensitivity can be achieved by the use of synthetic 
analogues.  This may be in part due to better kinetic parameters, i.e. lower KM 
(affinity of enzyme and substrate) caused by a greater affinity of the substrate for the 
active site of the enzyme and higher Vmax (a measure of the limiting rate of 
transformation of the substrate).  These two catalytic constants are often expressed 
together as the kcat/KM ratio (kcat being the rate constant related to Vmax).  Equally 
important for sensitivity is the mode of measurement of the product from a synthetic 
substrate.  If the product molecule from a synthetic substrate is highly coloured, e.g. 
resorufin, or fluorescent, e.g. 4-methylumbelliferone (4-MU), then the 
spectrophotometric method used to measure product formation can greatly increase 
sensitivity and hence lower detection limits, e.g. acid phosphatase. This enzyme 
occurs in human semen, being derived from the prostate gland.  It also has wider 
distribution in animal prostate tissue.  Determination of acid phosphatase activity is 
important in the diagnosis of metastatic spread of prostate cancer, particularly to 
bony tissue.  In general, acid phosphatase may be determined using a variety of 
‘natural’ substrates, e.g. glycerol phosphate or glucose-6-phosphate, by measurement 
of the release of inorganic phosphate, such as the method of (Fiske and Subbarow, 
1925), or it can be measured by the formation of glycerol or glucose by colorimetric 
methods.  However, these methods are relatively insensitive and do not lend 
themselves to a kinetic assay.  One exception would be the coupling of glucose 
oxidation by adding glucose oxidase to generate hydrogen peroxide.  H2O2 in the 
presence of peroxidase can then oxidise a pro-chromogen such as o-dianisidine or 
diaminobenzidine to yield a coloured product end point. 
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In place of such natural substrates, it is possible to use a variety of synthetic 
(artificial) substrates, since the phosphatase exhibits group specificity.  Examples 
include:- 
i. Phenolphthalein diphosphate 
ii. Thymolphthalein phosphate 
iii. Fluorescein diphosphate 
iv. p-nitrophenol phosphate 
v. Indoxyl phosphate 
vi. X-phosphate 
vii. 4-Methylumbelliferyl phosphate 
 
The high molar absorptivities of the released chromogens give a sensitive assay.  
Similarly with β-galactosidase, the natural substrate for which is lactose, the 
synthetic substrate o-nitrophenyl-β-D-galactoside (ONPG) was shown to be thirty 
times more effective as a substrate.  Additionally the o-nitrophenol produced is 
readily detected and measured by the yellow colour (λmax = 410 nm) (Lederberg, 
1950).  
The vast majority of these artificial substrates are synthetic, made explicitly for the 
detection of enzymes in specific circumstances and therefore warrant a more indepth 
section in this introduction. 
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1.5 Synthetic substrates 
 
A wide variety of synthetic substrates targeting a similarly wide range of enzymatic 
activities are currently available.  Many of these are used routinely in hospital 
laboratories, food technology and in research.  Most of these generate either a strong 
colour or fluorescence when hydrolysed or otherwise transformed.  A few produce 
bio or chemiluminescence.  The various groups may be categorised for convenience 
as follows. 
 Nitrophenols 
 Indoxyls 
 Naphthols 
 p-Nitranilides 
 Methylumbelliferones 
 7-Amino-4-methylcoumarins 
 Phthaleins 
 Phenoxazines 
 Fluorones 
In addition, there are many recently developed substrates outside of the above list. 
 
1.5.1 Nitrophenols 
 
 
One of the earliest synthetic enzyme substrates to be developed was o-nitrophenyl-β-
D-galactoside (ONPG) (Seiderman and Link, 1950) shown below in Figure 1.17. 
 
O
N
+
O
-
O
OH
OH
OHOH
O
 
Figure 1.17:  Structure of nitrophenyl-β-D-galactoside. 
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It was shown to be a good substrate for β-galactosidase having good characteristics 
and yielding a strong yellow colouration at pH 7.5 (Lederberg, 1950).  
The reason for the rapid transformation/hydrolysis of ONPG is due largely to the 
ability of nitrophenol to act as a good leaving group.  The phenoxide ion produced is 
stabilised by resonance and consequently of lower energy than the nitrophenolic 
substrate (Figure 1.18).  Since systems tend to a state of minimum energy, the rate of 
cleavage of the glycosidic bond is enhanced. 
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Figure 1.18:  The two resonance structures of nitrophenol. 
 
ONPG has been used in the detection and enumeration of coliforms in water by a 
membrane filtration technique (Apte et al., 1995) and also in a medium for screening 
for Salmonella spp. (Berlutti et al., 1986).  
o-Nitrophenyl-β-D-glucoside was similarly developed as a substrate for β-
glucosidase  (Jermyn, 1955) and has been used as a reagent in the investigation of 
immunologically based separations in capillary electrophoresis (Ljungberg et al., 
1998).  The corresponding p-isomer has been employed in plant biotechnology 
(Marcinowski and Grisebach, 1978) and in the identification of members of the 
genus Bacillus (Mizuno et al., 1998). 
The enzyme β-glucuronidase occurs in the great majority of naturally occuring E. 
coli, but excluding the enteropathogenic 0157 strain.  Other coliforms, in the main, 
do not produce β-glucuronidase and thus differentiation is achievable (Kilian and 
Bulow, 1976).   
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A very important substrate in this group was developed and used to identify and 
demonstrate E. coli.: p-nitrophenyl-β-D-glucuronide (Kilian and Bulow, 1979) 
(Figure 1.19). 
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Figure 1.19:  p-Nitrophenyl-β-D-glucuronide. 
 
The above substrates are all hydrolysed by the relevant β-glycosidase enzyme.  
Nitrophenolic substrates targeting α-glycosidase are also commercially available, 
including p-nitrophenyl-α-D-glucoside, which has been used clinically in a urine 
screening test for Pompes disease (Schram et al., 1979).  Pompes disease is a 
metabolic disorder caused by a lack of α-glycosidase, which is required to metabolise 
glycogen.  An excessive amount of glycogen in the body results in myopathy, 
particularly of the heart. 
The use of nitrophenolic substrates is not limited to the glycosidases.  Phosphatase 
and lipase substrates have also been developed.  An example of the former, p-
nitrophenyl phosphate (Figure 1.20), has been used extensively to assay both acid 
and alkaline phosphatase in human serum (Lowry, 1957; Bretaudiere et al., 1977).  
This substrate has also been involved in studies to identify rapidly E. coli (Husson et 
al., 1989) and makes up part of the BD (Becton, Dickinson and Company) ‘BBL 
Crystal
TM
 Enteric/Non-fermentor Identification System, a micro-method test kit for 
the identification of aerobic Gram-negative bacteria that belong to the 
Enterobacteriaceae family, as well as some of the more commonly isolated 
fermenting and non-fermenting Gram-negative bacilli.   
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p-Nitrophenyl acetate has been used to determine lipase activity in milk (Wang, 
1981).  
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Figure 1.20:  p-Nitrophenyl phosphate (K+ salt). 
 
 
 
1.5.2 Indoxyls 
 
Indoxyl substrates are probably the most widely used chromogenic substrates, 
particularly in microbiological culture media.  When they were first introduced, it 
was not into microbiology, but into histochemistry for histochemical applications in 
the 1950’s (Pearson, 1957). 
Their great value is that they can produce insoluble deposits, which are highly 
coloured, and therefore specifically located at the site of the enzyme action.  When 
an indoxylic substrate is cleaved by enzyme action, it produces free indoxyl, i.e. 3-
hydroxyindole (Figure 1.21).   
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N
H  
Figure 1.21:  3-Hydroxyindole. 
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Under oxidative conditions, two molecules of indoxyl dimerise to form a molecule of 
a highly coloured indigo dye (Figure 1.22).  This has considerable application in 
diagnostic microbiology because the indigo dye is capable of binding strongly to the 
bacterial colonies.  This means that the colour is generated in a highly localised 
manner on those colonies which contain the enzyme responsible for the cleavage of 
the substrate.  Thus, it allows a very clear differentiation of the organisms that are to 
be targeted within a mixed culture. The other advantage of indoxylic substrates is 
that they exhibit a very low toxicity towards most microorganisms 
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Figure 1.22:  Indigo dye. 
 
The molecule indoxyl does not occur itself as free indoxyl, but is very widely 
distributed as the β-glucoside in a variety of plants.  It was commonly referred to as 
plant indican (Figure 1.23) and was the source of indigo for centuries for the process 
of indigo dyeing.  The plant was macerated to release the β-glucosidase enzyme, 
which then cleaved the β-glucoside to give free indoxyl.  The cloth was then 
impregnated with this to give a deposit of indigo by atmospheric oxidation. 
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Figure 1.23:  Plant indican. 
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Whilst substrates based on indoxyl itself have been very useful in the past to identify 
β-glucosidase or bacteria that produce this enzyme, e.g. E. coli (Ley et al., 1988; 
Delisle and Ley, 1989), they do not give very bright colours; they tend to give rather 
grey-blue shades.  However, it is possible, by halogenation of the core indole nucleus 
at specific positions in the benzenoid ring to give much brighter colours and also to 
increase the intensity of colouration.  The halogens involved may be any of the four 
normal ones – fluorine, chlorine, bromine or, more recently, iodine, and more than 
one position may be halogenated.  This usually does not affect the specificity of the 
substrate, but does alter the sensitivity and the ease of reading, which is important 
when one is dealing with, for example, a bacterial plate.   
The introduction of a bromine atom at position 5 of the indole nucleus produces 5-
bromoindole and substrates have been developed based on this. First synthesised for 
histochemical localization of glycosidases (Anderson and Leaback, 1961), then 
employed in bacterial identification, examples of these include Blue glucoside (5-
bromo-3-indolyl-β-D-glucoside) so named because of the intense dark blue colour 
that is generated by positive bacterial colonies which possess β-glucosidase.   
Additionally, 5-bromo-3-indolyl-β-D-galactoside, otherwise known as Blue gal, has 
been used as a histochemical substrate for the lac Z  gene (Weis et al., 1991), shown 
in Figure 1.24. 
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Figure 1.24:  Histochemical use of Blue gal.  Intercostal muscle of mouse stained with Blue gal (Weis 
et al., 1991). 
 
 
Blue nonanoate (5-bromo-3-indolyl nonanoate) is an esterase substrate (Figure 1.25) 
and has been used in investigations of Salmonella esterase and in the visualisation of 
Salmonella colonies (Agban et al., 1990; Orenga, 2009). 
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Figure 1.25:  Structure of blue nonanoate. 
 
Introduction of a chlorine atom at position 6 of the indole nucleus produces 6-
chloroindoxyl and this is the basis of many substrates of the Rose/Salmon series, so 
called because the red-pink colour of the colonies is very evident.  The same is true 
of its applications in histochemistry.  Thus, for example, Salmon glucopyranoside (6-
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chloro-3-indolyl-β-D-glucopyranoside) has been synthesised and its use was reported 
in the year 2000 (de Siloniz et al., 2000) (Figures 1.26 and 1.27).  
 
Cl
O
OH
OH
OH
OH
O
N
H  
Figure 1.26:  Structure of 6-chloro-3-indolyl-β-D-glucopyranoside. 
 
 
 
Figure 1.27:  6-chloro-3-indolyl-β-D-glucopyranoside hydrolysed by Yersina pseudotuberculosis. 
Picture courtesy of Glycosynth. 
 
Rose acetylglucosaminide (6-chloro-3-indolyl-n-acetyl-β-D-glucosaminide) is a 
substrate for β-N-acetylglucosaminidase and has been reported to have value in the 
differentiation of the Candida spp. (Gilbert, 2002). 
A combination of halogen atoms with 5-bromo and 6-chloro substituents in the 
indole nucleus produces 5-bromo-6-chloroindoxyl and this forms a magenta 
precipitate when released from appropriate substrates.  Consequently, the substrates 
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are usually referred to as Magenta substrates.  An example is 5-bromo-6-chloro-3-
indolyl-β-D-galactopyranoside and this has been used as a substrate for gene 
expression studies (Mohler and Blau, 1996). 
Magenta-caprylate is used to visualise Salmonella spp. (Cassar and Cuschieri, 2003) 
(Figure 1.28). 
 
 
Figure 1.28   Magenta-caprylate hydrolysed by Salmonella spp. results in magenta coloured colonies. 
Picture courtesy of Carlroth Ltd. 
 
 
  
 
The corresponding N-acetyl-β-D-glucosaminide (5-bromo-6-chloro-3-indoxyl N-
acetyl-beta-D-glucosaminide) has been used as a histochemical substrate for 
demonstration of N-acetyl-β-D-glucosaminidase (hexosaminidase) and this produces 
a magenta precipitate localised at the site of the hexosaminidase (Wolf et al., 1965).   
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The corresponding β-D-glucopyranoside (5-bromo-6-chloro-3-indolyl-β-D-
glucopyranoside) (Figure 1.29), has shown value in the detection and differentiation 
of Vibrio spp. (Rambach, 2007). 
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Figure 1.29:  Structure of 5-bromo-6-chloro-3-indolyl-β-D-glucopyranoside. 
 
Even more widely used indoxylic substrates have the bromine atom substituted at 
position 5 and chlorine at position 4.  The change in colouration becomes quite 
striking.  The 5-bromo-4-chloroindoxyl when released produces blue colouration on 
appropriate colonies or in histochemical applications.  It is commonly referred to as 
X and the best known derivative of this is certainly X-gal (Figure 1.30). 
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Figure 1.30:  Structure of 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside. 
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X-gal or 5-bromo-4-chloro-3-indolyl-β-D-galactoside is a chromogenic substrate and 
is used to distinguish recombinant tranformants (white) from non-recombinant 
transformants (blue) when using plasmids carrying the lac Z 
 
gene associated with β-
galactosidase production (Blue/white screening) in molecular biology (Figure 1.31).  
 
 
Figure 1.31:  Blue/white screening.  E. coli on LB agar containing X-gal. 
 
It has also been used as a substrate for the detection of coliforms in water (Ley et al., 
1993), urine (Kodaka et al., 1995) and food (Manafi and Rotter, 1991).   
The corresponding glucoside (X-gluc) has been used in an assay for the identification 
of enterococci, which are β-glucosidase positive (Manafi and Sommer, 1993; Manafi, 
1997). 
X-glucuronide has been used in a medium for direct plating of E. coli (Frampton et 
al., 1988; Ogden and Watt, 1991) then for membrane filtration for the enumeration of 
E. coli and coliforms from drinking water (Sartory and Howard, 1992).  In this case, 
the X-glucuronide only picks out the E. coli, where as a second substrate is necessary 
to evaluate the coliforms (Figure 1.32). 
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Figure 1.32:  Trypsin Bile agar containing X-gluc (TBX agar).  E. coli are coloured blue/green by 
reaction of β-D-glucuronidase.  Other Enterobacteriaceae (e.g., Salmonella, Streptococcus, 
Klebsiella) are clear or inhibited.  Picture courtesy of Carlroth Ltd. 
 
In the detection and demonstration of salmonella X-α-gal has proved to be very 
useful, producing green or green-blue colonies with this substrate (Perry et al., 1999). 
One important feature of indoxylic substrates is that it is possible to combine more 
than one with a different enzymatic specificity targeted and thereby demonstrate at 
least two different bacterial species on the same plate provided that the contrast 
between the two colours is great enough, for example the Alpha-beta chromogenic 
medium (ABC medium) (Perry et al., 1999).  ABC medium contains X-α-gal as 
described above and also 3,4-cyclohexenoesculetin-β-D-galactoside (CHE-gal).  
CHE-gal produces brown/black colonies from non-Salmonella Enterobacteriaceae 
(Figure 1.33). 
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Figure 1.33:  Alpha-beta chromogenic medium.  Typical colonies produced by S. typhi on ABC 
medium (left) and a wild strain of S. napoli isolated in mixed culture from a stool sample (right) 
(Perry et al., 1999). 
 
Alternatively, it is possible to use an esterase substrate based on X-nonanoate or X-
octanoate for the detection of this particular class of bacterium.   
Further modifications of the indoxyl molecule are possible to create further 
variations in colour of the colonies produced.  Thus, for example, substitution of a 
fluorine atom into position 6 will give the 6-fluoroindolyl derivative which produces 
bright red colonies.  Glycosides of this core molecule include, for example, Rouge-
gal.  Substitution of iodine into position 5 produces the corresponding iodo 
compound.  Colonies exhibited here are violet. 
An important modification is to methylate the nitrogen atom of the indole ring to 
produce N-methyl compounds such as 1-methyl-3-indolyl-β-D-galactoside (green-β-
D-gal, so called because it produces green colonies).  These galactoside substrates of 
fluoro, iodo and methyl indoxyls have demonstrated applications in the screening of 
recombinant transformants as they produce brightly coloured, vivid and, therefore 
easily identifiable colonies (Sambrook, 1989). 
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1.5.3 Naphthols 
 
These are mainly derived from the two isomers, 1-naphthol and 2-naphthol, or 
derivatives of these, particularly 6-bromo-2-naphthol.  It is well known that 1- and 2-
naphthols are capable of generating highly coloured dyes by linkage to diazonium 
salts.  This, of course, produces azo dyes.  Consequently, a variety of substrates 
based particularly on 2-naphthol, have been developed.  Furthermore, derivatives of  
2-naphthol with a substituent in the 3 position have been prepared many years ago, 
particularly by German chemists for use in the dye industry, and are named 
according to the German language as, e.g. naphthol AS-BI and naphthol AS-D 
(Figure 1.34).  The purpose of these was to extend the conjugation and give brighter 
colours with higher molar extinction coefficients. 
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Figure 1.34:  Structures of naphthol AS-BI (left) and naphthol AS-D (right). 
 
The simpler substrates are usually based either on 2-naphthol or 6-bromo-2-naphthol.  
More complex substrates which have a greater degree of application, particularly in 
histochemistry, are derived from naphthol AS-BI and AS-D.  For example, naphthyl 
AS-BI-β-D-glucuronide has been used as a biochemical and histochemical substrate 
for the determination of β-D-glucuronidase.  The coupling reagent employed is a 
stabilised diazonium salt such as hexazonium pararosanilin, which gives a precipitate 
at the site of the glucuronidase within the cell (Fishman, 1964; Hayashi et al., 1964). 
Likewise, naphthyl AS-D-chloroacetate is a substrate for esterase activity and has 
been used in a similar manner to the glucuronide for localisation studies.  In 
particular, myeloid cancer cells of leukaemia have shown a high level of esterase 
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activity which can be demonstrated histochemically (Figure 1.35) (Moloney et al., 
1960; Leder, 1970). 
 
 
Figure 1.35:  Esterase activity for naphthol AS-D chloroacetate substrate.  Shown in the bone marrow 
smear of a patient with pernicious anemia.  The mature and immature neutrophilic leukocytes 
demonstrate a strongly positive cytoplasmic red staining in contrast to the completely negative 
megoblasts (Moloney et al., 1960). 
 
2-Naphthyl-α-D-glucopyranoside is interesting in the sense that it has been used as a 
substrate for glycogen synthetase (Meezan et al., 1997).  It is usually rather difficult 
to use such substrates for biosynthetic enzymes, but the nature of the glycogen 
synthetic scheme is that glucose units are added via progressive α-glycosidic links 
onto the growing chain and, as this happens, the molecule of naphthol is released 
which can be visualised by the addition of a stabilised diazonium salt, as has been 
indicated. 
Substrates based on 1-naphthol are less common but have received a degree of 
interest within the last 10 years due to the development of the twin substrate protocol 
(Pemberton et al., 1999; Burestedt et al., 2000). 
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In this, a substrate such as 1-naphthol-β-D-galactoside is incorporated simultaneously 
into a growing medium with a peptidase substrate based on an aromatic amine such 
as dimethyl-p-phenylene diamine (DMpPD) or 2,6-dichloro-4-aminophenol (DCAP).  
The simultaneous release of these core molecules from the peptidase and glycosidase 
substrates involved leads to a coupling in the presence of the enzyme cytochrome 
oxidase, which is present in the majority of Enterobacteriaceae to some degree 
(Figure 1.36).  This produces a blue colouration thereby increasing the selectivity of 
the system, since two enzymatic activities are necessary to generate the colour.  This 
system is used by bioMerieux to a substantial degree in the automated identification 
protocol inherent in the Vitek cards (Bascomb and Manafi, 1998). 
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Figure 1.36:  Indophenol blue formed by coupling 1-naphthol and DMpPD. 
 
 
1.5.4 p-Nitroanilides 
 
 The molecule of p-nitroaniline or 4-nitroaniline may be regarded as an analogue of p-
nitrophenol.  This has already been discussed as a core molecule for the creation of 
substrates for glycosidases, phosphatases, lipases, etc.  The molecule of 4-
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nitroaniline has an amino group conjugated through to a nitro group at the other end 
of the molecule (Figure 1.37).  Consequently, the amino group can be substituted by 
peptide groupings to give substrates for peptidases of various types.   
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Figure 1.37:  Structure of 4-nitroaniline. 
 
For example, L-alanyl-p-nitroanilide (Figure 1.38) is a substrate for alanine 
aminopeptidase, which is widely distributed in Gram-negative bacteria, but not so in 
those that are Gram-variable or Gram-positive bacteria.  When the peptide bond is 
hydrolysed, the products are obviously alanine and 4-nitroaniline.  The 4-nitroaniline 
is recognised by the intense yellow colour which it exhibits at 405-410 nm (Redondo 
et al., 1986).   
 
O NH2
CH3NHN
+
O
-
O  
Figure 1.38:  Structure of L-alanyl-p-nitroanilide. 
 
Substrates, such as alanyl-p-nitroanilide, are good substrates, in the sense of having 
good kinetic constants.  The kcat/KM ratio is high, in fact considerably higher than 
many other aminopeptidase core molecules, such as, 7AMC.   
Whilst the yellow colour of p-nitroaniline is quite strong, there is often a problem in 
biological systems where there is a yellow background colour anyway.  This makes it 
quite difficult to differentiate the yellow colour due to p-nitroaniline from the 
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background.  In these cases, it is possible to add a second reagent to couple with the 
p-nitroaniline released.   
Two possibilities exist.  Firstly, the p-nitroaniline may be coupled with a stable 
diazonium salt, such as Fast Blue RR salt or some analogue.  Alternatively, the 
reagent p-dimethylaminocinnamaldehyde has been used.  This usually gives a much 
stronger colour in the red-purple region with a much higher molar absorptivity.  
However, in all these cases, the released p-nitroaniline tends to diffuse away from the 
site of production and hence these substrates are not ideally suitable for bacterial 
identification or for histochemical applications.  They are more suited to detection of 
the enzyme in liquid culture. 
A typical example of the use of such substrates in the biological sciences is the 
detection of γ-glutamyl transpeptidase or γ-glutamyl transferase (γ-GT), which is an 
important enzyme in the detection of liver disease.  Since the levels of γ-GT vary 
over a very wide range depending on the severity of the condition, various substrates 
have been used to detect this enzyme in blood.  Certainly, γ-glutamyl nitroanilide is 
one such substrate (Figure 1.39) and γ-glutamyl AMC has also been used to measure 
levels in human serum (Prusak et al., 1980).  It is necessary in this reaction to have 
an acceptor peptide to ensure that the enzyme being detected is the transferase and 
not merely a hydrolase.  For this purpose, glycylglycine is usually used as the 
acceptor. 
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Figure 1.39: L-γ-glutamyl nitroanilide.  
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 Another example of the application of peptidase substrates based on p-nitroaniline is 
the use of pyroglutamyl-p-nitroanilide for the detection of Group A Streptococci and 
also enterococci and their differentiation from other Streptococci (Manafi et al., 
1991) .  In this case, it is necessary to detect the p-nitroaniline released using 
reagents such as dimethylaminocinnamaldehyde (Doronin et al., 2004).  
 
 
1.5.5 Methylumbelliferones 
 
4-Methylumbelliferone (4-MU), (Figure 1.40) is a trivial name for 7-hydroxy-4-
methylcoumarin.  The possession of the coumarin ring, with suitable substitution of 
hydroxyl or amino groups confers highly fluorescent properties upon the molecule 
and this is exploited of in the creation of enzymatic substrates. 
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Figure 1.40:  Structure of 4-methylumbelliferone. 
 
When the hydroxyl group at position 7 is free, e.g. in the molecule of 
methylumbelliferone, there is a strong fluorescence due to electron release from the 
hydroxyl group conjugated through to the carbonyl group in position 2 over a planar 
structure.  There is a very high degree of fluorescence with excitation at 360 nm and 
fluorescence at approximately 440 nm giving a bright sky-blue fluorescence which is 
easily detectable and measurable.  This fluorescence is, however, pH dependent 
reaching a maximum at pH ~ 9-10, although a strong fluorescent is still exhibited at 
pH ~ 7-8 (Figure 1.41). 
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Figure 1.41:  Fluorescence of 4-methylumbelliferone. 
 
Many examples of methylumbelliferone substrates exist.  For example, the β-D-
galactoside, 4MU-β-D-gal has been used for fluorimetric assay of lectin binding to 
yeast cells (Oda et al., 1997) and for the detection of faecal coliforms (Berg and 
Fiksdal, 1988).  Similarly, the α-D-galactoside has been used in a medium for 
detecting faecal Streptococci (Littel and Hartman, 1983).  The α-D-glucoside has had 
histochemical applications (Gossrau, 1977) and also in clinical chemistry in the 
detection of Pompe’s disease (Fensom et al., 1976). 
The N-acetyl-β-D-glucosaminide (Figure 1.42) is a fluorogenic substrate for the 
enzyme N-acetyl-β-glucosaminidase and this substrate has been used to assess the 
presence of fungi in soil (Miller et al., 1998) and also to measure the biomass of 
heterotrophic nanoplankton (Zubkov and Sleigh, 1998). 
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Figure 1.42:  Structure of N-acetyl-β-D-glucosaminide. 
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More complex substrates based on 4MU are known and quite widely available.  For 
example, the α-L-fucoside has been used for the identification of slow growing 
mycobacteria (Grange and Mcintyre, 1979). 
4MU phosphate has been used in many applications.  Particularly important was the 
differentiation of mycobacterial strains by Grange (Grange, 1978).  In fact, very 
many of the 4MU substrates have found application in the differentiation of groups 
of microorganisms and have been of great value in the taxonomic evaluation of these 
groups (Goodfellow et al., 1990). 
 
1.5.6 7-Amino-4-methylcoumarins 
 
Like the 4MU substrates, those based on 7-amino-4-methylcoumarins (7AMC) 
contain the coumarin nucleus and in fact 7AMC may be regarded as the amino 
analogue of 4MU (Figure 1.43).  Due to the possession of the amino group it may 
give rise to substrates for a wide variety of peptidases, in particular aminopeptidases. 
 
NH2
CH3
OO  
Figure 1.43:  Structure of 7AMC 
 
When hydrolysed, the 7AMC released gives a strong blue fluorescence similar to that 
of 4MU.  Unlike 4MU, however, the fluorescence of the released 7AMC is not pH 
dependent, since the amino group is only ionised at very low pH outside of the 
physiological range.  The fluorescence is strong and the substrate may be converted 
into a chromogenic form by addition of a reagent such as p-
dimethylaminocinnamaldehyde to detect the released amine (Figure 1.44).  This 
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gives a strong blue-violet colour and this has been applied to identify certain 
peptidases (Clark and McLauchlin, 1997). 
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Figure 1.44:  7AMC p-dimethylaminocinnamaldehyde. 
 
Both 7AMC and 4MU based substrates are well designed for use in microtitre wells.  
The use of these substrates is applicable to the scanning of a wide range of organisms 
as is necessary in taxonomic evaluations (Goodfellow, 1991 ). 
Specific examples of the use of 7AMC based substrates include that of L-alanyl 7-
amido-4-methylcoumarin (AAMC) (Figure 1.45), which is a fluorogenic substrate 
for aminopeptidase M, i.e. microsomal alanyl aminopeptidase.  It is shown to be the 
major aminopeptidase from human skeletal muscle showing the highest activity with 
this substrate (Mantle et al., 1983).  
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Figure 1.45:  Structure of L-alanyl 7-amido-4-methylcoumarin. 
 
AAMC has proved to be a reliable method to differentiate between Gram-positive 
and Gram-negative bacteria (Manafi and Kneifel, 1990).  Only Gram-negative 
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bacteria have the necessary enzyme to cleave this substrate and therefore produce 
fluorescence. 
More complex substrates based on AMC include 
t
BOC-val-pro-arg-7-AMC, which is 
an effective substrate for thrombin, and this has been used haematologically in the 
evaluation of certain coagulation abnormalities (Enyedy and Kovach, 2004).  
 
 
1.5.7 Phthaleins 
 
Phthaleins are used as pH indicators, especially in titrations, as they can give 
dramatic colour changes.  Phenolphthalein is colourless in acid or neutral conditions 
below pH 8.2 and bright pink to purple in basic conditions (Figure 1.46). 
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Figure 1.46:  Phenolphthalein pH effect. 
 
Phenolphthalein is used in the Kastle-Meyer forensic presumptive blood test.  The 
test involves reducing phenolphthalein, by boiling in zinc powder, to phenolphthalin. 
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This colourless form is oxidised by the peroxidase-like activity of haemoglobin 
reacting with hydrogen peroxide to the pink form (Tobe et al., 2007).   
Phenolphthalein is a core molecule for substrates such as β-D-glucuronide (Marsh 
and Reid, 1965; Tsukada and Yoshino, 1987) and phosphates (Babson et al., 1966).  
In humans, raised levels of β-gluronidase has clinical significance as an indicator of 
such diseases as diabetes and pancreatic cancer (Schrecker and Chirigos, 1978).  
Phenolphthalein phosphates have been successfully used in automated procedures for 
serum alkaline phosphatase quantification (Comfort and Campbell, 1966) and in agar 
for the detection of phosphatase positive colonies of Staphylococccus aureus 
(MacFaddin, 2000).  
Thymolphthalein has similar properties but differs by changing from colourless to 
blue at pHs above 9.5.  This compound has also been used as a core molecule to 
determine phosphatase activity (Dalal et al., 1971). 
 
 
1.5.8 Phenoxazines 
 
Phenoxazines are highly coloured polycyclic ring structures (Figure 1.47).  
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Figure 1.47:  Structure of phenoxazine. 
 
Phenoxazines occur naturally in the polypeptide antibiotic actinomycins.  These 
groups are rarely used as antibiotics nowadays due to their high toxicity and their 
ability to bind to and damage genetic material. Due to this affinity, actinomycin D, 
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and in particular a fluorescent variation known as 7-aminoactinomycin D, can be 
used as stains for DNA in the fields of flow cytometry and fluorescent microscopy 
(Rabinovitch et al., 1986).  
Other compounds, such as cresyl violet (Figure 1.48) and Nile blue, contain a 
phenoxazine ring and are used as biological stains and textile dyes.  
 
 
 
 
 
 
 
 
 
 
Figure 1.48:  Cresyl violet stained neurons in the cerebellum.  A basic stain commonly used to 
visualise nervous system tissues as it has a strong affinity for the acidic components of the neurons, 
especially those of rough endoplasmic reticulum.  Picture courtesy of VetMed Resource.  
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A widely used phenoxazine system involves resazurin and two derivatives.  
Resazurin can be irreversibly reduced to resorufin which in turn can be reversibly 
reduced to dihydroresorufin (Figure 1.49). 
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Figure 1.49:  Reduction of resazurin to resorufin to dihydroxyresorufin. 
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Resazurin is purple in colour, resorufin is bright pink and fluorescent.  
Dihydroresorufin is colourless (Figure 1.50). 
 
 
 
 
 
Figure 1.50:  Colour contrast of resazurin (top) and resorufin (bottom). 
 
Bacterial contamination in raw milk has been characterised by the reduction of 
resazurin (decrease in purple colour) by viable, metabolically active cells (reduction 
by microbial dehydrogenase enzymes generating NADH).  The oxidation of 
dihydroresorufin (colourless→pink) is used as an indicator of oxygen contamination 
when culturing anaerobic bacteria.  These colour differences also give scope for 
chromo and fluorogenic substrates. 
Resorufin-β-D-galactopyranoside (Wittrup and Bailey, 1988) and glucopyranoside 
(Hays et al., 1998) are both commercially available and have been used to assay their 
respective enzymes. 
Resorufin acetate (Figure 1.51) has been used in studies of esterase activity (Kitson 
and Kitson, 1997).   
 
O O
N
O
OCH3  
Figure 1.51:  Structure of resorufin acetate. 
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There is also a series of ethoxyphenoxazine substrates (ethyl, pentyl and benzyl) that 
have been developed to investigate the mixed function oxidase, cytochrome P450, a 
prolific enzyme associated with metabolism and the breakdown of toxins (Figure 
1.52) (Burke et al., 1985). 
O O
N
O
 
Figure 1.52:  Structure of 7-benzyloxyresorufin. 
 
Amplex Red (10-acetyl-3,7-dihydroxyphenoxazine) (Figure 1.53) is produced by 
Invitrogen as a phenoxazine substrate for oxidases.  Oxidases are commonly tested 
for in microbiology as they are a natural by-product of oxygen metabolism.  The 
purpose of the test is to differentiate bacteria that contain cytochrome c oxidase and 
can, via an electron transport chain, use oxygen for energy production.  
 
O CH3
OHOH
N
 
Figure 1.53:  Structure of Amplex Red 
 
Amplex Red was initially developed as a substrate to measure hydrogen peroxide 
(Zhou et al., 1997).  During the reaction, the acetyl group is removed by the 
peroxidase in the presence of hydrogen peroxide leaving fluorescent resorfin.  
Amplex Red has been coupled to other enzyme reactions that produce hydrogen 
peroxide allowing sensitive assays for glucose (Kitazawa et al., 2007), galactose, 
cholesterol and phosphate.  The mechanism for the coupled glucose assay is shown 
below (Figure 1.54), where the action of glucose oxidase produces hydrogen 
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peroxide which is then utilized by peroxidise in the creation of resorufin.  The 
resulting oxygen by-product is then incorporated and the reaction cycle continues on. 
OH
OH OH
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glucose oxidase
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O CH3
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Figure 1.54:  Amplex Red coupled to an assay for glucose. 
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1.5.9 Fluorones 
 
Fluoresceins and rhodamines belong to a group of fluorescent compounds whose 
basic arrangement comprises of a fluorone ring structure (Figure 1.55). 
 
OO
fluorone
 
Figure 1.55:  Fluorone ring structure. 
 
Fluorescein or resorcinolphthalein, as it is also known, has a pka of 6.9 in acidic 
conditions, the lactone ring is closed but in alkaline conditions the lactone ring is 
open (Figure 1.56), pka changes to 6.4.  In even higher alkalinity the carboxyl and 
hydroxyl groups are de-protonated resulting in greater fluorescence due to increased 
free electron movement. 
 
O
OOH O
O O
-
O
-
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O
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Figure 1.56:  Fluorescein pH effect.   
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Fluorescein sodium dye is a standard opthalmic test for corneal abrasions.  A drop of 
dye solution is placed on the eye and fills any defects while the excess liquid is 
blinked away.  The eye is then exposed to blue light at 490 nm which excites the dye 
causing it to fluoresce at 530 nm, revealing any imperfections (Figure 1.57) (Snyder, 
2005). 
 
   
     No staining, not clinically significant                            Severe staining, treatment required. 
Figure 1.57:  Corneal staining with fluorescein sodium (Snyder, 2005). 
 
Eosin Y is a tetrabromo derivative of fluorescein (Figure 1.58) and is used in a 
number of histological staining techniques, the most commonly used being 
haematoxylin and eosin (H & E).   
 
Br
BrBr
Br
O
OH OO
O
 
Figure 1.58: Structure of eosin Y. 
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Eosin is an acidic dye that binds to basic cell structures (usually proteins) such as 
cytoplasm.  Haematoxylin is the opposite, being a basic dye that binds to acidic 
structures, e.g. nucleic acids (Figure 1.59). 
 
 
Figure 1.59:  An example of haematoxylin and eosin staining.  A basophil granulocyte surrounded by 
lightly staining eosinophilic erythrocytes in an H&E staining.  Picture courtesy of the Department of 
Histology, Jagiellonian University Medical College. 
 
Eosin diacetate (Figure 1.60), a fluorogenic substrate for lipases and esterases has 
been produced (Guilbault, 1966).   
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Figure 1.60:  Structure of eosin diacetate. 
 
Fluorescein isothiocyanate (FITC) is employed in techniques such as flow cytometry 
and immunofluorescence to label proteins, mainly antibodies.  Its ability to bind to 
proteins is due to the isothiocyanate group which readily reacts with nucleophilic 
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amino groups on proteins to form a stable thiourea bond, known as a conjugation 
reaction (Figure 1.61 and 1.62) (Riggs et al., 1958). 
SN
O
OH
OOH O
fluorescein isothiocyanate
R
NH
S
NH
O
OH
OOH O
RNH2+
FITC labelled protein
where R = a protein
 
Figure 1.61:  Conjugation reaction of fluorescein isothiocyanate. 
 
 
Figure 1.62:  Pasteurella tularensis stained with anti-tularensis serum labeled with FITC (Riggs et 
al., 1958). 
 
A number of substrates have been synthesised using fluorescein to measure enzyme 
activity.  These include a galactopyranoside and a phosphate (Rotman et al., 1963).   
Also, lipases have been studied in soil using fluorescein diacetate (Green et al., 
2006).  Other fluorescein lipase substrates have been evaluated, e.g. dibutyrate and 
dilaurate (Ge et al., 2007).   
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Like fluorescein there are several rhodamine derivatives.  Rhodamine B (Figure 
1.63) is used as part of a staining technique in fluorescence microscopy for 
mycobacterium and other acid-fast bacteria.  This auramine-rhodamine stain can also 
detect parasite oocysts, which would otherwise be difficult to identify using more 
traditional stains (Figure 1.64). 
 
CH3
CH3
CH3
CH3
O
O
N N
+
O
 
Figure 1.63:  Structure of rhodamine B. 
 
 
Figure 1.64:  Oocysts of Cryptosporidium parvum stained with the fluorescent stain auramine-
rhodamine.  Picture courtesy of Centers for Disease Control, Division of Parasitic Diseases, U.S.A. 
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Like FITC, rhodamine isothiocyanate has been employed to label antibodies (Figure 
1.65) (Riggs et al., 1958; Smith et al., 1962). 
 
 
Figure 1.65:  Bacillus anthracis stained with anti-rabbit serum labeled with rhodamine B ITC (Riggs 
et al., 1958). 
 
A rhodamine 110 substrate has been developed by Invitrogen as a way to quantify 
specific petidases (Leytus et al., 1983a; Leytus et al., 1983b).  An amino acid or 
peptide is covalently bound to both of the amino groups on the rhodamine 110 
molecule.  This complex is known as a bisamide and, in this form, colour and 
fluorescence are subdued.  The relevant peptidase enzyme removes the amino acids 
or peptides in two stages.  The first converts the substrate into a monoamide, which 
is fluorescent.  The second stage releases the highly fluorescent rhodamine 110 
(Figure 1.66).  
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Figure 1.66:  Two stage removal of amino acids or peptides to produce highly fluorescent rhodamine 
110. 
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1.6 Aims and objectives 
 
The specific aim of this study was to produce novel glycosidase enzyme substrates 
and apply them to uses in biomedical science. 
 
The specific objectives of this study are as follows: 
1) To synthesise a range of chromogenic and fluorogenic core compounds. 
2) To evaluate their suitability as chromophores and fluorophores and as metal 
chelators. 
3) Attempt to glycosidate suitable core compounds. 
4) Evaluate successful substrates with respect to applications in biomedical 
science. 
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CHAPTER TWO 
Chromogenic core molecules 
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2.1 Introduction 
 
Two classes of chromogenic core molecules can be distinguished.  These are firstly, 
those prepared by the Knoevenagel condensation method and secondly, those 
prepared by a cyclisation reaction.  
The Knoevenagel reaction, so named after the Russian chemist, Emil Knoevenagel, 
involves the condensation of a carbonyl compound, usually an aromatic aldehyde 
with a compound possessing an activated methylene group.    
This methylene or CH2 group is usually activated by one or two electron 
withdrawing groups, e.g. nitro, trifluoromethyl, carbonyl, etc.  The effect of these 
electron withdrawing groups is to make it more likely for the CH2 group to lose a 
proton and produce a carbanion, which then reacts with the electron deficient centre 
of the aromatic aldehyde thus generating a C=C double bond and creating, 
essentially, a styryl compound.  This will be illustrated with the examples below. 
 
 4-nitrovinyl-2-methoxyphenol 
 4-nitrovinyl-2-methoxy-6-bromophenol 
 2-hydroxy-1-naphthaldehyde (commercial sample from Sigma) 
 1-nitrovinyl-2-naphthol 
 4-hydroxy-3-methoxybenzylidene-1,3-indandione 
 4-hydroxy-3-methoxycinnamylidene-1,3-indandione 
 4-acetoxy-3-methoxycinnamylidiene-1,3-indandione 
 4-hydroxy-3-methoxycinnamylidene-3-phenyl-5-isoxazolone 
 
In all of these reactions, to form the carbanion from the activated methylene group, it 
is necessary to add a base and the nature of the base will become apparent in a 
subsequent description of the methodology.  
These next two examples did not involve a Knoevenagel condensation, but made use 
of the formation of a hydrazone group derived by condensation of the aldehyde with 
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a substituted phenylhydrazine.  Such hydrazones can have intense colours and are 
used to identify aldehydes and ketones (Bartos and Pesez, 1979); they could 
therefore, in this particular case, act as core molecules for subsequent derivatisation. 
 2-hydroxy-1-naphthaldehyde-4-nitrophenylhydrazone 
 2-hydroxy-1-naphthaldehyde-2,4-dinitrophenylhydrazone 
 
The final core molecule was synthesised by condensation of 1,6-
dihydroxynaphthalene with phthalic anhydride using zinc chloride as condensing 
agent. 
 Naphthofluorescein 
 
 
2.2.1 Synthesis of 4-nitrovinyl-2-methoxyphenol 
 
This compound had already been prepared several years ago (Milhazes et al., 2006), 
but its synthesis was undertaken again to gain experience in this type of Knoevenagel 
reaction. 
This compound was made as a model for future Knoevenagel condensations. 
Ammonium acetate (1.5 g, 20 mmol) and absolute ethanol (25 ml) were placed in a 
100 ml conical flask and stirred until dissolved.  Glacial acetic acid (1 ml) then 4-
hydroxy-3-methoxybenzaldehyde (vanillin) (2.2), (1.52 g, 10 mmol) were added.  
After dissolving, nitromethane (2.1) (1.22 g, 20 mmol) was added and the solution 
left stirring at room temperature for 24 h.  The reaction mixture was subject to 
vacuum filtration and the residue washed with ethanol chilled to 4 °C (30 ml).  The 
residue was then dissolved in boiling ethanol and allowed to recrystallise by cooling 
on ice for 1 h.  TLC in ethyl acetate showed a single spot.  The 4-nitrovinyl-2-
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methoxyphenol (2.3) crystals were dried in a vacuum desiccator (1.37 g, 70.2 % 
yield) (Figure 2.1). 
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Figure 2.1:  Acid catalysed formation of 4-nitrovinyl-2-methoxyphenol. 
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Analytical data 
Mp 169-171 ºC (lit. 168-171 ºC).   
IR νmax cm
-1
, 3464 (O-H), 1485, 1353 (N-O2). 
1
H-NMR (d6-DMSO, 270 MHz)  8.1(1H, d, J=13.6 Hz, vinylicH), 8.0 (1H, d, 
J=13.4 Hz, vinylicH), 7.5 (1H, d, J=2.0 Hz, ArH), 7.3 (1H, d, J=8.2 Hz,  ArH), 6.8 
(1H, d, J=8.2 Hz, ArH), 3.8 (3H, om, CH3). 
13
C-NMR (d6-DMSO, 270 MHz)  152, 149, 141, 136, 127, 122, 116, 113, 56. 
ESI-MS (M-H)
‾
 calculated/found; 194.17/194.12. 
 
 
Alternative method for 4-nitrovinyl-2-methoxyphenol 
 
Piperidine (2.4) (0.85 g, 10 mmol) and 4-hydroxy-3-methoxybenzaldehyde (2.2) 
(1.52 g, 10 mmol) were placed in a 100 ml conical flask and stirred until dissolved.  
Nitromethane (2.1) (1.22 g, 20 mmol) was then added and the solution left stirring at 
room temperature for 24 h.  The 4-nitrovinyl-2-methoxyphenol (2.3) was then 
purified as in the previous method (0.77 g, 39.5 % yield) (Figure 2.2). 
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Figure 2.2:  Base catalysed formation of 4-nitrovinyl-2-methoxyphenol. 
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2.2.2 Synthesis of 4-nitrovinyl-2-methoxy-6-bromophenol 
 
This compound had been previously synthesised (Raiford, 1944) but repeated to 
illustrate the effect of a halogen atom suitably disposed in the aromatic nucleus and 
to study its effect on the colour and the pH dependence of this type of molecule. 
It was synthesised as for 2.2.1, except 5-bromo-4-hydroxy-3-methoxybenzaldehyde 
(2.4) (2.31 g, 10 mmol) was used instead of 4-hydroxy-3-methoxybenzaldehyde.  
Yielded 2.29 g, 83.6 % of 4-nitrovinyl-2-methoxy-6-bromophenol (2.6) (Figure 2.3). 
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Figure 2.3:  Formation of 4-nitrovinyl-2-methoxy-6-bromophenol. 
 
Analytical data 
Mp 187-189 ºC (lit. 190-191 ºC). 
IR νmax cm
-1
, 3465 (O-H), 1488, 1350 (N-O2), 679 (C-Br). 
1
H-NMR (d6-DMSO, 270 MHz)  8.1(1H, d, J=13.6 Hz, vinylicH), 8.0 (1H, d, 
J=13.4 Hz, vinylicH), 7.6 (1H, d, J= 7.9 Hz, ArH), 7.2 (1H, d, J=6.4 Hz, ArH), 3.8 
(3H, om,CH3). 
13
C-NMR (d6-DMSO, 270 MHz)  151, 149, 140, 138, 129, 123, 116, 110, 57. 
ESI-MS (M-H)
‾
 calculated/found; 273.07/274.16. 
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2.2.3 2-Hydroxy-1-naphthaldehyde 
 
This core compound was investigated but was commercially available from Sigma. 
 
 
HO
OH
(2.7)
 
Figure 2.4: Structure of 2-hydroxy-1-naphthaldehyde. 
 
 
2.2.4 Synthesis of 1-nitrovinyl-2-naphthol 
 
This compound had been previously synthesised (Dauzonne and Royer, 1984).  1-
nitrovinyl-2-naphthol (2.8) was synthesised as for 2.2.1 4-nitrovinyl-2-
methoxyphenol, except the scale was doubled in size and 4-hydroxy-3-
methoxybenzaldehyde was replaced with 2-hydroxy-1-naphthaldehyde (2.7) (3.44 g, 
20 mmol).  Yielded 3.6 g, 83.7 % of 1-nitrovinyl-2-naphthol (2.8) (Figure 2.5). 
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Figure 2.5:  Formation of 1-nitrovinyl-2-naphthol. 
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Analytical data 
Mp 220-222 ºC (lit. 224 ºC). 
IR νmax cm
-1
, 3332 (O-H), 1510, 1355 (N-O2). 
1
H-NMR (d6-DMSO, 270 MHz)  8.2 (1H, d, J=8.4 Hz,  ArH), 7.8 (3H, t, J=9.4 Hz, 
ArH), 7.6 (1H, t, J=7.5 Hz, ArH), 7.4 (1H, t, J=7.5 Hz, ArH), 7.0 (1H, d, J=8.9 Hz,  
ArH), 6.7 (1H, d, J=3.0 Hz,  ArH). 
 
 
 
2.2.5 Synthesis of 4-hydroxy-3-methoxybenzylidene-1,3-indandione 
 
The indandione compounds were prepared by the Knoevenagel condensation since 
indandione contains an activated CH2 group activated by two flanking carbonyl 
groups and this was considered to be a good choice for reaction. 4-hydroxy-3-
methoxybenzylidene 1,3-indandione had been previously synthesised (Inayama et al., 
1976). 
4-Hydroxy-3-methoxybenzaldehyde (2.2) (0.76 g, 5 mmol) was dissolved in 
methanol (10 ml) in a 50 ml conical flask and stirred.  To this 1,3-indandione (2.9) 
(0.73 g, 5 mmol) was added.  After 5 min ammonium acetate (0.6 g, 8 mmol) 
dissolved in methanol (5 ml) with glacial acetic acid (1 ml).  The solution was 
allowed to stand at room temperature for 1 h during which time precipitation 
occurred.  The crystals were filtered under pressure then washed with 5 ml chilled (4 
°C) methanol.   
TLC in ethyl acetate showed only a single spot near the solvent front.  The 4-
hydroxy-3-methoxybenzylidene-1,3-indandione (2.10) crystals were dried in a 
vacuum desiccator (0.83 g, 59.3 % yield) (Figure 2.6). 
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Figure 2.6:  Formation of 4-hydroxy-3-methoxybenzylidene 1,3-indandione. 
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Analytical data 
Mp 211-213 ºC (lit. 213-215 ºC). 
1
H-NMR (d6-DMSO, 270 MHz)  8.7 (1H, s, ArH), 7.9-8.0 (4H, om, ArH), 7.8 (1H, 
s, ArH), 6.9 (1H, d, J=8.2 Hz,  ArH), 3.9 (3H, s, CH3). 
 
 
2.2.6 Synthesis of 4-acetoxy-3-methoxycinnamylidene-1,3-indandione 
 
This compound was synthesised as for 2.2.5 using 4-acetoxy-3-
methoxycinnamaldehyde (2.11) (6.61 g, 30 mmol) and 1,3-indandione (2.9) (4.38 g, 
30 mmol). 
The product was purified by adding the crystals to stirred, boiling methanol (300 ml) 
in 500 ml conical flask.  The solution was poured into a new flask, leaving any 
undissolved material behind and allowed to re-crystallize by cooling the flask on ice 
(0 °C) for 1 h.  TLC in showed only a single spot near the solvent front.  The 4-
acetoxy-3-methoxycinnamylidene-1,3-indandione (2.12) crystals were dried in a 
vacuum desiccator (3.0 g, 48.4 % yield) (Figure 2.7). 
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Figure 2.7:  Formation of 4-acetoxy-3-methoxycinnamylidene-1,3-indandione. 
 
Analytical data 
Mp 180-182 ºC. 
IR νmax cm
-1
, 1760, 1678 (C=O). 
1
H-NMR (d6-DMSO, 270 MHz)  7.9 (5H, om, ArH), 7.6-7.8 (2H, dd, J1=9.5 Hz,  
J2=8.0 Hz, ArH), 7.4-7.5 (2H, om, ArH), 7.2-7.3 (2H, d, J=8.0 Hz, ArH), 3.9 (4H, 
om, ArH + CH3). 
13
C-NMR (d6-DMSO, 270 MHz)  195, 190, 189, 168, 153, 152, 151, 144, 142, 141, 
136, 134, 133, 129, 128, 125, 124, 122, 113, 56, 21. 
ESI-MS (M-H) calculated/found; 347.35/348.92. 
HRMS (M+NH4) calculated/found; 366.3866/366.1341. 
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2.2.7 Synthesis of 4-hydroxy-3-methoxycinnamylidene-1,3-indandione 
 
This compound had been previously synthesised (Inayama et al., 1976).   4-Hydroxy-
3-methoxycinnamylidene-1,3-indandione (2.14) and was synthesised as for 2.2.5 
except 4-hydroxy-3-methoxybenzaldehyde was replaced with 4-hydroxy-3-
methoxycinnamaldehyde (2.13) (0.89g, 5mmol).  Yielded 0.92 g, 60.1 % (Figure 
2.8). 
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Figure 2.8:  Formation of 4-hydroxy-3-methoxycinnamylidene-1,3-indandione. 
 
Analytical data 
Mp 225-227 ºC (lit. 224-226 ºC). 
IR νmax cm
-1
, 3216 (O-H), 1713, 1658 (C=O). 
1
H-NMR (d6-DMSO, 270 MHz)  10.1 (1H, s, OH), 8.2 (1H, dd, J=11.9 Hz, J=11.6 
Hz, ArH), 7.9 (4H, s, ArH), 7.6 (2H, om, ArH), 7.3 (2H, s + d, J=8.2 Hz, ArH), 6.9 
(1H, d, J=7.9 Hz, ArH), 3.9 (3H, s, CH3). 
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13
C-NMR (d6-DMSO, 270 MHz)  191, 190, 154, 151, 149, 146, 142, 141, 136 (x2), 
128, 126, 124, 123 (x2), 121, 117, 112, 56. 
ESI-MS (M-H)
‾
 calculated/found; 305.31/305.16. 
 
 
2.2.8 Synthesis of 4-hydroxy-3-methoxycinnamylidene-3-phenyl-5-isoxazolone 
 
This is an analogous compound to the previously mentioned indandione but using 3-
phenyl-5-isoxazolone (2.15) as the compound bearing the activated methylene group. 
4-Hydroxy-3-methoxycinnamylidene-3-phenyl-5-isoxazolone (2.16) was synthesised 
as for 2.2.5 using 4-hydroxy-3-methoxycinnamaldehyde (2.13) (0.89 g, 5 mmol) and 
3-phenyl-5-isoxazolone (0.80 g, 5 mmol).  Yielded 1.2 g, 74.8 % (Figure 2.9). 
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Figure 2.9:  Formation of 4-hydroxy-3-methoxycinnamylidene-3-phenyl-5-isoxazolone. 
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Analytical data 
Mp 186-188ºC 
IR νmax cm
-1
, 3407 (O-H), 1739, 1613 (C=O). 
1
H-NMR (d6-DMSO, 270 MHz)  10.3 (1H, Broad s, OH), 8.1 (1H, dd, J1=11.6 Hz, 
J2=11.4 Hz, ArH), 7.2 + 7.5-7.8 (9H, om, ArH), 6.9 (1H, d, J=7.8 Hz, ArH), 3.8 (3H, 
s, CH3). 
13
C-NMR (d6-DMSO, 270 MHz)  171, 163, 156, 153, 152, 149, 131, 130 (x2), 129 
(x2), 128, 127, 126, 120, 117, 113, 112, 56. 
ESI-MS (M-H) calculated/found; 320.33/320.11. 
HRMS (M-H) calculated/found; 320.3267/320.0922. 
 
 
2.2.9 Synthesis of 2-hydroxy-1-naphthaldehyde-4-nitrophenylhydrazone 
 
2-Hydroxy-1-naphthaldehyde (2.7) (0.86 g, 5 mmol) was dissolved in ethanol (20 
ml).  4-Nitrophenylhydrazine (2.17) (0.77 g, 5 mmol) was dissolved in ethanol (10 
ml) with concentrated hydrochloric acid (5 ml) and water (10 ml).  The two solutions 
were mixed and stirred for 10 min.  The precipitate was filtered, washed with a 50% 
(v/v) mixture of ethanol and water (50 ml) then dried.  2-hydroxy-1-naphthaldehyde-
4-nitrophenylhydrazone (2.18) was recrystalised from hot ethanol (20ml).  Yield 0.8 
g, 52.1 % (Figure 2.10). 
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Figure 2.10:  Formation of 2-hydroxy-1-naphthaldehyde-4-nitrophenylhydrazone. 
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Analytical data 
Mp 249-251 ºC.   
IR νmax cm
-1
, 3290 (O-H), 1590 (C=N), 1476, 1300 (N-O2). 
1
H-NMR (d6-DMSO, 270 MHz)  11.4 (1H, s, ArH), 11.2 (1H, s, ArH), 9.0 (1H, s, 
ArH), 8.8 (1H, d, J=8.2 Hz, ArH), 8.2 (2H, d, J=9.4 Hz, ArH), 7.9 (2H, d, J=8.7 Hz, 
ArH), 7.6 (1H, t, J=7.8 Hz, ArH), 7.4 (1H, t, J=7.4 Hz, ArH), 7.2 (1H, d, J=8.9 Hz, 
ArH), 7.1 (2H, d, J=9.2 Hz, ArH). 
13
C-NMR (d6-DMSO, 270 MHz)  157, 151, 142, 139, 133, 132, 130, 129, 128, 127 
(x2), 124, 123, 119, 112 (x2), 111. 
ESI-MS (M-H)
‾
 calculated/found; 306.30/306.11. 
HRMS (M+H) calculated/found; 308.3034/308.1034. 
 
 
 
2.2.10 Synthesis of 2-hydroxy-1-naphthaldehyde-2,4-dinitrophenylhydrazone 
 
 
This compound had been previously synthesised (Ibanez et al., 2002).  2-hydroxy-1-
naphthaldehyde-2,4-dinitrophenylhydrazone (2.20) was synthesised as for 2-
hydroxy-1-naphthaldehyde-4-nitrophenylhydrazone but 4-nitrophenylhydrazine was 
replaced with 2,4-dinitrophenylhydrazine (2.19) (0.99 g, 5 mmol). Yield 1.42 g, 80.7 
% (Figure 2.11). 
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Figure 2.11:  Formation of 2-hydroxy-1-naphthaldehyde-2,4-dinitrophenylhydrazone. 
Analytical data 
Mp 290-292 ºC (lit. not stated) 
IR νmax cm
-1
, 3274 (O-H), 1586 (C=N), 1511, 1322 (N-O2), 1498, 1266 (N-O2). 
1
H-NMR (d6-DMSO, 270 MHz)  11.6 (1H, s, ArH), 11.3 (1H, s, ArH), 9.5 (1H, s, 
ArH), 8.8 (1H, d, J=8.1 Hz, ArH), 8.3 (2H, d, J=9.1 Hz, ArH), 7.9 (2H, d, J=8.4 Hz, 
ArH), 7.6-7.7 (1H, om, ArH), 7.4 (1H, t, J=7.0 Hz, ArH), 7.2 (1H, d, J=9.1 Hz, 
ArH). 
13
C-NMR (d6-DMSO, 270 MHz) – Spectrum too weak for analysis. 
ESI-MS (M-H) calculated/found; 351.30/351.11. 
HRMS (M-H) calculated/found; 351.3010/351.0725. 
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2.2.11 Synthesis of naphthofluorescein 
 
This molecule, although already known (Fischer, 1914), appeared to have desirable 
characteristics both to act as a pH indicator and to form enzyme substrates e.g. 
glycosides.  The core molecule was synthesised by condensation of 1,6-
dihydroxynaphthalene (2.21) with phthalic anhydride using zinc chloride as 
condensing agent. 
1,6-dihydroxynaphthalene (3.2 g, 20 mmol) and phthalic anhydride (2.22) (1.5 g, 10 
mmol) were intimately mixed with fused zinc chloride (2.7 g, 20 mmol) and heated 
in a hard glass boiling tube in an oil bath at 120 °C for 3 h with occasional stirring 
using a glass rod.  After cooling, the solid melt was removed by breaking the tube 
and subsequently ground in a pestle and mortar.  The powder was extracted by 
stirring with excess warm sodium hydroxide (2 M).  The deep blue solution was 
filtered and the stirred solution was acidified to ~ pH 3 using HCl (2 M).  The 
flocculent red precipitate of undissociated naphthofluorescein (2.23) was removed by 
suction filtration and washed with more HCl (2 M) and then with distilled water.  
The dried product was difficult to recrystallise and hence was purified by 
redissolving in alkali followed by acidification as previously described.  Yield 2.8 g, 
32.4 % (Figure 2.12). 
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Figure 2.12:  Formation of naphthofluorescein. 
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Analytical data 
Mp 190-192 ºC (lit. 189 ºC) 
1
H-NMR (d6-DMSO, 270 MHz)  10.2 (2H, s, OH), 8.7 (2H, d, J=8.9 Hz, ArH), 7.8 
(2H, om, ArH), 7.4 (2H, d, J=8.7 Hz, ArH), 7.3 (2H, d, J=9.4 Hz, ArH), 7.2 (2H, s, 
ArH), 6.7 (2H, d, J=8.9 Hz, ArH). 
 
 
83 
 
2.3 Results  
 
The majority of compounds synthesised showed strong colouration especially on the 
alkaline side of neutrality.  This is, of course, not surprising, since a hydroxy group is 
present in them all and the hydroxyl group is capable of ionisation.  Consequently, 
colours were recorded across the pH range and absorption spectra were measured. 
The core compounds (100 mg/L) were dissolved in 50% (v/v) ethanol/water and the 
pH adjusted with either HCl (0.2 M) or NaOH (0.2 M).  When appropriate, the 
compounds were observed under U.V. light (~350 nm) and any florescence was 
recorded (Table 2.1). 
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Table 2.1:  Colour change of synthesised core compounds due to varying pH. 
 
Core compound pH 
     3       5       7        9      11     13 
4-nitrovinyl-2-methoxyphenol 
 
 
4-nitrovinyl-2-methoxy-6-bromophenol 
 
 
1-nitrovinyl-2-naphthol 
 
 
2-hydroxy-1-naphthaldehyde 
 
 
4-hydroxy-3-methoxybenzylidene- 
1,3-indandione  
 
4-hydroxy-3-methoxycinnamylidene- 
1,3-indandione  
 
4-acetoxy-3-methoxycinnamylidene- 
1,3-indandione  
 
4-hydroxy-3-methoxycinnamylidene- 
3-phenyl-5-isoxazolone  
 
2-hydroxy-1-naphthaldehyde- 
4-nitrophenylhydrazone  
 
2-hydroxy-1-naphthaldehyde- 
2,4-dinitrophenylhydrazone  
 
naphthofluorescein 
  
 
naphthofluorescein under U.V. 
  
 
p-naphtholbenzein 
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Spectrum scans from 300 to 700 nm were recorded at each pH using a Biotek 
Synergy multi-detection microplate reader.  A representative sample of these can be 
seen below in Figures 2.13 and 2.14 (others appear in Appendix B). 
 
Figure 2.13:  Spectrum scan of 4-hydroxy-3-methoxycinnamylidene-1,3-indandione. 
 
 
Figure 2.14:  Spectrum scan of naphthofluorescein. 
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2.4 Discussion 
 
The results indicate that many of these compounds have the capacity to be used as 
pH indicators, e.g. in bacterial identification by alkalisation reactions, such as 
decarboxylase or urease activity. 
A more complete analysis, however, would be necessary before this could be applied 
in a practical microbiological situation.  The change in coloration and spectra, which 
is dependent on pH, also indicated that if the hydroxyl group was protected, as in fact 
would be the case in glycosidation, then the colour could be markedly reduced and 
such glycosides should therefore be capable of acting as substrates for the 
appropriate glycosidase, since cleavage of the glycoside group would restore the 
hydroxyl function and restore the colour of the original chromogen.   
Consequently, several of these compounds were subject to glycosidation and the 
results of this are given later, in the appropriate section. 
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CHAPTER THREE 
Chelating core molecules 
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3.1 Introduction 
 
In this section, as well as the novel compounds synthesised, several commercially 
available chelators, such as alizarin, have been included for subsequent glycosidation 
or other method of derivatisation. 
The term chelation is used to describe the process by which structures possessing 
certain groups, which usually are electron rich and spatially adjacent or proximate, 
react with metal ions, thereby giving stable complexes.  The types of ions involved 
are usually those of the transition elements i.e. iron, cobalt, nickel, zinc, manganese, 
copper, etc, and also the rare earth metals, such as lanthanum, cerium and europium.  
However, other multivalent ions may also chelate, especially if these are highly 
electron deficient and have a strong multivalent positive charge, e.g. Al
3+
, where an 
appropriate ion affinity exists.  Even ions like Mg
2+
 can chelate under appropriate 
circumstances.  An example would be 8-hydroxyquinoline (8HQ) which forms a 
stable and highly fluorescent magnesium complex involving two molecules of 8HQ.  
8-Hydroxyquinoline-5-sulphonic acid has been proposed as a reagent for the 
determination of low concentrations of magnesium in serum by fluorescence (Zhu 
and Kok, 1998).  
The chelates so formed are frequently highly coloured due to electronic transitions.  
This is particularly so with the transition elements.  In addition, the chelates are often 
insoluble in aqueous media due to the association of two or more chelating molecules 
with one metal ion, e.g. Fe
2+
.2CHE (Figure 3.1).  This has considerable importance 
in the creation and design of chelating substrates for use in agar plate methodology 
for use in microbial identification protocols (James et al., 1996). 
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Figure 3.1:  Hydrolysis of CHE-Gal by E. coli in the prescence of iron (II) (James et al., 1996). 
 
Often a metal chelate exhibits a dark coloration (black or dark brown) which can be 
observed in the colonies above.  However, some chelating agents give rise to highly 
coloured metal chelates and the colour frequently depends on the metal ion which is 
present.  A suitable example would be alizarin, which gives a deep purple iron 
chelate, a deep red aluminium chelate (James et al., 2000b) and also various colours 
with other metals, such as chromium and tin, etc (Figure 3.2). 
 
   
Figure 3.2:  Colonies of E. coli showing hydrolysis of alizarin-β-D-galactoside in the presence of 
ferric ions (left) and aluminium ions (right) (James et al., 2000b). 
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One important feature of metal chelates is the stability constant.  This defines the 
tendency of the chelate to dissociate into its component parts.  The general formula 
would be:     
chelating agent + M
2+
  ↔ chelate 
If the chelate is very stable, the dissociation constant will be very low, for example 
frequently in the order of 10
-20
, 10
-30
 M
-1
.   
For microbiological identification purposes it is desirable to have a very stable 
chelate because if the chelate tends to dissociate and produce more of the free 
chelating agent then spreading of the colour is likely to be observed on the agar plate 
(Figure 3.3). 
 
 
Figure 3.3:  Aliz-gal with lanthanum nitrate spreading. 
 
This same order of magnitude of the dissociation constant, i.e. 10
-30 
M
-1
, or even 
lower, is observed with some of the naturally occurring chelating molecules which 
are present in bacteria, such as, enterobactin or enterochelin, where their function in 
the wild state is to access particularly iron, as Fe
2+
 and Fe
3+
, into the bacteria. 
Enterobactin is a siderophore, which is a peptide produced and released by Gram- 
negative bacteria, such as E. coli and Salmonella spp.  It binds to Fe
3+
 with the 
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affinity 10
52
 M
-1
 which is then taken up by the cell via active transport (Raymond et 
al., 2003) where, it is proposed, Fe
3+
 is reduced to  Fe
2+
 with ferrienterobactin 
esterase (Ward et al., 1999).  Due to this strong affinity, enterobactin can chelate 
when Fe
3+ 
concentrations are low, e.g. in living organisms.  Pathogens can utilize this 
to commandeer iron from other organisms. 
Some chelating agents are used therapeutically (chelation therapy), e.g. to eliminate 
excess or unwanted ions from the body.  Such an example would be the compound 
desferrioxamine, which has a very high affinity for iron and can actually remove iron 
from temporary deposits in the body, such as ferritin and haemosiderin, by making it 
more easily excreted in urine, therefore preventing any liver damage the toxic iron 
would have caused.  However, it is not strong enough to dissociate haem and 
therefore intact red cells are not destroyed.  This is used in the treatment of a 
hereditary condition, known as haemachromatosis or sideraphilia, characterised by 
excess absorption of iron, which is fairly common in Africa (Gordeuk et al., 2004) 
Several groups or types of group may be involved in the formation of a metal 
chelate.  One of the most common is probably what is termed O-O coordination, 
where two adjacent hydroxyl groups serve to anchor the metal ion to the organic 
structure.  Again, this is seen very well in alizarin (Figure 3.4) and also in the 
molecule of cyclohexenoesculetin (CHE).  This will be alluded to later. 
 
Al
3+
OH
O
-
O
O
OH
O
-
O
O
 
Figure 3.4:  Possible chelation of alizarin and aluminium through two adjacent hydroxyl groups. 
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Derivatives of alizarin, and also CHE, have been synthesised, largely in these 
laboratories, over the last several years and have found application in microbial 
identification protocols, particularly those of bioMérieux and also Lab M.   
A similar compound, 3,4-dihydroxyflavone has been synthesised and is marketed  by 
Glycosynth.  Here again, this may have certain applications as the glycoside or 
riboside (Butterworth et al., 2004), where it may be useful in the differentiation  and 
identification of Gram-negative bacteria. 
A rather different form of O-O coordination is where a hydroxy group is adjacent to 
a carbonyl group in a suitable orientation.  Again, this will be described later since 
several of the compounds synthesised in this particular exercise bear that structure.  
O-N coordination is also seen, where there is a hydroxyl group adjacent to an amino 
group or some other nitrogen function.  Frequently that nitrogen function represents a 
ring nitrogen atom of, say, pyridine or a quinoline ring and here again, one can refer 
back to 8-hydroxyquinoline which is the archetypal compound of this type (James 
and Yeoman, 1987; James and Yeoman, 1988). 
N-N coordination is also observed with molecules such as o-phenanthroline and 2,2-
bipyridyl.  However, these compounds do not have any great application in terms of 
microbial identification or creation of enzyme substrates, since they have no 
derivatisable groupings.  They are, however, used in the colorimetric, and sometimes 
fluorimetric, determination of metal ions, such as iron (Heaney and Davison, 1977; 
Wright, 1983).  
One further possibility is N-S coordination.  This is rather more limited in the 
acceptance of a metal ion.  Not all metals will chelate with such structures and those 
which do frequently require conditions of pH which are inimicable to growth and to 
physiological conditions.  Also, these metals which are involved are usually of the 
heavy metal type, i.e. lead, mercury, cadmium, etc, and, consequently, because of the 
toxicity of these metals, they have very little application in the design of enzyme 
substrates. 
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In the present study, several potential chelating core molecules were synthesised, 
these being: 
 
 2-(3,4-dihydroxybenzylidene)-1,3-indandione 
 3,4-dihydroxybenzylidene benzhydrazide  
 3,4-dihydroxybenzylidene isonicotinic hydrazide  
 7,8-dihydroxy-4-methylcoumarin (otherwise known as daphnetin) 
 1-methyl-2-phenyl-3-hydroxy-4(1H)-quinolone 
 1-methyl-2-(4-fluorophenyl)-3-hydroxy-4(1H)-quinolone 
 
For comparative purposes and in order to create a wider range of glycosides 
eventually, several existing chelating agents were also investigated for their metal 
binding capacity.  These included: 
 
 5-nitrosalicylaldehyde 
 alizarin (1,2-dihydroxyanthraquinone) 
 3-hydroxyflavone 
 5,7-dichloro-8-hydroxy-2-methylquinoline 
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3.2.1 Synthesis of 2-(3,4-dihydroxybenzylidene)-1,3-indandione. 
 
Previously synthesised (Artico et al., 1998), this compound was produced by a type 
of Knoevenagel reaction by condensation of 3,4-dihydroxybenzaldehyde (3.1) with 
indandione (2.9) according to standard conditions, as previously described earlier 
when synthesising chromogenic core compounds. 
3,4-Dihydroxybenzaldehyde (0.69 g, 5 mmol) was dissolved in methanol (10 ml) in a 
50 ml conical flask and stirred.  To this, 1,3-indandione  (0.73 g, 5 mmol) was added.  
After 5 min, ammonium acetate (0.6 g, 8 mmol) dissolved in methanol (5 ml) with 
glacial acetic acid (1 ml) were added.  The solution was allowed to stand at room 
temperature for 1 h, during which time precipitation occurred.  The crystals were 
filtered, then washed with methanol (5 ml) chilled to 4 °C.   
TLC in ethyl acetate showed only a single spot near the solvent front.  The 2-(3,4-
dihydroxybenzylidene)-1,3-indandione (3.2) crystals were dried in a vacuum 
desiccator (0.72 g, 54.1 % yield) (Figure 3.5). 
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Figure 3.5:  Formation of 2-(3,4-dihydroxybenzylidene)-1,3-indandione. 
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Analytical data 
Mp 260-262 ºC (lit. 262-264 ºC). 
1
H-NMR (d6 DMSO, 270 MHz)  10.5 (1H, s, OH), 9.6 (1H, s, OH), 8.4 (1H, s, 
ArH), 7.8-8.1 (5H, om, ArH), 7.2 (1H, s, ArH), 6.9 (1H, d, J=8.4 Hz, ArH). 
 
 
3.2.2 Synthesis of 3,4-dihydroxybenzylidene benzhydrazide 
 
This was synthesised by condensation of the previously mentioned 
dihydroxybenzaldehyde (3.1), but with benzhydrazide (3.3) (1 g, 7 mmol) in place of 
1,3-indandione.  Yielded 0.75 g, 41.9 % 3,4-dihydroxybenzylidene benzhydrazide 
(3.4) (Figure 3.6). 
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Figure 3.6:  Formation of 3,4-dihydroxybenzylidene benzhydrazide. 
98 
 
Analytical data 
Mp 219-221 ºC. 
IR νmax cm
-1
, 3302, 3180 (O-H), 1649 (C=O), 1578 (C=N). 
1
H-NMR (d6 DMSO, 270 MHz)  9.4 (2H, Broad s, OH), 8.3 (1H, s, ArH), 7.9 (2H, 
d, J=6.7 Hz, ArH), 7.5 (3H, om, ArH), 7.3 (1H, s, ArH), 6.8-6.9 (2H, dd, J1=8.1 Hz, 
J2=8.2 Hz, ArH).  
13
C-NMR (d6-DMSO, 270 MHz)  163, 149, 148, 146, 134, 132, 129 (x2), 128 (x2), 
126, 121, 116, 113. 
ESI-MS (M-H) calculated/found; 255.26/255.17. 
HRMS (M-H) calculated/found; 255.2567/255.0771. 
 
 
3.2.3 Synthesis of 3,4-dihydroxybenzylidene isonicotinic hydrazide 
 
3,4-dihydroxybenzylidene isonicotinic hydrazide (3.6) had been previously 
synthesised   (Luedy-Tenger, 1956).  This compound was synthesised as for 3,4-
dihydroxybenzylidene benzhydrazide, but with isonicotinic hydrazide (3.5) (1g, 7 
mmol) instead of benzhydrazide (0.8 g, 44.5% yield) (Figure 3.7). 
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Figure 3.7:  Formation of 3,4-dihydroxybenzylidene isonicotinic hydrazide. 
 
Analytical data 
Mp 260-262 ºC (lit. 259-261.5 ºC). 
IR νmax cm
-1
, 3241, 3088 (O-H), 1644 (C=O), 1588 (C=N). 
1
H-NMR (d6 DMSO, 270 MHz)  9.5 (1H, s OH), 9.4 (1H, s, OH), 8.8 (2H, d, J=5.9 
Hz, ArH), 8.3 (1H, s, ArH), 7.8 (2H, d, J=4.5 Hz, ArH), 7.3 (1H, s, ArH), 6.8-7.0 
(2H, dd, J1=8.2 Hz, J2=7.9 Hz, ArH). 
13
C-NMR (d6-DMSO, 270 MHz)  162, 151 (x2), 150, 149, 146, 141, 126, 122 (x2), 
121, 116, 113. 
ESI-MS (M-H) calculated/found; 256.24/256.16. 
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3.2.4 Synthesis of 7,8-dihydroxy-4-methylcoumarin 
 
7,8-dihydroxy-4-methylcoumarin (3.9) was synthesised by the Pechmann 
condensation (Pechmann, 1883) of pyrogallol (3.7) and ethyl acetoacetate (3.8) with 
sulphuric acid as a proton donor (De and Gibbs, 2005; Kumar et al., 2005). 
Pyrogallol (1,2,3-trihydroxybenzene) (3.78 g, 30mmol) was melted into ethyl 
acetoacetate (4.29 g 33mmol) in a 250 ml conical flask by gentle warming.  The melt 
was rapidly cooled to room temperature and stirred with 75% (w/w) sulphuric 
acid/distilled water (100 ml) while being cooled in a water bath (10 °C).  The 
reaction mixture was inspected after several hours to observe a precipitate and then 
left stirring overnight (total time 24 h).  The reaction mix, which initially became 
very viscous, formed a slurry containing the suspected coumarin.  The reaction mix 
was then poured into well stirred iced water (500 ml total volume) in a thin stream.  
The precipitate which formed was removed by suction filtration under reduced 
pressure and washed well with ice cold distilled water and dried.  The residue was 
dried in air at room temperature and recrystallised by initially dissolving in the 
minimum quantity of hot ethanol, followed by addition of water until the formation 
of crystals was apparent.  After cooling in the fridge for 3 h, the solid product was 
removed by suction filtration and air dried as before (3 g, 52.1 % yield) (Figure 3.8). 
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Figure 3.8:  Formation of 7,8-dihydroxy-4-methylcoumarin. 
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Analytical data 
Mp 230-232ºC (lit. 235ºC). 
1
H-NMR (d6 DMSO, 270 MHz)  9.5-10.0 (2H, Broad, OH), 7.1 (1H, d, J=8.7 Hz, 
ArH), 6.8 (1H, d, J=8.7 Hz, ArH), 6.1 (1H, s, alkeneH), 2.3 (3H, s, CH3). 
 
 
 
3.2.5 Synthesis of 1-methyl-2-phenyl-3-hydroxy-4(1H)-quinolone 
 
Similar in structure to 3-hydroxyflavone, a series of hydroxyquinolone compounds 
were first synthesised by Yushchenko (Yushchenko et al., 2006a) who reported their 
fluorescence properties. This, along with the compounds having a hydroxyl group 
necessary for glycosidation or attachment of other groups to create potential 
substrates (e.g. by esterification), would make them suitable candidates as 
fluorophores.  The position of a hydroxy group adjacent to a carbonyl group also 
adds the possibility of metal chelation.  Both of these attributes were thought worthy 
of further investigation. 
The hydroxyquinolone compound was synthesised by condensation of anthranilic 
acid or its N-methyl derivative with the appropriate substituted phenacyl halide. 
N-Methylanthranilic acid (3.10) (3.2 g, 20 mmol) was suspended in 
dimethylformamide (10 ml) with potassium carbonate (3 g, 20 mmol).  The mixture 
was stirred and heated at 70 °C for 1 h then allowed to cool to room temperature.  
Phenacyl bromide (2-bromoacetophenone) (3.11) (2.4 g, 20 mmol) was added.  The 
mixture was stirred and heated to 50 °C for 1 h then poured into stirring distilled 
water (100 ml).  A precipitate was formed, which was filtered, washed with distilled 
water (100 ml), then dried in a vacuum dessicator (yield 3.6 g, 71.7%, of phenacyl-
N-methylanthranilate). 
Phenacyl-N-methylanthranilate (3.12) (2 g, 7.5 mmol) was suspended in 
polyphosphoric acid (PPA) (13.2 g, 7.5 mmol), heated at 120 °C for 2 h, then poured 
into stirring ice water (80 ml) to produce a black oil.  After stirring for 1 h, the oil 
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became a grey solid (yield 1.2 g).  The solid was filtered then allowed to dry before 
being recrystallised from warm DMF (20 ml).  Yield 0.5 g, 26.5%, of 1-methyl-2-
phenyl-3-hydroxyquinolone (3.13) (Figure 3.9). 
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Figure 3.9:   Formation of 1-methyl-2-phenyl-3-hydroxy-4(1H)-quinolone. 
 
Analytical data 
Mp 265-266ºC (lit. 262 ºC). 
1
H-NMR (d6 DMSO, 270 MHz)  8.3 (1H, d, J=7.9 Hz, ArH), 7.3-7.9 (8H, om, 
ArH), 3.5 (3H, s, CH3). 
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3.2.6 Synthesis of 1-methyl-2-(4’-fluorophenyl)-3-hydroxy-4(1H)-quinolone 
 
An analogue of the previous compound, again synthesised by (Yushchenko et al., 
2006a), with the addition of a fluorine atom on the aryl ring was synthesised.  
N-Methylanthranilic acid (3.10) (12.8 g, 80 mmol) was reacted in a similar manner to 
3.2.5 except 4’-Fluorophenacyl bromide (3.14) (17.2 g, 80 mmol) was used instead 
of 2-bromoacetophenone (yield 20 g, 87.0%, of 4’-fluorophenacylanthranilate). 
4’-Fluorophenacylanthranilate (2 g, 7 mmol) was suspended in polyphosphoric acid 
(13.2 g, 7.5 mmol) and again treated as for 3.2.5.  Yield 1.2 g, 63.7%, of 1-methyl-2-
(4’-fluorophenyl)-3-hydroxy-4(1H)-quinolone (3.15) (Figure 3.10). 
 
4'-fluorophenacyl 
bromide
1-methyl-2-(4'-fluorophenyl)-
3-hydroxy-4(1H)-quinolone
F
Br
O
F
OH
CH3
O
NCH3
NH
O OH
+
N-methylanthranilic 
acid
PPA
120 
o
C
(3.10) (3.14) (3.15)
 
Figure 3.10:   Formation of 1-methyl-2-(4’-fluorophenyl)-3-hydroxy-4(1H)-quinolone. 
 
Analytical data 
Mp 241-243ºC (lit. 238 ºC) 
1
H-NMR (d6 DMSO, 270 MHz)  8.3 (1H, d, J=8.2 Hz, ArH), 7.4-8.1 (7H, om, 
ArH), 3.7 (3H, s, CH3). 
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The following possible chelating agents were investigated but were already 
commercially available (Figures 3.11, 3.12, 3.13, 3.14). 
 
3.2.7 5-Nitrosalicylaldehyde 
 
OH
OH
O
-
O
N
+ (3.17)
 
Figure 3.11:  Structure of 5-nitrosalicylaldehyde. 
1
H-NMR (d6 DMSO, 270 MHz)  10.3 (1H, s, CHO), 8.4 (1H, d, J=12.1 Hz, ArH), 
8.3 (1H, d, J=8.9 Hz, ArH), 7.2 (1H, d, J=9.1 Hz, ArH). 
 
 
3.2.8 Alizarin 
 
O
O
OH
OH
(3.18)
 
Figure 3.12:  Structure of alizarin. 
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3.2.9 3-Hydroxyflavone 
 
 
OH
O
O
(3.19)
 
Figure 3.13:  Structure of 3-hydroxyflavone. 
 
 
 
3.2.10 5,7-Dichloro-8-hydroxy-2-methylquinoline 
 
 
OH
Cl
Cl CH3N
(3.20)
 
 
Figure 3.14:  Structure of 5,7-dichloro-8-hydroxy-2-methylquinoline. 
 
 
 
 
 
 
 
 
109 
 
3.3 Results 
  
As for the chromogenic compounds, the majority of the potential chelating 
compounds showed some coloration, especially in highly alkali conditions.  Again, 
this is probably due to the precence of hydroxyl groups capable of ionisation.  
Colours were recorded across the pH range, the absorption spectra measured and any 
flourescence observed under U.V. light (~350 nm) was also recorded.  
The core compounds (100 mg/L) were dissolved in 50% (v/v) ethanol water and the 
pH adjusted with either HCl (0.2 M) or NaOH (0.2 M).  
To investigate any chelation effects, samples of these compounds at pH 7, as 
described above, were mixed with a selection of metal sulfate salts, i.e. aluminium, 
cobalt, ferrous, ferric ammonium, magnesium and zinc sulphates (500 mg/L),  the 
results of which were recorded in Tables 3.1a and 3.1b.  
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Table 3.1a:  pH effect and metal interaction of chelating core compounds.  Colour change due to 
varying pH, (top row); possible chelation with different metal ions (bottom row). 
Chelating compound pH 
    3       5       7        9      11     13 
    Al      Co    Fe2+   Fe3+   Mg    Zn 
2(3,4-dihydroxybenzylidene)- 
1,3-indandione 
 
 
3,4-dihydroxybenzylidene  
benzhydrazide 
 
 
3,4-dihydroxybenzylidene  
isonicotinic hydrazide 
 
 
7,8-dihydroxy-4-methylcoumarin 
 
 
7,8-dihydroxy-4-methylcoumarin  
under U.V. 
 
 
1-methyl-2-phenyl-3-hydroxy- 
4(1H)-quinolone 
 
 
1-methyl-2-phenyl-3-hydroxy- 
4(1H)-quinolone under U.V. 
 
 
1-methyl-2-(4-fluorophenyl)- 
3-hydroxy-4(1H)-quinolone 
 
 
1-methyl-2-(4-fluorophenyl)- 
3-hydroxy-4(1H)-quinolone under U.V. 
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Table 3.1b:   pH effect and metal interaction of chelating core compounds continued. 
 
Chelating compound pH 
    3       5       7        9      11     13 
   Al     Co    Fe2
+ 
 Fe3
+
  Mg    Zn 
5-nitrosalicylaldehyde 
 
 
alizarin 
 
 
3-hydroxyflavone 
 
 
3-hydroxyflavone 
 
 
5,7-dichloro-8-hydroxy-2-methylquinoline 
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Spectrum scans from 300 to 700 nm were recorded at each pH using a Biotek 
Synergy multi-detection microplate reader.  A representative sample of these can be 
seen below in Figures 3.15, 3.16 and 3.17 (others appear in Appendix B). 
 
Figure 3.15:  Spectrum scan of 2(3,4-dihydroxybenzylidene)-1,3-indandione. 
 
 
Figure 3.16:  Spectrum scan of 5-nitrosalicylaldehyde. 
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Figure 3.17:  Spectrum scan of alizarin. 
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3.4 Discussion 
 
Again these results showed compounds such as 2-(3,4-dihydroxybenzylidene)-1,3-
indandione and alizarin had possible uses as pH indicators due to their variation in 
colour across the pH range.  Both of these also produced a range of colours when 
chelated with metal ions.  It was also noted that some alizarin chelates, such as those 
with iron and magnesium, precipitated out of solution. 
Other compounds of interest included 5-nitrosalicylaldehyde, which gave a strong 
yellow coloration even at pHs on the acidic side of neutral.  With the addition of 
ferrous iron, this coloration was darkened making it more intense. 
3-Hydroxyflavone gave some coloration just above neutrality but its most striking 
characteristics were its fluorescence and its ability to form chelates, which altered or 
enhanced this fluorescence. 
1-Methyl-2-phenyl-3-hydroxy-4(1H)-quinolone and its fluoro analogue were also 
highly fluorescent and again this could be altered or enhanced with metal chelation. 
Other compounds that showed no or little coloration darkened when chelated to 
ferrous iron and it was thought even this trait could be exploited.   
As with the chromogenic core compounds, several of these chelating compounds 
were subject to glycosidation and the results of this are given later in the appropriate 
section. 
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CHAPTER FOUR 
Glycosides and other derivatives 
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4.1 Glycosides introduction 
 
Most of the derivatives of the molecules mentioned have been of the glycoside class; 
although certain esters have been synthesised, targeting the glycosidase and esterase 
enzymes, which are widely distributed across a variety of bacteria and also in both 
the animal and plant kingdoms. 
In microbial identification systems, glycosidases are widely targeted.  This has 
previously been described in the introduction section related to indoxylic and other 
glycosidic substrates. 
The synthesis of glycosides depends largely on whether the attempted glycoside is of 
the α or β type.  In the main, the β-glycosidases have been examined predominantly.  
These are widely distributed and have been useful in the identification of coliforms, 
E. coli and many other organisms.  More recently, the α-glycosides have assumed 
prominence, particularly with respect to such organisms as Staphylococcus aureus 
and Salmonella spp, where α-glucosidase and α-galactosidase have been specifically 
targeted for identification purposes. 
Several methods of synthesis of β-glucosides have been used dating back to the work 
of Koenigs and Knorr in the late 19
th
 Century and, in fact, the Koenigs-Knorr method 
is still widely used today, although often substantially modified.  Essentially, the 
Koenigs-Knorr method uses an activated form of the sugar which is to be attached to 
the aglycone.  This activation is usually through the possession of a halogen atom, 
very frequently bromine, at the anomeric position, i.e. position 1 of the sugar 
molecule.  The other hydroxyl groups require protection and this is usually done by 
acetylation, although, in some cases, where extra stability is required or alternatively 
there is a need for removal by hydrogenolysis rather than hydrolysis, the benzyl 
group is employed.  Most commonly, however, compounds such as 1-bromo-2,3,4,6-
tetraacetyl galactopyranose (Figure 4.1) are used.  This compound is frequently 
referred to as acetobromogalactose and has the α-configuration as normally made.  
The possession of the α-configuration is not unusual, since the α form is usually the 
most stable and, in the course of transfer of the sugar unit to an aglycone, there is an 
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inversion of configuration such that the use of the α-bromo compound produces the 
β-glycoside.  
O
O
O
CH3
CH3
CH3
O
OO
Br
O
CH3
O
O
 
Figure 4.1:  Structure of acetobromo-α-D-galactose. 
 
Certain of these activated sugar units are commercially available, in particular, so-
called α-acetobromoglucose and α-acetobromogalactose (Sigma).  The others can be 
made by relatively straightforward means involving the use of acetic anhydride and 
bromine plus red phosphorus to generate the hydrogen bromide necessary for 
bromination at the anomeric position.  In a typical method, the aglycone is reacted 
with e.g. α-acetobromoglucose in a mixture of water and acetone, necessary to obtain 
homogeneity in the presence of a base such as sodium hydroxide or potassium 
hydroxide.  As the reaction proceeds, a substitution occurs leading to the elimination 
of the Br
-
 ion which is taken up by the alkali.  It is necessary in such reactions to 
check the pH periodically because, as the pH falls, the reaction tends to slow down 
and precipitation of the aglycone frequently occurs.  It is common practice therefore 
to add small quantities of alkali during the Koenigs-Knorr reaction. 
The protected glycoside can be isolated by standard means and the acetyl group 
subsequently removed by using alkali, either sodium hydroxide or, if the molecule 
tends to be unstable, sodium methoxide in absolute methanol is more frequently 
employed.  This method has been commonly used in the present work. 
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A modification of this method involves dissolving the aglycone as the sodium or 
potassium salt in anhydrous dimethylformamide and adding the α-acetobromo sugar.  
This has the advantage of avoiding aqueous conditions which can lead to degradation 
of the glycosidating agent. 
A third procedure which also involves non-aqueous conditions is reported by 
Haughland (Haughland, 2002).  In this, the aglycone is dissolved in dichloromethane 
with the aid of a base.  Generally, a pyridine based compound is used: 2,6-lutidine or 
2,4,6-collidine.  The silver carbonate is added and, after the addition of the α-
acetobromo sugar, the reaction proceeds at room temperature.  Glycosidation is 
accompanied by release of the bromide ion, which is trapped by the silver carbonate 
to form insoluble silver bromide.  This tends to drive the reaction towards 
completion.  It is possible to get considerably higher yields by this method than by 
the standard Koenigs-Knorr procedure.  However, it is not suitable for all aglycones.  
For example, where a vicinal dihydroxy system exists, it has been found that 
complexation with silver ions can occur which inhibits the glycosidation. 
Consequently, a variety of methods have been attempted in this particular project, 
depending upon the nature of the aglycone. 
The following core molecules have been subject to glycosidation: 
 2-hydroxy-1-naphthaldehyde 
 1-nitrovinyl-2-naphthol 
 4-hydroxy-3-methoxycinnamylidene-1,3-indandione 
 4-hydroxy-3-methoxycinnamylidene-5-phenylisoxazolone 
 5-nitrosalicylaldehyde 
 7,8-dihydroxy-4-methylcoumarin 
 alizarin 
 3-hydroxyflavone 
 1-methyl-2-(4’-fluorophenyl)-3-hydroxy-4(1H)-quinolone 
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 5,7-dichloro-8-hydroxy-2-methylquinoline 
 naphthofluorescein 
 p-naphtholbenzein 
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4.2 Glycosides experimental methods and mechanisms 
 
4.2.1 Synthesis of 2-hydroxy-1-naphthaldehyde-β-D-galactoside 
 
A Koenigs-Knorr reaction using 2,6-lutidine  and silver carbonate was performed. 
2-Hydroxy-1-naphthaldehyde (2.7) (1.72 g, 10 mmol) was dissolved in dry DCM (20 
ml), and 2,6 lutidine (4.1) (2 ml, 20 mmol) was added.  The solution was then stirred 
for 15min.  Silver carbonate (2.75 g, 10 mmol) was added and then stirred for 10 
min.  Acetobromo-α-D-galactose (4.2) (4.1 g, 10 mmol) was added and then stirred 
for a further 24 h.  A sample was taken for TLC using ethyl acetate as a solvent.  The 
TLC plate was flooded with Brady’s reagent (see Appendix A).  A red spot at the 
solvent front indicated unreacted 2-hydroxy-1-naphthaldehyde.  The TLC plate was 
then flooded with charring reagent (see Appendix A) and gently heated on a hot 
plate.  A black or charred spot on the baseline showed unreacted acetobromo-α-D-
galactose and a black spot on the solvent front showed acetylated 2-hydroxy-1-
naphthaldehyde-β-D-galactoside (4.3).  The reaction was allowed to progress for 
another 24 h at which time TLC showed only a small red spot at the solvent front 
when flooded with Brady’s reagent and a small black or charred spot on the baseline 
and a large black spot at the solvent front when charred.   
A bed of silica gel 2 cm deep was made in a sintered-glass funnel and primed with 
DCM (20 ml).  The solution was then poured into the funnel and the filtrate 
collected.  More DCM (20 ml) was poured into the funnel and also collected.  TLC 
of the filtrate showed no free 2-hydroxy-1-naphthaldehyde as no red spot was 
observed with the addition of Brady’s reagent.   The filtrate was placed in a 250 ml 
separating funnel and washed with sodium bicarbonate (50 ml, 0.2 M), then three 
time with hydrochloric acid (50 ml, 0.2 M) and finally with distilled H2O (50 ml)  
The DCM solution was then placed in a 250 ml conical flask with excess dry 
magnesium sulphate and stirred for 1 h, then filtered.  The solution was evaporated 
under reduced pressure at 40 °C using a rotary evaporator, then dried in a vacuum 
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desiccator to give a 3.0 g, 59.7%, yield of acetylated 2-hydroxy-1-naphthaldehyde-β-
D-galactoside (Figure 4.2). 
Removal of the acetyl groups from the protected galactoside (de-protection) was 
attempted with sodium methoxide (2 ml, 200 mmol) (see Appendix A) but failed to 
give rise to a product from which a successful compound could be isolated. 
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-
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O
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-
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O
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O
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O
O
O
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O
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tetraacetyl 
2-hydroxy-1-naphthaldehyde-
-D-galactoside
:
H
HO
O
acetobromo- -D-galactose
+
(2.7) (4.1)
(4.3)
(4.2)
 
Figure 4.2:  Formation of tetraacetyl 2-hydroxy-1-naphthaldehyde-β-D-galactoside.  Glycosidation 
via Koenigs-Knorr lutidine/silver carbonate method, deprotection using sodium methoxide failed. 
 
Analytical data 
1
H-NMR (d6-DMSO, 270 MHz)  10.5 (1H, s, CHO) 9.1 (1H, d, J=8.2 Hz, ArH), 
7.2-8.5 (difficult to interpret ArH), 4.0-6.0 (7H, difficult to interpret AlH) 1.9-2.2 
(12H, 4s, AlH). Impure. 
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4.2.2 Synthesis of 1-nitrovinyl-2-naphthol-β-D-galactoside 
 
A Koenigs-Knorr method using 2,6-lutidine  and silver carbonate was performed. 
1-nitrovinyl-2-naphthol (2.8) (2 g, 10 mmol) was placed in a 100 ml conical flask 
with 30ml DCM and stirred.  2,6 Lutidine (4.1) (2 ml, 20 mmol) was then added and 
stirred for 15 min.  Silver carbonate (2.75 g, 10 mmol) (see Appendix A) was added 
and then stirred for 10 min.  Acetobromo-α-D-galactose (4.2) (4.1 g, 10 mmol) was 
added and then stirred for a further 24 h.  A sample was taken for TLC using ethyl 
acetate as a solvent showed two spots, one on the solvent front and another trailing.  
On exposure to ammonia the front spot gave a purple colour (1-nitrovinyl-2-
naphthyl) and when flooded with charring reagent (see Appendix A) and gently 
heated on a hot plate the trailing spot blackened (acetylated 1-nitrovinyl-2-naphthyl-
β-D-galactoside (4.4)).   
A bed of silica gel 2 cm deep was made in a sintered-glass funnel and primed with 
DCM (20 ml).  The solution was then poured into the funnel and the filtrate 
collected.  More DCM (20 ml) was poured into the funnel and also collected.  TLC 
of the filtrate showed no free 1-nitrovinyl-2-naphthol as a purple spot when exposed 
to ammonia, but there was still a charred spot.  The filtrate was placed in a 250 ml 
separating funnel and washed with sodium bicarbonate (50 ml, 0.2 M), then three 
times with hydrochloric acid (50 ml, 0.2 M) and finally with H2O (50 ml).  The DCM 
solution was then placed in a 250 ml conical flask with excess dry magnesium 
sulphate and stirred for 1 h, then filtered.  The solution was evaporated under 
reduced pressure at 40 °C using a rotary evaporator, then dried in a vacuum 
desiccator (1.35 g yield, 24.7%).  The foam was dissolved in methanol (20 ml).   
Sodium methoxide (2 ml, 200 mmol) (see Appendix A) was added to the methanol 
solution, stirred briefly then chilled at 4 °C for 24 h to allow de-protection (4.5-4.8).    
The solution was evaporated under reduced pressure to ~25 ml at 60 °C then allowed 
to recrystallise by cooling the flask on ice (0 °C) for 1 h.  The sand coloured 1-
nitrovinyl-2-naphthol-β-D-galactoside (4.8) crystals were filtered under pressure then 
dried in a vacuum desiccator (1 g yield, 74.0%), (Figure 4.3). 
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Figure 4.3:  Formation of 1-nitrovinyl-2-naphthol-β-D-galactoside.  Glycosidation via Koenigs-Knorr 
lutidine/silver carbonate method; deprotection using sodium methoxide. 
 
NMR in d6-DMSO not possible due to the insolubility of the compound. 
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4.2.3 Synthesis of 4-β-D-galactosidoxy- and 4-β-D-glucosidoxy-3-
methoxycinnamylidene-1,3-indandione 
 
4-β-D-Galactosidoxy-3-methoxycinnamylidene-1,3-indandione 
A Koenigs-Knorr reaction using potassium hydroxide as a base was performed. 
4-Acetoxy-3-methoxycinnamylidene-1,3-indandione (2.12) was hydrolysed via the 
following method:   4-acetoxy-3-methoxycinnamylidene-1,3-indandione (2.6 g, 7.5 
mmol) and methanol (75 ml) were added to a 250 ml conical flask and stirred at 0 °C 
in an ice bath.  Potassium hydroxide (1.1 g, 20 mmol) was dissolved in distilled H2O, 
(5 ml) added to the above suspension and stirred for 2 h.  Ice (100 g) was then added 
and the pH adjusted to pH 3 using 2 M hydrochloric acid.  The resulting precipitate 
was filtered under pressure then dried in a vacuum desiccator (2.2 g yield, 95.8%). 
4-Hydroxy-3-methoxycinnamylidene-1,3-indandione (2.14) (1.53 g, 5 mmol) and 
acetone (15 ml) were placed in a 50 ml conical flask and stirred.  Potassium 
hydroxide (0.28 g, 5 mmol) was dissolved in distilled H2O (2 ml) and then added to 
the above suspension.  The pH was measured with Whatman Universal Indicator 
papers and found to be pH 12 then stirred for 30 min.  Acetobromo-α-D-galactose 
(4.2) (2.46 g, 6 mmol) was dissolved in acetone (2 ml) and added and stirring 
continued for 24 h.  The pH was regularly adjusted to pH 12 using potassium 
hydroxide (0.28 g, 5 mmol).  TLC using ethyl acetate as a solvent showed a yellow 
band (product) at the solvent front and a blue spot on the base line (starting material) 
when exposed to ammonia fumes.  The reaction was allowed to continue for a further 
24 h, after which TLC showed the yellow band and a smaller blue spot with exposure 
to ammonia fumes.  The solution was then evaporated at 40 °C using a rotary 
evaporator.  Dichloromethane (50 ml) was used to re-dissolve the product which was 
then transferred to a 250 ml conical flask.  Anhydrous magnesium sulphate (1 g) was 
added and stirred for 1 h to remove any water.  The magnesium sulphate was 
removed by filtration and then discarded.  Alumina (1 g) was added to the solution 
and stirred for 1 h to remove any unreacted starting material.  The alumina was 
removed by filtration and discarded.  TLC using ethyl acetate as a solvent showed 
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only a yellow band at the solvent front and a no blue spot on the base line when 
exposed to ammonia fumes. The solution was transferred to a 100 ml round bottom 
flask then evaporated under reduced pressure to a ‘foam’ at 40 °C (yield 1.5 g, 47.1% 
of acetylated 4-β-D-galactosidoxy-3-methoxycinnamylidene-1,3-indandione (4.9)).  
The foam was dissolved in methanol (50 ml).   
De-protection was performed with sodium methoxide as in previous glycosidations.  
The 4-β-D-galactosidoxy-3-methoxycinnamylidene-1,3-indandione (4.10) crystals 
were filtered under pressure then dried in a vacuum desiccator (0.7 g yield, 63.3%) 
(Figure 4.4). 
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Figure 4.4:  Formation of 4-β-D-galactosidoxy-3-methoxycinnamylidene-1,3-indandione.  
Glycosidation via Koenigs-Knorr potassium hydroxide method, deprotection using sodium methoxide. 
 
NMR in d6-DMSO - Spectrum too weak for analysis. 
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4-β-D-Glucosidoxy-3-methoxycinnamylidene-1,3-indandione 
4-β-D-glucosidoxy-3-methoxycinnamylidene-1,3-indandione (4.11) was synthesised 
as for 4-β-D-galactosidoxy-3-methoxycinnamylidene-indandione but acetobromo-α-
D-galactose was replaced with acetobromo-α-D-glucose (4.15) (yield 0.75 g, 67.8%) 
(Figure 4.5). 
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Figure 4.5:  Structure of 4-β-D-glucosidoxy-3-methoxycinnamylidene-1,3-indandione. 
 
 
NMR in d6-DMSO - Spectrum too weak for analysis. 
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4.2.4 Synthesis of 5-nitrosalicylaldehyde-β-D-galactoside 
 
This compound had previously been synthesised (Kroger and Thiem, 2007) but its 
biomedical properties had not been evaluated in great detail. 
A Koenigs-Knorr reaction using 2,6-lutidine  and silver carbonate was performed as 
for 4.2.2.  5-Nitrosalicylaldehyde (3.17) (1.67 g, 10 mmol) and acetobromo-α-D-
galactose (4.2) (4.1 g, 10 mmol) were reacted to give acetylated nitrosalicylaldehyde-
β-D-galactoside (3.1 g, 62.3%, yield). 
De-protection was performed with sodium methoxide as in previous glycosidations.  
The 5-nitrosalicylaldehyde-β-D-galactoside crystals (4.13) were filtered under 
pressure then dried in a vacuum desiccator (1.72 g, 83.8% yield) (Figure 4.6). 
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Figure 4.6:  Structure of 5-nitrosalicylaldehyde-β-D-galactoside. 
 
Analytical data 
Mp 198-201 ºC (lit. 203 ºC). 
1
H-NMR (d6-DMSO, 270 MHz)  10.3 (1H, s, CHO), 8.5 (1H, d, J=8.0 Hz, ArH), 
8.3 (1H, d, J=6.4 Hz, ArH), 7.1 (1H, d, J=8.9 Hz, ArH), 4.7 (1H, d, J=15.1 Hz, AlH), 
3.2-3.8 (?H, om, AlH). 
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4.2.5 Synthesis of 7,8-dihydroxy-4-methylcoumarin-β-D-glucoside 
 
A Koenigs-Knorr reaction using potassium hydroxide as a base was performed as for 
4.2.3. 7,8-Dihydroxy-4-methylcoumarin (3.9) (0.96 g, 5 mmol) and 
acetobromoglucose (4.15) (3.1 g, 7.5 mmol) were reacted but, due to poor yield (<50 
mg), the Koenigs-Knorr method using 2,6-lutidine  and silver carbonate was 
attempted. 
 
Alternative method for 7,8-dihydroxy-4-methylcoumarin-β-D-glucoside 
A Koenigs-Knorr reaction using 2,6-lutidine  and silver carbonate was performed as 
for 4.2.2.  7,8-Dihydroxy-4-methylcoumarin (3.9) (0.96 g, 5 mmol) and 
acetobromoglucose (4.15) (2.1 g, 5 mmol) were reacted to give acetylated 7,8-
Dihydroxy-4-methylcoumarin. 
De-protection was performed with sodium methoxide as in previous glycosidations.  
The solid was recrystallised from hot ethanol.  TLC showed a single spot on the 
baseline that charred.  The 7,8-dihydroxy-4-methylcoumarin-β-D-glucoside (4.14) 
crystals were filtered then dried in a vacuum desiccator (0.8 g, 45.2%, yield) (Figure 
4.7).   
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Figure 4.7:  Structure of 7,8-dihydroxy-4-methylcoumarin-β-D-glucoside. 
 
NMR in d6-DMSO - Spectrum too weak for analysis. 
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4.2.6 Synthesis of alizarin-2-yl-β-D-glucoside and β-D-galactoside 
 
Synthesis of alizarin-2-yl-β-D-glucoside 
The galactoside analogue of this compound had previously been synthesised (James 
et al., 2000b) and a modified method was followed to produce the glucoside. 
A Koenigs-Knorr reaction using potassium hydroxide as a base was performed. 
Alizarin (3.18) (6 g, 25 mmol) was placed in a 250 ml conical flask and suspended in 
acetone (70 ml).  To this, aqueous potassium hydroxide (70 ml, 0.3 M) was added 
and stirred.  Acetobromo-α-D-glucose (4.15) (10.3 g, 25 mmol) was dissolved in 
acetone (10 ml) then added to the above solution and stirred for 12 h.  More aqueous 
potassium hydroxide (10 ml, 1.25 M) was added, followed by acetobromo-α-D-
glucose (4.1 g, 10 mmol) dissolved in acetone (5 ml).  The solution was stirred for a 
further 12 h.  The acetone was then removed by rotary evaporation at 40 °C.  The pH 
of the solution was lowered to pH 5 by the addition of glacial acetic acid.  The 
resulting precipitate was filtered and washed with cold H2O (50 ml).  TLC, using 
ethyl acetate as a solvent, showed free alizarin as a red spot near the solvent front and 
also tetraacetyl-alizarin-glucoside as a pale yellow spot trailing that charred  The 
solid was dried in a vacuum dessicator then dissolved in DCM (200 ml) and 
triethylamine (2 ml, 20 mmol) added.  Basic alumina was added until TLC showed 
no free alizarin remained in solution by the lack of a red spot near the solvent front.  
The solution was filtered and the filtrate was rotary evaporated at 40 °C to dryness.  
A yellow solid was produced (4.9 g, 34.4%, yield).  
Tetraacetyl alizarin-2-yl-β-D-glucoside (4.16) (1.1 g, 2 mmol) was added to methanol 
(60 ml) and stirred.  Aqueous sodium hydroxide (30 ml, 0.125 M) was added to 
deprotect and gave a red solution.  The solution was heated at 65 °C for 15 min, then 
cooled to 0 °C.  The resulting precipitate (sodium salt of alizarin-2-yl-β-D-glucoside 
(4.17)) was filtered and washed with ether (30 ml) then dried in a vacuum dessicator 
(0.5 g, 62.1% yield) (Figure 4.8) 
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Figure 4.8:  Formation of alizarin-2-yl-β-D-glucoside.  Glycosidation via Koenigs-Knorr potassium 
hydroxide method, deprotection using sodium hydroxide. 
Analytical data 
Mp 240-242 (lit. 237ºC). 
1
H-NMR (d6-DMSO, 270 MHz)  8.2 (1H, d, J=7.6 Hz,  ArH), 8.1 (1H, d, J=7.6 Hz,  
ArH), 7.8 (1H, t, J=7.1 Hz,  ArH), 7.7 (1H, t, J=7.6 Hz,  ArH), 7.0 (2H, d, J=8.3 Hz,  
ArH), 4.7 (1H, d, J=7.8 Hz,  AlH), 3.0-4.0 (?H, om, AlH). 
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Synthesis of alizarin-2-yl-β-D-galactoside 
Alizarin-2-yl-β-D-galactoside (4.18) had previously been synthesised and evaluated 
as a substrate to differentiate bacteria (James et al., 2000b), but the synthesis was 
repeated as the application of this substrate as a molecular biology tool was 
investigated later in this study. 
 
The synthesis was as for alizarin-2-yl-β-D-glucoside but acetobromo-α-D-galactose 
(4.2) (10.3 g, 25mmol) was substituted for acetobromo-α-D-glucose (yield 0.55 g, 
68.3%) (Figure 4.9). 
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Figure 4.9:  Structure of alizarin-2-yl- -D-galactoside. 
 
Analytical data 
Mp 242ºC (lit. 237ºC). 
1
H-NMR (d6-DMSO, 270 MHz)  8.3 (1H, d, J=7.4 Hz, ArH), 8.1 (1H, d, J=7.4 Hz, 
ArH), 7.8 (1H, t, J=7.2 Hz, ArH), 7.7 (1H, t, J=7.3 Hz, ArH), 7.1 (2H, d, J=8.2 Hz, 
ArH), 4.7 (1H, d, J=7.7 Hz, AlH), 3.0-4.0 (?H, om, AlH). 
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4.2.7 Synthesis of 3-hydroxyflavone-β-D-glucoside and β-D-galactoside 
 
Synthesis of 3-hydroxyflavone-β-D-glucoside 
A Koenigs-Knorr reaction using potassium hydroxide as a base was performed as for 
4.2.3.  3-Hydroxyflavone (3HF) (3.19) (4.76 g, 20 mmol) and acetobromo-α-D-
glucose (4.15) (8.2 g, 20 mmol) were reacted.  When deprotected yielded 4.5 g, 
56.2%, (Figure 4.10) 3-hydroxyflavone-β-D-glucoside (4.19). 
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Figure 4.10:  Structure of 3-hydroxyflavone-β-D-glucoside. 
 
Analytical data 
Mp 178-180 ºC. 
1
H-NMR (d6-DMSO, 270 MHz)  8.2 (2H, t, J=4.9 Hz,  ArH), 7.7-7.9 (3H, t, J=7.8 
Hz, ArH), 7.4 (4H, om, ArH), 3.0-5.5 (11H, om, AlH). 
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Alternative method for the synthesis of 3-hydroxyflavone- β-D-glucoside 
A Koenigs-Knorr reaction using 2,6-lutidine  and silver carbonate was performed as 
for 4.2.2.  3-Hydroxyflavone (3.19) (0.28 g, 5 mmol) and acetobromo-α-D-glucose 
(4.15) (3 g, 7.5 mmol) were reacted and when deprotected gave 0.1 g, 6.1 % yield of 
3-hydroxyflavone- β-D-glucoside (4.19).   
 
Synthesis of 3-hydroxyflavone-β-D-galactoside 
This compound had been previously synthesised (Chen et al., 2006).  3-
Hydroxyflavone-β-D-galactoside (4.20) was prepared as for 3-hydroxyflavone-β-D-
glucoside (Koenigs-Knorr method using potassium hydroxide), but acetobromo-α-D-
galactose (4.2) (8.2 g, 20 mmol) was substituted for acetobromo-α-D-glucose (yield 
4.0 g, 50.0%), (Figure 4.11). 
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Figure 4.11:  Structure of 3-hydroxyflavone-β-D-galactoside. 
 
Analytical data 
Mp 180-181 ºC (lit. 175-177 ºC). 
1
H-NMR (d6-DMSO, 270 MHz)  8.2 (2H, t, J=4.9 Hz,  ArH), 8.1 (1H, t, J=7.9 Hz, 
ArH), 7.9 (1H, t, J=7.8 Hz, ArH), 7.8 (1H, t, J=4.2 Hz, ArH) 7.5 (4H, om, ArH), 3.0-
5.5 (11H, om, AlH). 
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4.2.8 Synthesis of 1-methyl-2-(4’-fluorophenyl)-3-hydroxy- 
4(1H)-quinolone-β-D-glucoside 
 
A Koenigs-Knorr reaction using potassium tert-butoxide as a base was performed. 
1-Methyl-2-(4’-fluorophenyl)-3-hydroxyquinolone (3.15) (1.35 g, 5 mmol) was 
suspended in dimethylformamide (10ml) with potassium tert-butoxide (0.56 g, 5 
mmol) to form a potassium salt.  The suspension was stirred until dissolved, then 
acetobromoglucose (4.15) (1.03 g, 2.5 mmol) was added.  After 4 h, more 
acetobromoglucose (1.03 g, 2.5 mmol) was added and the solution was stirred for a 
further 24 h. TLC, using ethyl acetate as a solvent, showed a large spot above the 
base line which fluoresced green under U.V. light (1-methyl-2-(4’-fluorophenyl)-3-
hydroxyquinolone) and a small spot near the solvent front which fluoresced blue 
under U.V. light and charred (acetylated 1-methyl-2-(4’-fluorophenyl)-3-
hydroxyquinolone-β-D-glucoside).  To increase conversion to the tetraacetyl form, 
18-crown-6 (0.13 g, 0.5 mmol) was added and the reaction stirred for another 24 h.  
TLC showed the reaction had not progressed therefore this method was abandoned. 
 
Alternative method for 1-methyl-2-(4’-fluorophenyl)-3-hydroxy-4(1H)-quinolone-β-
D-glucoside 
A Koenigs-Knorr reaction using 2,6-lutidine  and silver carbonate was performed as 
for 4.2.2.  1-Methyl-2-(4’-fluorophenyl)-3-hydroxyquinolone (3.15) (1.35 g, 5 mmol) 
and acetobromoglucose (4.15) (2.9 g, 7 mmol) were reacted to produce acetylated 1-
methyl-2-(4-fluorophenyl)-3-hydroxyquinolone-β-D-glucoside (1.5 g, 50.0%, yield).   
De-protection was performed with sodium methoxide as in previous glycosidations 
(0.92 g, 85.3%, yield 1-methyl-2-(4’-fluorophenyl)-3-hydroxy-4(1H)-quinolone-β-D-
glucoside (4.21)) (Figure 4.12). 
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Figure 4.12:  Structure of 1-methyl-2-(4’-fluorophenyl)-3-hydroxy-4(1H)-quinolone-β-D-glucoside. 
 
Analytical data 
1
H-NMR (d6-DMSO, 270 MHz)  7.0-8.3 (8H, om, ArH), 4.9(1H, d, J=3.5 Hz, 
ArH), 2.3 (3H, s, CH3), 2.8-4.3 (?H, om, AlH).  Impure. 
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4.2.9 Synthesis of 5,7-dichloro-8-hydroxy-2-methylquinoline-β-D-galactoside 
 
A Koenigs-Knorr reaction using potassium hydroxide as a base was performed as for 
4.2.3.  5,7-Dichloro-8-hydroxy-2-methylquinoline (Sigma) (3.20) (1.14 g, 5 mmol) 
and acetobromo-α-D-galactose (4.2) (2 g, 5 mmol) were reacted to give acetylated 
5,7-dichloro-8-hydroxy-2-methylquinoline-β-D-galactoside (1.6 g, 57.3%, yield).  
The solid was dissolved in methanol (20ml).   
De-protection was performed with sodium methoxide as in previous glycosidations 
(0.95 g, 85.0% yield of 5,7-dichloro-8-hydroxy-2-methylquinoline-β-D-galactoside 
(4.22)) (Figure 4.13).   
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Figure 4.13:  Structure of 5,7-dichloro-8-hydroxy-2-methylquinolone-β-D-galactoside. 
 
Analytical data 
Mp 242 ºC. 
1
H-NMR (d6-DMSO, 270 MHz)  8.5 (1H, d, J=8.6 Hz, ArH), 7.9 (1H, s, ArH), 7.7 
(1H, d, J=8.6 Hz, ArH), 6.4 (1H, om, ArH), 5.1-5.2 (2H, dd, J1=7.6 Hz, J2=6.0 Hz, 
ArH), 4.5-4.7 (2H, dd, J1=4.5 Hz, J2=4.4 Hz, AlH), 3.3-3.8 (?H, om AlH), 2.7 (3H, s, 
CH3). 
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4.2.10 Synthesis of naphthofluorescein-β-D-glucoside 
 
A Koenigs-Knorr reaction using potassium hydroxide as a base was performed as for 
4.2.3.  Naphthofluorescein (2.23) (1.3 g, 3 mmol) and acetobromo-α-D-glucose 
(4.15) (2.06 g, 5 mmol) were reacted but, it was not possible to dry the 
naphthofluorescein-tetraacetyl-glucoside therefore the deprotection was not 
attempted. 
 
Alternative method for the synthesis of naphthofluorescein-β-D-glucoside 
A Koenigs-Knorr reaction using 2,6-lutidine  and silver carbonate was performed as 
for 4.2.2.  Naphthofluorescein (2.23) (1.3 g, 3 mmol) and acetobromoglucose (4.15) 
(2.5 g, 6 mmol) were reacted to give acetylated naphthofluorescein-β-D-glucoside 
(1.42 g, 62.1%, yield). 
Removal of the acetyl groups from the protected galactoside (de-protection) was 
attempted with sodium methoxide (2 ml, 200 mmol) (see Appendix A) but failed to 
give rise to a product from which a compound could be isolated successfully. 
NMR in d6-DMSO not possible due to the insolubility of the compound. 
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4.2.11 p-Naphtholbenzein-β-D-galactoside 
 
This synthesis was not attempted, since a galactoside sample of p-naphtholbenzein 
(4.23) had already been prepared (James et al., 2000a) (Figure 4.14)  via the 
Koenigs-Knorr method using potassium hydroxide as a base and had been evaluated 
by Prof. J. Perry at Freeman Hospital.  However, the application of this substrate as a 
molecular biology tool was investigated later in this sudy.  Also the microbiological 
results of this substrate were included for comparative purposes.  
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Figure 4.14:  Structure of p-naphtholbenzein-β-D-galactoside. 
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4.3 Carboxylic esters introduction 
 
It was decided to concentrate mainly on the esters since these have value in 
microbiological identification of Salmonella spp. (Manafi and Sommer, 1992; Cooke 
et al., 1999; Perez et al., 2003). 
Because esters are frequently relatively unstable, the synthesis of esters was confined 
to the molecule of alizarin, since it had been found previously that the esters of this 
dihydroxy compound are relatively stable in comparison to other phenolic esters. 
The following esters were synthesised: 
 Alizarin-2-octanoate 
 Alizain-2-palmitate 
 Alizarin benzoate 
 
These were prepared by a standard technique involving the particular acid chloride.  
It was necessary to use an acyl chloride or an acyl halide or an acyl anhydride in this 
procedure to form the particular ester.   
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4.4 Carboxylic esters experimental methods and mechanisms 
 
4.4.1 Synthesis of alizarin-2-octanoate 
 
This compound had been previously synthesised (Mellidis and Papageorgiou, 1986), 
but its biological properties had not been evaluated. 
Alizarin (3.18) (4.8 g, 20 mmol) and dry dichloromethane (150 ml) were added to a 
500 ml round bottomed flask and stirred until dissolved.  Triethylamine (4.24) (4.1 g, 
40 mmol) was then added and stirred.  
Octanoyl chloride (4.25) (3.25 g, 20 mmol) was dissolved in dry dichloromethane 
(10 ml) then dripped into the above alizarin solution and stirred for 1 h.  The solution 
went from purple to an orange/yellow colour.  Thin layer chromatography (TLC), 
performed in ethyl acetate, showed a leading yellow spot (alizarin-2-octanoate) with 
a purple trail (alizarin).  To remove some of the unreacted alizarin, aluminium oxide 
(25 g) was added and stirred for 15 min then the mixture was filtered. 
The pH of the solution was then neutralized by the addition of acetic acid.  As the pH 
decreased the colour changed from orange/yellow to yellow.  The solution was then 
evaporated under reduced pressure at 40 °C.  Dryness was achieved by increasing the 
temperature to 70 °C to evaporate the last of the liquid.  Yellow crystals were 
formed.  TLC showed a leading yellow spot (alizarin-2-octanoate) with a slight 
purple trail (alizarin). 
The crystals were dissolved in acetone (50 ml), transferred to a 100 ml round 
bottomed flask and rotary evaporated until ~20 ml remained.  60-80 Light petroleum 
(1 ml) was added which caused the alizarin-2-octanoate (4.26) to precipitate, leaving 
the unreacted alizarin in the acetone.  The solution was cooled to -20 °C for 30 min 
to maximise crystallisation then filtered.  TLC showed a single yellow spot with no 
purple trail.  The crystals were dried in a vacuum desiccator (4.3 g, 58.7%, yield) 
(Figure 4.15).  
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Figure 4.15:  Formation of alizarin-2-octanoate. 
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Analytical data 
Mp 122-124 ºC (lit. 121-123 ºC). 
1
H-NMR (d6-DMSO, 270 MHz)  7.5-8.3 (3H, t, J=7.8 Hz, ArH), 2.7 (2H, t, J=7.3 
Hz, CH2), 1.6 (2H, p, J=6.3 Hz, ArH), 1.2 (8H, om, ArH) 0.8 (3H, s, CH3). 
 
 
4.4.2 Synthesis of alizarin-2-palmitate 
 
The procedure for the preparation of 4.4.1 alizarin-2-octanoate was followed 
substituting palmitoyl chloride (4.27) (5.5 g, 20 mmol) for octanoyl chloride.  
Crystallisation was achieved by dissolving the crude material in hot methanol (50 
ml), and cooling to -20 °C (5.3 g, 55.4%, yield of alizarin-2-palmitate (4.28)) (Figure 
4.16). 
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Figure 4.16:  Formation of alizarin-2-palmitate. 
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4.4.3 Synthesis of alizarin-2-benzoate 
 
Alizarin-2-benzoate (4.30) had been previously synthesised (Green, 1927).  The 
procedure for the preparation of 4.4.1 alizarin-2-octanoate was followed substituting 
benzoyl chloride (4.29) (2.8 g, 20 mmol) for octanoyl chloride.  Crystallisation was 
achieved by dissolving the crude material in hot methanol (50 ml) and cooling to -20 
°C (6.0 g, 87.1%, yield) (Figure 4.17). 
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Figure 4.17:  Formation of alizarin-2-benzoate. 
 
Analytical data 
Mp 213-214 ºC (lit. 208-210 ºC). 
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4.5 Results 
 
Examination of the properties of selected glycosides which were synthesised fall into 
three broad categories: 
a) Examination in a microbiological situation, usually as a plate method to 
assess their capability to differentiate between different spp of bacteria. 
b) Molecular biology application as device for the screening of recombinant and 
non-recombinant transformants. 
c) Biochemical characteristics, enzyme assay, kinetics. 
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4.5.1 Microbiological evaluation 
 
The microbiological work was mainly carried out by Proffessor John Perry at 
Freeman Hospital, Department of Microbiology and the author is indebted to him for 
the information and the related photographs which appear subsequently. 
In this section, the results are presented in comparison to various known glycosidase 
substrates which are being used in bacterial identification such as those based on 
Alizarin and p-naphtholbenzein. 
All substrates were dissolved in 1-methyl-2-pyrrolidone (1 ml) then incorporated into 
either Columbia agar (4.06 g/99 ml distilled water) which had previously been 
sterilised, then cooled to 50 °C or, in the case of possible chelators, the same agar, 
but containing 500 mg/L ferric ammonium citrate (FAC) (Table 4.1).  Control plates 
with no substrates, only Columbia agar or Columbia agar containing FAC were also 
prepared. 
 
Table 4.1:  Substrate quantity and media selection. 
Substrate Amount  
(mg) 
Columbia 
agar 
Columbia 
agar + FAC 
alizarin-2-yl-β-D-galactoside 5   
4-β-D-glucosidoxy-3- 
methoxycinnamylidene-1,3-indandione 
20   
3-hydroxyflavone-β-D-glucoside 30   
p-naphtholbenzein-β-D-galactoside 10   
5-nitrosalicylaldehyde-β-D-galactoside 30   
 
The substrates were tested against a range Gram-negative and positive-bacteria and 
also yeasts.  Inocula for each type of microorganism were prepared in physiological 
saline to give a suspension equivalent to 0.5 McFarland units (approximately 
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100,000 colony forming units/μl).  The inocula (1 μl) were applied to the agar plate 
using multi-point inoculation (Denley), the pattern of which can be seen in Figure 
4.18.  The plates were then incubated at 37 °C for 24 h, the results of which can be 
seen in Table 4.2.  Images of the more successful plates can be seen in Figure 4.19. 
 
Figure 4.18:  Pattern of multi-point inoculation.  Numbers correspond to the microorganisms in Table 
4.2
 1  2 
3 4 5 6 7 
8 9 10 11 12 
13 14 15 16 17 
 18 19 20 
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Bacteria Control 
Growth 
Control*  
Growth 
Aliz-gal 
Growth   Colour 
MCI-gluc 
Growth Colour 
3HF-gluc 
Growth   Colour 
PNB-gal 
Growth   Colour 
NSA-gal 
Growth   Colour 
 
Gram negatives              
1 E. coli NCTC 10418 + + + ++Purple + - + Tr.brown + +orange + +orange(D)  
2 S. marcescens NCTC 10211 + + + ++Purple + - + - + +orange + +orange(D)  
3 Ps. Aeruginosa NCTC 10662 + + + - + - + - + - + -  
4 B. cepacia LMG 1222 + + + - + - + - + - + -  
5 Y. enterocolitica NCTC 11176 + + + - + - + - + - + -  
6 S. typhimurium NCTC 74 + ++ + - + - + - + - + -  
7 C. freundii 46262 (wild) + + + ++Purple + - + - + +orange + +orange(D)  
8 M. morganii 462403 (wild) + ++ + - + - + - + - + -  
9 E. cloacae NCTC 11936 + ++ + ++Purple + - + - + +orange + +orange(D)  
10 P. rettgeri NCTC7475 +/- ++ Tr. - Tr. - +/- - +/- - +/- -  
              
Gram Positives              
11 B. subtilis NCTC 6372 + + + - + - + +brown +/- - + -  
12 E. faecalis NCTC 775 + + + ++Purple + - + +brown - - + -  
13 E. faecium NCTC 7171 + + + ++Purple + - + +brown + - + -  
14 St. epidermidis NCTC 11047 + + + - + - + - - - + -  
15 St. aureus NCTC 6571 + + + ++Purple + - + - + - + -  
16 M.R.S.A. NCTC 11939 + + + ++Purple + - + Tr.brown + - + -  
17 S. pyogenes NCTC 8306 + + + - + - + - - - + -  
18 L. monocytogenes NCTC 11994 + + + - + - + ++brown + - + -  
              
Yeasts              
19 C. albicans ATCC 90028 + + + - + - + - + - + -  
20 C. glabrata NCPF 3943 +/- +/- +/- - +/- - +/- - +/- - +/- -  
Table 4.2:  Microbiological evaluation of selected substrates. 
Growth code: +      good,   
  +/-    weak,  
  Tr.    trace,  
-    none. 
 
 
Colouration code:      ++   strong 
        +     moderate 
        Tr.   trace   
         -       none 
        (D)   diffusion of colour 
* Control containing ferric ammonium citrate 
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Figure 4.19:  Multi-point inoculation of (from top left) Aliz-gal, 3HF-gluc, NSA-gal, PNB-gal and 
PNB-gal exposed to NaOH (1 M). 
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The fluorescence properties of 3HF-gluc were evaluated by incorporating the 
substrate in agar as described in Table 4.1, except for replacing ferrous ammonium 
citrate with zinc acetate (500 mg/L).  The agar plate was inoculated with Serratia 
marcescens NCTC 10211 and incubated at 37 °C for 17 h.   
Serratia marcescens NCTC 10211, a β-glucosidase producing Gram-negative 
bacterium, showed no or little activity with the same substrate when tested under the 
conditions described previously.  When exposed to U.V. light, evidence of enzyme 
activity could be seen in the form of fluorescent colonies (Figure 4.20), indicating 
that the fluorescence properties of this substrate were highly sensitive when 
compared to its chromogenic properties. 
 
 
Figure 4.20:  Hydrolysis of 3HF-gluc by Serratia marcescens NCTC 10211 as seen under U.V. light. 
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4.5.2 Biochemical evaluation 
 
To further evaluate 3-hydroxyflavone-β-D-glucoside, an assay with β-glucosidase 
was devised and its reaction kinetics determined. 
 
Enzyme kinetics of 3-hydroxyflavone-β-D-glucoside  
1 mmol of 3-hydroxyflavone (3HF) (Sigma) (Figure 4.21) was dissolved in the 
minimum amount of ethanol and made to one litre with distilled water.   The 
fluorescence maximum (λF) of this core compound (Figure 4.22) was determined 
using a Hitachi F-4000 fluorescence spectrophotometer and found to be Ex 380, Em 
530 nm. 
OH
O
O
 
Figure 4.21:  Structure of 3-hydroxyflavone (3HF). 
 
   
Figure 4.22:  Fluorescence of 3HF. 
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It has been documented that 3HF can chelate with certain metal ions (Cornard and 
Merlin, 2003; Valente et al., 2007) (Figure 4.23) and the products of these chelations 
or complexes have different λF (Boudet et al., 2000; Protti et al., 2008).  These 
changes in λF can be explained by the complexes forming different structures, i.e. 
their shape. 
Zn
2+
O
-
O
O
O
-
O
O
 
Figure 4.23:  3HF chelation with zinc. 
 
The effects of three possible metal chelations were investigated; aluminium, 
magnesium and zinc (Table 4.3).  From these preliminary measurements, zinc was 
selected for further study as it gave the greatest increase in fluorescence.  
 
Table 4.3:  Fluorescence of 3HF metal complexes.  1 mmol/L 3HF was dissolved in 50% (v/v) 
ethanol and varying amounts of metal (2, 10 and 100 μmoles) were added. 
Metal λF 2 μmoles 10 μmoles 100 μmoles  
Aluminium 390Ex 460Em 55 60 25  
Magnesium 418Ex 480Em 522 248 26  
Zinc 408Ex 475Em 1048 522 37  
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A more in depth study was made of the effect zinc concentration had on fluorescence 
(Figure 4.24). 
 
 
Figure 4.24:  Fluorescence measurements of 3HF + varying amounts of zinc compared to the effects 
of the same quantities of 3HF and zinc separately. 
 
From this data it was determined that optimum fluorescence was achieved when 1.1 
μmoles of zinc were added to a sample containing 2 μmoles (2 ml of 1 mmol/L) of 
3HF.  This corresponded to the theory that if the complex formed has the same 
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structure as previous studies have ascertained (Cornard and Merlin, 2003; Valente et 
al., 2007) (Figure 4.23 above), two molecules of 3HF are bound to one molecule of 
zinc, and if 2 ml of 1 mmol/L 3HF contains 2 μmoles then the greatest fluorescence 
should be obtained when 1 μmole of zinc was added. 
The complex has increased in size and planarity compared to a free 3HF molecule.  
This may explain the dramatic increase in fluorescence found with the complex.  It 
can also be noted, that as the excess amount of zinc increased, a quenching effect 
took place decreasing the amount of fluorescence.  
 
The glucoside of 3HF (3HF-gluc) was then reacted with β-glucosidase enzyme 
(Sigma) at varying pH using the following reaction mixture. 
2 ml 0.05 M sodium acetate/acetic acid buffer containing:- 
1 mmol/L 3HF-gluc 
1 μl 5 M zinc sulphate 
0.05 ml 10 g/L β-glucosidase 
So as not to affect the concentrations and pH of the reactants, zinc was to be 
delivered in a small volume and therefore of high concentration (i.e. 1 μl of 5 M 
ZnSO4 which contains 1.132 μmoles Zn).  The reactions were monitored for 30 min, 
at 37 
o
C, at pH 5-8 and the rates of the reaction are shown (Figure 4.25). 
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Figure 4.25:  Rate of reactions of 3HF-gluc and β-glucosidase at pH 4-8. 
 
The pH optimum for this enzyme system was determined to be pH 6. 
Using the same reaction mixture at pH 6, the substrate concentration was varied 
(Figure 4.26). 
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Figure 4.26:  Rate of reactions of 3HF-gluc and β-glucosidase at substrate concentrations 0.01-1 
mmol/L. 
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To convert FU into concentrations (mmol/L) of 3HF complex, a standard curve was 
prepared and measured.  A linear relationship between FU and 3HF concentration 
was found to exist up to 0.75 mmol/L (Figure 4.27). 
 
 
 
Figure 4.27:   Linear standard curve for 3HF complex. 
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This, along with the results gained from varying the substrate concentration, can be 
used to calculate the following kinetics data (Figure 4.28). 
 
 
Figure 4.28:  Lineweaver-Burk plot for 3HF-gluc. 
 
A linear trendline was plotted from the Lineweaver-Burk data.  Error bars represent 
the standard deviation from the mean.  The correlation coefficient (r
2
) between 
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outcomes and their predicted values was calculated as 0.9963 (where values 
approaching 1 are desirable), therefore the data was acceptable. 
Vmax = 10.85 μmoles of product released per minute, per μmole of enzyme 
or 0.18 kcat (μmoles of product realeased per second, per μmole of enzyme). 
KM = 0.23 mmol/L 
The significance of these values are discussed later in chapter 6 when compared to 
those of the well documented artificial substrate 4-methylumbelliferyl-β-D-
glucopyranoside (MUD). 
 
 
Confirmation of lipase activity with alizarin-2-octanoate 
 
The detection of lipase activity has clinical significance, as it is produced by 
Salmonella, Aeromonas and Acinetobacter spp.  One of the tests used for this 
purpose in Public Health, Pathological and Veterinary laboratories is the C8 esterase 
test, which employs 4-methylumbelliferyl caprilate (Freydiere and Gille, 1991). 
To confirm that alizarin-2-octanoate could be used as a substrate to detect, or even 
quantify, lipase activity, the following initial investigations were performed.   
Alizarin-2-octanoate (10 mg) was dissolved in 1-methyl-2-pyrrolidone (1 ml), then 
added to sodium acetate buffer (99 ml, 0.05 M) and adjusted to pH 8 with acetic acid  
(1 M) to give a stock solution with a concentration of 100 mg/L.   
Lipase from Candida cylindracea, a lipase enzyme active with intermediate chain 
esters (Cambou and Klibanov, 1984), and lipase from Rhizopus arrhizus, active with 
long chain esters (Kim and Chung, 1989),  both from Sigma, were prepared in the 
above buffer at a concentration of 1 mg/ml (equivalent to 10 U/ml).   
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To alizarin-2-ocatanoate (100 μl), lipase from Rhizopus arrhizus (lipase R) was 
added (2.5  μl) and the reaction monitored by recording the production of alizarin at 
520 nm over time (Figure 4.29 and 4.30). 
 
 
Figure 4.29:  Alizarin-2-ocatanoate (left) and when reacted with lipase R (right). 
 
 
 
Figure 4.30:  Production of alizarin when alizarin-2-octanoate is acted upon by lipase R. 
 
 
From Figure 4.30 above it can be seen that the reaction reaches end point at 
approximately 15 min. 
164 
 
Dilutions of the substrate were prepared (0, 10, 20, 50 and 100 mg/L) and reacted 
with lipase from Candida cylindracea (lipase C) and lipase R.  Readings were taken 
at 520 nm after incubation for 15 min (Figure 4.31 and 4.32). 
 
 
Figure 4.31:  Increasing concentrations of alizarin-2-octanoate (top row left to right) and then reacted 
with lipase C (centre) and lipase R (bottom). 
 
 
Figure 4.32:  Variation of alizarin-2-octanoate concentration. 
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Both enzymes showed activity with alizarin-2-octanoate, although lipase C appeared 
to convert substrate to product faster than lipase R.  This substrate may have value in 
detecting lipases.  
Initial investigations were also made into the ability of alizarin-2-octanoates to 
identify a Salmonella spp.  Alizarin-2-octanoate (100 mg) was dissolved in dimethyl 
sulfoxide (6 ml) and Tween 20 (7.5 ml), then incorporated into Columbia agar (40.6 
g/986.5 ml) containing 500 mg/L ferric ammonium citrate, which had previously 
been sterilised, and then cooled to 50 °C.  The agar plate was inoculated with 
Salmonella typhimurium NCTC 74 and incubated at 37 °C for 17 h.   
After this time, the substrate had been hydrolysed by the Salmonella to produce 
diffuse, yet vivid, purple colonies (Figure 4.33). 
 
 
Figure 4.33:  Hydroysis of alizarin-2-octanoate by Salmonella typhimurium NCTC 74 to produce a 
purple iron chelate. 
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4.5.3 Molecular biology application 
 
Alizarin-2-yl-β-D-galactoside 
The role of β-galactosides in the field of molecular biology, e.g. screening for 
recombinant and non-recombinant transformants of bacterial E. coli cells carrying 
the lacZ gene, was mentioned in the introduction.  The need for a highly colourful 
contrast between the two types of cells, when grown on an agar plate medium, is of 
the utmost importance. 
The most popular and well known substrate used for this purpose is X-gal.  When 
released by β-galactosidase, the indoxyl group gives light blue colour in the presence 
of oxygen (Kodaka et al., 1995).   
Similarly 3,4-cyclohexenoesculetin-β-D-galactopyranoside (CHE-gal) is also 
commercially available (S-gal
®
 from Sigma) and gives black colonies when chelated 
with ferrous iron (James et al., 1996). 
Both of these substrates have certain draw backs.  X-gal is expensive and time 
consuming to prepare, while the iron present with CHE-gal can also interact with 
deaminases to give coloured products (Carricajo et al., 1999). 
Alizarin-2-yl-β-D-galactoside (Aliz-gal) was selected as a possible alternative to 
these.  Previous work with Aliz-gal involved testing the substrate against β-
galactosidase from a range of Gram-negative bacteria.  From this, it was shown Aliz-
gal was a useful and highly sensitive substrate (James et al., 2000b), but no work was 
carried out to compare it to the other substrates for  screening for recombinant and 
non-recombinant transformants of E. coli cells carrying the lacZ gene. 
To optimise the colour produced and decrease the background colour of the agar 
medium, thus giving the greatest contrast between coloured and white (colourless) 
colonies, the following investigations were performed. 
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Both recombinant and non-recombinant transformed cells were prepared using a 
modified Cohen method (Cohen et al., 1972) (see preparation of chemically 
competent cells in Appendix C). 
A pGEM-T plasmid (Promega) with an insert and a plasmid without an insert were 
chemically transformed into competent E. coli strain XL1 Blue cells.  The plasmids 
were prepared via MIDAS® PlasimidSpin™ miniprep kit Protocol (Appendix C) and 
were kindly supplied by Ian E. Brown.  Cells transformed with the plasmid without 
the insert can produce β-galactosidase and therefore cleave the substrate to give 
coloured colonies.  In cells transformed with the plasmid with the insert present, the 
insert blocks production of β-galactosidase by interrupting the genetic sequence of 
the enzyme.  As a result, there is no cleavage of substrate and colonies remain white.  
In further molecular work, white colonies are generally selected as they contain the 
insert to be studied. 
When the transformation mixture was plated onto LB/ampicillin agar containing X-
gal and incubated for 24 h at 37 
o
C both blue and white colonies were observed 
(Figure 4.34). 
 
 
Figure 4.34:  Transformed recombinant and non-recombinant XL1 Blue cells. 
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To ascertain the optimum amount of Aliz-gal needed to produce coloured colonies 
the following agar medium was prepared with varying concentrations of the 
substrate: 
 10 g Tryptone 
 5 g Yeast extract 
 10 g NaCl 
12 g Agar No. 1 
in 1  L of distilled water  
 
The medium was sterilised via autoclave, cooled to 55 
o
C before 100 mg ampicillin 
and 0.030 g IPTG (isopropyl-β-D-thiogalactopyranoside) were added.   Aliz-gal was 
then added in amounts varying from 0.01-0.3 g/L.  10 μl of transformation mixture 
was spread on the surface of the plates and incubated for 24 h at 37 
o
C (Figure 4.35). 
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  Insufficient Aliz-gal (little colouration). 
  Optimised Aliz-gal 
 Excess Aliz-gal (colour overloaded) 
Figure 4.35:  Aliz-gal concentration (0.001 - 0.03 g/100ml Agar).  
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The optimum concentration was 0.1 g/L.  Below this, there was, not enough substrate 
to give sufficient colour for identification of non-recombinant transformants.  
Conversely, above 0.1 g/L the plate was overloaded and it was difficult to detect 
recombinant transformants. 
Using the agar medium described previously with 0.1 g/L Aliz-gal, the chelating 
effect of different metals was investigated.  To the agar, 10 mmol/L of the metals 
below were added (Table 4.4). 
 
Table 4.4: Summary of the effects of various metal chelators with aliz-gal (the more pluses the 
greater the effect). 
Metal salt Colour Intensity Diffusion Toxicity 
Aluminium sulfate red + + + - - 
Bismuth ammonium citrate purple + + - + + 
Ceric ammonium nitrate purple + + + + + - 
Lanthanum chloride red/purple + + + + 
Tin chloride red/purple + + + + 
 
 
The most intense, non-toxic chelators, that did not spread through the agar came 
from aluminium sulfate (Figure 4.36). 
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Figure 4.36:  The effect of different metal chelators with Aliz-gal in LB/ampicillin agar.  Starting 
from top right; aluminium sulfate, bismuth ammonium citrate, ceric ammonium nitrate, lanthanum 
chloride and tin chloride. 
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A range of aluminium salts (10 mmol/L) were then investigated (Table 4.5). 
 
Table 4.5:  Effects of various aluminium salts with aliz-gal (the more pluses the greater the effect). 
Metal salt Colour Intensity Diffusion 
Aluminium ammonium sulfate red + + + - 
Aluminium nitrate red + + - 
Aluminium potassium sulfate red + + - 
Aluminium sulfate red + + + - 
Aluminium sulfate + ammonium ferric citrate purple + + + + 
 
 
Only aluminium sulfate + ammonium ferric citrate showed undesirable diffusion 
through the agar medium.  Aluminium sulfate and aluminium ammonium sulfate 
showed the most intense and vivid colours (Figure 4.37).   
Results showed alizarin-2-yl-β-D-galactoside, when optimised as in the conditions 
described above, could be used to identify recombinant and non-recombinant 
transformants.  Comparisions between this and other screening substrates already 
commercially available are made later. 
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Figure 4.37:  The effect of different aluminium salts with Aliz-gal in LB/ampicillin agar.  Starting 
from top right; ammonium sulfate, nitrate, potassium sulfate, sulfate, sulfate + ammonium ferric 
citrate. 
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p-Naphtholbenzein-β-D-galactoside 
Another galactoside which could be used as a similar molecular biological tool was 
p-naphtholbenzein-β-D-galactoside (PNB-gal).  LB agar plates were made in an 
identical manner to those described earlier with alizarin-2-yl-β-D-galactoside, but 
using 0.1g/L p-naphtholbenzein-β-D-galactoside, and the same transformed cells 
were used; the results can be seen in Figure 4.38. 
 
Figure 4.38:  PNB-gal incorporated into solid agar media for use in the screening of recombinant and 
non-recombinant transformants (left) and after exposure to ammonia fumes (right). 
 
Under normal physiological conditions yellow/pink colonies of non-recombinant 
cells were observed alongside white recombinant cells.  Under alkali conditions, such 
as exposure to ammonia fumes or the addition of a drop of NaOH (1 M), the p-
naphtholbenzein darkened to give the much more intense green/blue coloration of its 
ionised form (Figure 4.39). 
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Figure 4.39:  pH effect of p-naphtholbenzein. 
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4.6 Discussion 
 
Various high points emerge from the work.  These are largely related to the 
chelators, since the chelators showed the best localisation on colonies when 
incorporated into agar media or produced strong coloration or fluorescence in liquid 
assays when investigating enzyme kinetics.  This is to be expected in view of the 
results obtained with alizarin and CHE based substrates (James et al., 2000b; James 
et al., 1996).  The core molecules of particular interest were: 
 alizarin (1,2-dihydroxyanthraquinone) 
 5-nitrosalicylaldehyde 
 3-hydroxyflavone 
 
 
4.6.1 Alizarins 
 
The synthesis of alizarin-2-yl-β-D-glucoside (Figure 4.40) was first described by 
Robertson (Robertson, 1930; Robertson, 1933).  This was part of an investigation 
into the structure of the naturally occurring alizarin which, in plants, is present as a 
complex glycoside termed ruberythric acid.  The β-glucoside had been synthesised, 
but none of its biological properties had been investigated in detail.  This was re-
investigated in more recent years (James et al., 2000b).  The scope of possibilities for 
these compounds is considerable and in the present work an attempt was made to re-
examine the glycosides and other derivatives of this core molecule. 
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Figure 4.40:  Structure of alizarin-2-yl-β-D-glucoside. 
 
The glycosides were synthesised by a conventional Koenigs-Knorr reaction.  
However, a modification was introduced which greatly simplified the work-up, 
taking advantage of the fact that free alizarin binds strongly to basic alumina, whilst 
glycosides and other derivatives do not since the vicinal dihydroxy system is no 
longer present.  A column technique was employed and gave easily observable bands 
of the reaction components. 
Deacetylation of the tetraacetyl derivatives proved to be relatively straightforward 
using aqueous methanolic alkali.  This relatively drastic treatment could not be used 
with many protected glycosides, but, in the case of alizarin, the glycosidic link is 
considerably more stable.  This is due to there being no powerful electron 
withdrawing groups present, such as those found in methylumbelliferone or 
resorufin, which can weaken the glycosidic link. 
In an attempt to utilise these compounds in a practical situation in the field of 
molecular biology, alizarin-2-yl-β-D-galactoside was compared with various other 
galactosides for demonstration of recombinant and non-recombinant transformants in 
bacterial cells carrying the lacZ gene, in conjunction with a range of salts, to provide 
the chelatable metal.  The alizarin galactoside along with the p-naphtholbenzein 
galactoside also tested for this application, gave equal or better results as regards 
colour and definition than most of the other substrates chosen including the 
traditionally used X-gal. 
Seen together X-gal, CHE-gal, Aliz-gal and PNB-gal are comparable (Figure 4.41).  
All give vivid colours with good contrast.  Aliz-gal could be more cost and labour 
effective, as its core compound is already commercially available and less Aliz-gal is 
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needed in the agar medium (0.1 g/L compared to 0.3 g/L of CHE-gal found in pre-
prepared screening media from Sigma). 
PNB-gal is also of parity even with the necessity to expose the colonies to alkali 
conditions to get the maximum coloration, as each of the others requires an addition 
to enhance the visualised colour.  X-gal requires exposure to oxygen to produce 
indigo dye, while CHE-gal and Aliz-gal benefit from a metal chelator. 
 
      
      
Figure 4.41:  A comparison of four galactoside substrates separately incorporated into solid agar 
media for use in the screening of recombinant and non-recombinant transformants.  Starting from top 
right; X-gal, CHE-gal, Aliz-gal, PNB-gal. 
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A main point of the value of the alizarin system in the present context is the use of 
alizarin-2-octanoate (Figure 4.42) as a substrate for visualisation of C8 esterase or 
lipase.   
When employed in agar based medium positive colonies were readily recognised by 
formation of the purple coloured chelate.  It is well known that organisms, such as 
Salmonella, Aeromonas and Acinetobacter, have a strong lipase activity (Kok et al., 
1995; Lotrakul and Dharmsthiti, 1997; Cooke et al., 1999) and this is borne out in the 
present study.    
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Figure 4.42:  Structure of alizarin-2-octanoate. 
 
To demonstrate the activity of alizarin-2-octanoate, the substrate was incubated with 
lipase enzymes of commercial origin (Sigma).  Aqueous insolubility problems were 
evident but could be overcome by the addition of organic solvents or surfactants, 
such as initially dissolving the substrate in 1-methyl-2-pyrrolidone.  The lipase 
enzymes selected were shown to be active with alizarin-2-octanoate and the substrate 
could therefore be used to quantify these enzymes.  Microbial investigations would 
have to be carried out with a range of bacteria before its true value as method for 
detecting species such as Salmonella, could be commented upon. 
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4.6.2 5-Nitrosalicylaldehyde-β-D-galactoside 
 
5-Nitrosalicylaldehyde was chosen as it has a nitrophenolic structure analogous with 
p-nitrophenol, a well established synthetic substrate core compound discussed in 
Chapter 1 (Figure 4.43).   The presence of an aldehyde group adjacent to the phenolic 
hydroxyl gives the potential for chelation with metals, such as iron, which has the 
effect of darkening the coloration, therefore making it more intense. 
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Figure 4.43:  Structures of 5-nitrosalicylaldehyde (left) and p-nitrophenol. 
 
Glycosidation of the core molecule using α-acetobromogalactose gave, after 
deprotection, a reasonable yield of the β-galactoside.  This compound, when 
incorporated into agar-based medium in the presence of ferric ammonium citrate, 
gave orange colonies with relevant β-galactosidase producing bacteria.  It was 
theorized that a chelation complex would have the effect of restricting coloration to 
the colonies.  However, it was noticed that there was a certain degree of spreading of 
colour away from the colony mass, as there is with p-nitrophenol substrates. 
The results of the microbial investigations showed, that for Gram-negative bacteria, 
the 5-nitrosalicylaldehyde galactoside could detect the same species as its alizarin 
counterpart.  Of the Gram-positive bacteria, no species were active with this 
substrate, a trait which could be exploited in the identification of Gram-negative 
bacterial species. 
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4.6.3 3-Hydroxyflavones and hydroxyquinolones 
 
The compound 3-hydroxyflavone was chosen to study as some information was 
already available on the phosphate ester.  This appears in a patent (Jackim, 1969) 
describing the synthesis of the compound and its use as a sensitive method for 
estimating phosphatase enzyme.   
3-Hydroxyflavone (Figure 4.44) is only one of a number of hydroxyflavones which 
is capable of demonstrating fluorescence and also the property of chelation with 
appropriate metal ions.  Both 3-hydroxyflavone and 5-hydroxyflavone derive these 
properties from the proximity of the hydroxyl group to the carbonyl function of the 
γ-pyrone ring.  This allows for both intramolecular hydrogen bonding and metal 
chelation.   
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O
O
 
Figure 4.44:  Structure of 3-hydroxyflavone. 
 
Other hydroxyflavones, such as 3’,4’-dihydroxyflavone, and 7,8-dihydroxyflavone 
exhibit these properties because of the vicinal dihydroxy system, which is similar to 
that observed with CHE.  In fact 3’,4’-dihydroxyflavone has been successfully 
glycosidated and is marketed by Glycosynth as a potential substrate for bacterial 
identification, such as β-glucosidase positive Enterococcus faecalis (Burton, 2004). 
Initial studies showed that the 3-hydroxyflavone possessed better fluorescence and 
chelation properties than the corresponding 5-isomer.  Additionally, the 3-isomer is 
readily available and considerably less expensive. 
182 
 
Accordingly, 3-hydroxyflavone was derivatised as the β-glucoside and β-galactoside 
using both Koenigs-Knorr methodologies and the tetraacetyl intermediates 
deprotected using sodium methoxide.  Synthesis of the glucoside via the potassium 
hydroxide method gave a good yield of product while the 2,6-lutidine  and silver 
carbonate method did not give as great a yield.  This could be due to the formation of 
a silver complex owing to the strong chelating effect of 3-hydroxyflavone which 
would impair the progress of the glycosidation. 
The compound was investigated both as a substrate for isolated β-glucosidase 
enzyme and for microbial identification in agar medium.  This latter work carried out 
by Professor Perry (of the Freeman Hospital, Newcastle) showed that β-glucosidase 
containing strains gave strongly dark coloured colonies in the presence of iron, but 
only in the case of Gram-positive organisms (with the exception of one Gram-
negative bacteria, E. coli NCTC 10418, which gave only a trace amount of 
coloration).  The explanation for this is unclear but could be due to a membrane 
effect.  This effect is interesting, since it gives a potential method for discriminating 
Gram-positive organisms from β-glucosidase producing Gram-negative organisms.   
Of the bacteria that were active with this substrate, Listeria monocytogenes NCTC 
11994 gave the most vivid colonies.  The detection of this bacterium is of great 
interest due to it being a widely distributed food borne pathogen responsible for 
listeriosis and listeric meningitis (Becker et al., 2006).  It is possible that, with further 
study, this substrate could be developed as part of protocol of the isolation of Listeria 
spp. as it has similar properties to substrates such as 3,4-cyclohexenoesculetin-β-D-
glucoside (James, 2001) which Lab M employs in its Harlequin™ Listeria Medium 
(Figure 4.45)  (Smith et al., 2001). 
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Figure 4.45:  Listeria isolation with Harlequin™ Listeria Medium.  Brown colouration of colonies 
result from the chelation of CHE, released from CHE-β-D-glucoside, and ferrous gluconate. 
 
It was also observed that incubation of selected organisms on a medium containing 
3-hydroxyflavone-β-D-glucoside in the presence of zinc ions produced bright yellow 
colonies with appropriate β-glucosidase containing Gram-positive organisms.  This 
effect is interesting, since relatively few chromogenic substrates produce satisfactory 
yellow colonies.  This particular effect had also been noted by Professor Perry (of the 
Freeman Hospital, Newcastle) with respect to 3,4-dihydoxyflavone-β-D-galactoside 
(DHF-gal) synthesised by Dr M Burton of Glycosynth. 
To further investigate the properties of the glucoside, the compound was incubated 
under various conditions with β-glucosidase enzyme and the enzymatic 
characteristics, including kinetic data, determined. 
Compared to the commercially available and well documented artificial substrate 4-
methylumbelliferyl-β-D-glucopyranoside (MUD) (see Enzyme kinetics of 4- 
methylumbelliferyl-β-D-glucopyranoside – in Appendix B), 3-hydroxyflavone-β-D-
glucoside (3HF-gluc) had a lower Vmax (Table 4.6).   
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Table 4.6:  Comparison of Lineweaver-Burk enzyme kinetics data for MUD and 3HF-gluc. 
Substrate Vmax kcat KM 
MUD 25.32 0.42 0.30 
3HF-gluc 10.85 0.18 0.23 
 
 
This means β-glucosidase cleaves 3HF-gluc at a slower rate than MUD.  The 
Michaelis constants (KM) show this enzyme has a greater affinity for 3HF-gluc.  This 
is beneficial in these sensitive fluorescent molecules, as a smaller amount of enzyme 
and substrate are required to increase the reaction rate to half of its maximum and 
therefore can therefore be detected at an earlier stage. 
Another advantage 3HF-gluc has is that, unlike MU substrates, it adheres to bacterial 
colony cell mass and so does not spread through solid agar medium making the task 
of identification and isolation easier. 
 
There is a similarity of structure between 3-hydroxyflavone and certain of the 
hydroxyquinolones.  The compound 1-methyl-2-phenyl-3-hydroxy-4-quinolone, and 
certain of its derivatives, were synthesised and their fluorescence qualities were 
studied and recorded (Yushchenko et al., 2006a; Yushchenko et al., 2006b).  The 
proximity of the hydroxyl group to the carbonyl function of the quinolone ring gives 
rise to intramolecular hydrogen bonding and should therefore give rise to chelation 
possibilities.  Blocking the hydroxyl group by glycosidation, for example, would be 
expected to prevent this. 
In this present study the hydroxyquinolone was synthesised by the method described 
(Yushchenko et al., 2006a) and the related compound, 1-methyl-2-(4’-fluorophenyl)-
3-hydroxy-4(1H)-quinolone (Figure 4.46) was synthesised by a similar procedure.  
Examination of these compounds demonstrated the characteristic fluorescence 
properties and illustrated their capacity for chelation with a range of metal ions.   
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Figure 4.46:  Structure of 1-methyl-2-(4’-fluorophenyl)-3-hydroxy-4(1H)-quinolone. 
 
Several attempts at glycosidation were made using a variety of methods, but it was 
not possible to achieve satisfactory results.  This may have been due to the very 
limited solubility of these particular quinolones. 
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CHAPTER FIVE 
Gene cloning and protein expression 
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5.1 Introduction 
 
This study was to include the synthesis of a range of aminopeptidase substrates, 
particularly those of leucine aminopeptidase.  Due to the expense of the enzyme 
leucine aminopeptidase (£600/100 units, Sigma), it was not feasible to purchase the 
enzyme needed to test the effectiveness of the substrates.  It was therefore decided to 
attempt to clone the enzyme in order to produce a more cost effective supply. 
It has been documented that E. coli is a bacterial source of leucine aminopeptidase 
(Vogt, 1970; Murgier et al., 1976; Murgier et al., 1977; Lazdunski, 1989; Matsui et 
al., 2006). 
To demonstrate this, E. coli K12 was grown on nutrient agar at 37 
o
C for 24 h.  
Colonies were transferred to 0.1 M Tris buffer pH 7.4 (10 ml) until it gave a cell 
suspension with an absorbance value of 0.350 at 500 nm.  0.5, 0.05 and 0.005 mg/ml 
dilutions of L-leucine-7-amido-4-methyl-coumarin hydrochloride (Sigma) were 
prepared by dissolving the substrate first in 2 drops of dimethyl sulphoxide (DMSO) 
then Tris buffer.  To 1 ml of each dilution, 0.5 ml of the cell suspension was added 
then incubated at 37 
o
C for 1 h before being viewed under exposure to ultraviolet 
light.  The substrate was cleaved to produce fluorescent 7-amino-4-methyl-coumarin 
showing that aminopeptidase was indeed present in the E. coli K12 cell suspension 
(Figure 5.1). 
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Figure 5.1:  Action of E. coli K12 cell suspension on dilutions of L-leucine-7-amido-4-methyl-
coumarin hydrochloride in 0.1 M tris buffer pH 7.4.  Tubes contain (from left to right): E. coli + 
Buffer, 0.5 mg/ml substrate, 0.5 mg/ml substrate + E. coli, 0.05 mg/ml substrate, 0.05 mg/ml substrate 
+ E. coli, 0.005 mg/ml substrate, 0.005 mg/ml substrate + E. coli. 
 
A search performed on 27/4/07 of the National Center for Biotechnology 
Information’s database (http://www.ncbi.nlm.nih.gov/Genbank/), an annotated 
collection of all publicly available DNA and protein sequences, found a gene 
sequence from E.coli K12 that was annotated as a putative leucyl aminopeptidase 
(protein i.d. NP_418681, see protein and gene sequence in Appendix C).   
Forward and reverse primers were designed for this gene (1.509 kb) using the Primer 
Design Programme, part of the Saccharomyces Genome Database 
(http://www.yeastgenome.org/).  This design programme is a tool that can be used to 
design primers for genes other than those of Saccharomyces spp.  The primers;  
forward primer 5’-CAC CAC CAC CAC ATG GAG TTT AGT GTA AAA AGC-3’ 
and reverse primer 5’-GAG GAG AAG GCG CGT TAC TCT TCG CCG TTA AAC 
CCA-3’ were supplied in a lyophilised form by MWG Biotech (see MWG Oligo 
synthesis report in Appendix C).  The primers were reconstituted with 18.2 MΩ/cm 
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H2O to give a stock concentration of 100 mM (100 pm/μl) and stored at -20 
o
C.  This 
was further diluted to give a working concentration of 20 mM when required.   
 
 
5.2 Experimental Methods 
 
5.2.1 DNA extraction  
 
DNA was extracted from E. coli K12 using a Qiagen DNeasy kit (see protocol in 
Appendix C).  The purity of the four elutions from the DNeasy kit column were 
visualised (Figure 5.2) by running 5 μl on a 1%  (w/v) agarose gel containing 5 μl 1 x 
Sybr® Safe (Invitrogen) at 120 mA for 45 min (see agarose gel electrophoresis in 
Appendix C). 
 
 
Figure 5.2:  Elutions of purified genomic DNA from E. coli K12 (lanes 4-7).  Each sequential  elution 
being of a lower concentration.  Lane 1 contains ‘Bioline Hyperladder 1’size standards (10 Kbp top – 
0.2 Kbp bottom). 
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5.2.2 Gene amplification 
 
The putative gene for leucyl aminopeptidase was amplified from the purified 
genomic DNA.  A polymerase chain reaction (PCR) (Takagi et al., 1997) was 
performed by preparing the reaction mix below (Table 5.1) and carried out with an 
Eppendorf Mastercycler Gradient thermocycler under the following conditions 
(Table 5.1). 
 
Table 5.1:  Contents of PCR reaction mixture.   
* For contents of 10 x KOD buffer see Appendix C. 
Reagent Amount 
(μl) 
20 mM forward primer 1 
20 mM reverse primer 1 
2 mM dNTP’s 5 
25 mM MgSO4 2 
10 x KOD buffer* 5 
H2O  35.5 
gDNA 0.5 
KOD Hotstart Polymerase 
(1U/μl) 
1 
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Table 5.2:  Conditions of PCR reaction carried out with a Eppendorf Mastercycler Gradient 
thermocycler.   
 Temperature  (
o
C) Duration (minutes) 
Initial denature 95 2 
Denature 95 0.25 
Annealing 1 40 0.5 
Extension 72 2.37 
Denature 95 0.25 
Annealing 2 63.2 0.5 
Extension 72 2.37 
Extension 72 10 
Hold 10 ∞ 
 
A 5 μl sample of the amplified product was visualised in a 1% (w/v) agarose gel as 
described  above (Figure 5.3). 
 
 
Figure 5.3:  Amplified PCR product.  Gene of interest is approximately 1.5 Kbp. 
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The amplified PCR product was the correct size for the gene encoding NP_418681.  
To remove the smaller, fainter band, and also any unused nucleotides, the PCR 
product was cut out of the gel and purified using a QIAquick Gel Extraction kit (see 
protocol in Appendix C) to give a single band (Figure 5.4). 
 
Figure 5.4:  Extracted and purified PCR product. 
 
The modified pET-28a vector, pET-YSBLIC, was provided Dr. Mark Fogg of the 
University of York (Bonsor et al., 2006; Fogg and Wilkinson, 2008) and prepared for 
use by Dr Meng Zhang  (see pET-28a vector map and  construction of pET-YSBLIC 
vector in Appendix C) (Figure 5.5).   
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Figure 5.5:  Purified pET-YSBLIC vector. 
 
5.2.3 T4 DNA polymerase reaction 
 
The Bse RI linearised vector was treated with T4 DNA polymerase (T4pol), in the 
presence of dTTP, to create single-stranded ends (Table 5.3).  The PCR product was 
also treated with T4pol, in the presence of dATP, to create single-stranded ends that 
are complementary to the single-stranded ends of the vector (Table 5.4). 
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Table 5.3.  T4pol reaction with vector and thymidine triphosphate (dTTP). 
* For contents of 10 x T4pol buffer see Appendix C. 
Reagent Amount (μl) 
2 pM vector 146 
10 x T4pol buffer* 20 
25 mM dTTP 20 
100 mM dithiothretol 10 
T4pol (2.5 U/μl) 4 
 
 
Table 5.4:  T4pol reaction with PCR product and adenosine triphosphate (dATP). 
 
Reagent Amount (μl) 
0.2 pM PCR product 14.6 
10 x T4pol buffer 2 
25 mM dATP 2 
100 mM dithiothretol 1 
T4pol (2.5 U/ μl) 0.4 
 
 
Both reactions were incubated at 22 
o
C for 30 min then stopped by incubating at 75 
o
C for 20 min.  Excess nucleotides were removed using QIAquick Nucleotide 
Removing kit.   
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To anneal the product into the vector, a LIC (ligation independent cloning) annealing 
reaction was set up (Table 5.5). 
 
Table 5.5:  Annealing reaction. 
Reagent Amount 
(μl) 
vector/T4pol reaction mix 1 
PCR product/T4pol reaction mix 2 
22 
o
C, 10 min - 
100 mM EDTA 1 
22 
o
C, 10 min - 
 
 
The product of this reaction was a possible recombinant plasmid, which was then 
transformed into chemically competent E. coli XL1 Blue cells. 
 
5.2.4 Transfomation of annealing products 
 
Competent E. coli XL1 Blue cells (Stratagene) were prepared using a modified 
Cohen method (Cohen et al., 1972; Cohen et al., 1973) (see preparation of 
chemically competent cells in Appendix C). 
To 50 µl of competent E. coli XL1 Blue cells, 2 µl of annealing product was added 
and mixed gently, then left on ice for 10 min.  The mixture was heat shocked by 
incubating at 42
o
C for 90 s then placed back on ice for 2 min.  LB medium (200 µl) 
was added before incubation at 37
 o
C for 1 h. 
Transformation mixture (200 µl) was spread on a dried LB plate containing 
kanamycin (50 µg/ml) which was then incubated at 37
 o
C overnight. 
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Of the 18 colonies that grew, ten were inoculated into 5 ml of LB broth containing 
kanamycin (50 µg/ml), incubated at 37
 o
C and shaken at 200 rpm overnight. 
 
5.2.5 Isolation of plasmid 
 
From each of the LB cultures, 4.5 ml was centrifuged at 4,000 x g for 10 min and the 
supernatant was then discarded.  Plasmid samples of 50 µl were purified from the 
pellets using a QIAprep Spin Miniprep Kit (see protocol in Appendix C).  Of each 
sample, 48 µl was stored at -20 
o
C for further use if successful.  The remaining 2 µl 
were used in the following digest reactions. 
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5.2.6 Digest 
 
To ascertain which plasmids had successfully taken up inserts, the plasmids were 
digested with the enzymes Xho I and Xba I which have respective restriction sites 
within the vector either side of the gene insertion site (see pET-28a vector map in 
Appendix C) therefore releasing the insert, if present (Table 5.6). 
 
Table 5.6:  Contents of Digest reaction mixture. 
* For contents of 10 x digest buffer 2 see Appendix C. 
 
Reagent Amount (μl) 
Plasmid 2 
Xho I (20 kU/ml) 1 
Xba I (20 kU/ml) 1 
10 x BSA (10mg/ml) 1 
10 x digest buffer 2* 1 
H2O 4 
 
 
The digests were incubated at 37
 o
C for 2 h. The results were compared to  their 
equivalent undigested plasmid by running them through a  1% (w/v) agarose gel 
(Figure 5.6 and 5.7). 
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Figure 5.6:  Undigested and digested plasmid.  Lanes contain samples 1-5 (undigested then digested 
in the next lane); lane 7 contains hyperladder size standard. 
 
 
Figure 5.7:  Undigested and digested plasmid.  Lanes contain samples 6-10 (undigested then digested 
in the next lane); lane 3 contains hyperladder size standard. 
Samples 1, 4, 6, and 8 contained the insert (40% success rate).  From these 4, sample 
8 was selected for transformation. 
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5.2.7 Transformation of recombinant plasmid 
 
E. coli BL21 cells (Novagen) were transformed with undigested plasmid sample 8 
(stored at -20 
o
C when plasmid was isolated above) via the same method used to 
transform the annealing products above.  From this, a single colony was selected and 
inoculated into 5 ml of MDG medium (Studier, 2005) (see Appendix C), incubated at 
37
 o
C and shaken at 200 rpm overnight. 
MDG culture (0.5 ml) was added to 0.5 ml of 50% (v/v) glycerol, mixed and then 
stored at -80 
o
C   for possible future work.  The remaining 4.5 ml was added to 50 ml 
of ZYM medium (Studier, 2005) (see Appendix C), incubated at 30
 o
C and shaken at 
100 rpm for 24 h.  After this time, the optical density of the culture was measured at 
600 nm as >4 indicating sufficient growth had taken place to produce protein.   
 
5.2.8 Determination of solubility of protein 
 
ZYM culture (0.5 ml) was microcentrifuged at 18,000 x g for 2 min.  The 
supernatant was discarded.  To the pellet, 300 µl of solubilising buffer (see Appendix 
C) was added and then vortex mixed and boiled for two minutes.  This process 
solubilises the total protein present.   
The remaining 49.5 ml of ZYM culture was centrifuged at 4,000 x g for 15 min at 4
 
o
C.  The supernatant was discarded and the pellet resuspended in 5 ml of a buffer 
consisting of 50 mM Na2HPO4 (pH 7.4); 10 mM imidazole; 0.5 M NaCl.  The 
suspension was sonicated at an amplitude of 14 microns for two minutes (10 seconds 
on, 10 seconds off) on ice, to release the soluble proteins, before being centrifuged at 
20,000 x g for 30 min at 4
 o
C and the pellet discarded.  Supernatant (20 µl) was 
mixed with 5 µl SDS-PAGE loading buffer (see Appendix C), vortex mixed, then 
boiled for 2 min.  The two samples (for total and soluble protein) were compared on 
a 12% (w/v) SDS-PAGE gel (200 V, 100 mA for 60 min) which was stained with 
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Coomassie blue stain (see Appendix C), for 10 min before being destained, until blue 
bands could be seen on a clear background (Figure 5.8 and 5.9).  
 
 
Figure 5.8:  Total protein sample (lane 2); High (lane 1) and low (lane 12) molecular weight markers. 
 
 
 
 
 
Figure 5.9:  Soluble protein sample (lane 4); High (lane 1) and low (lane 12) molecular weight 
markers. 
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The gels above show a large band of hyper-expressed recombinant protein of an 
approximate relative molecular weight of 55,000.  By entering the amino acid 
sequence for the putative enzyme (obtained earlier from the NCBI Genbank 
database) into the ‘ProtParam’ tool on the Expasy website 
(http://www.expasy.ch/tools/protparam.html) its predicted molecular weight was 
calculated as 54,879.8 Da.  This corresponded to the size of the expressed protein.  
This protein was found to be soluble due to the appearance of a large band of protein, 
of the correct size, in the soluble protein sample. 
 
5.2.9 Purification by nickel affinity chromatography 
 
Of the supernatant used to produce the soluble protein sample, 50 µl was stored at 4 
o
C for later use when assaying for enzyme activity and the remaining 4.93 ml was 
processed through a nickel affinity column under the following conditions.   
The column was equilibrated to the same conditions as that of the supernatant by 
applying 30ml of start buffer (20 mM HEPES; 500 mM NaCl; 10mM imidazole, pH 
7.4) at a rate of 5 ml/min.  The supernatant was then introduced to the column. The 
protein binds to the nickel of the column because of the hexahistadine (histag) on the 
N-terminus of the protein.  Other proteins present will have less affinity for the 
nickel and will be eluted from the column.  To elute the protein in a controlled 
manner, an elution buffer (500 mM imidazole; 20 mM HEPES, pH 7.4) was applied 
on a linear increasing gradient  at a flow rate of 5 ml/min.  Fractions were collected 
every minute.  The results of this process are shown in the chromatogram below 
(Figure 5.10). 
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Figure 5.10:  Purification of protein  by nickel affinity chromatography. Chromatogram of 
absorbance at 280 nm against time in minutes.  Green line shows the increasing gradient of elution 
buffer.  Blue line shows changing absorbance at 280 nm. 
 
An increase in absorbance at 36 - 45 mins indicated a large amount of protein had 
been eluted from the column.  The fractions corresponding to those times were ran 
on a 12% (w/v) SDS-PAGE gel under conditions described previously (Figure 5.11) 
which showed that contaminating proteins had been removed. 
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Figure 5.11:  Purified protein.  Samples 36 - 45 (lanes 2 - 11); High (lane 1) and low (lane 12) 
molecular weight markers. 
 
5.2.10 Concentration of protein 
 
The pure protein fractions 36 – 45 were pooled and concentrated using a Vivascience 
‘vivaspin’ centifuge tube with a 30,000 Da molecular weight cut-off.  When 
centrifuged at 4,000 x g, anything with a MW below 30,000 Da is filtered from the 
pooled fractions, including buffer.  The fractions were concentrated until the volume 
decreased from 50 ml to approximately 0.5 ml.  The concentrate was washed 3 times 
with 5 mM HEPES buffer, pH 7.4 to remove imidazole, which can be inhibitory to 
enzymes, and again concentrated to a final volume of 0.5 ml.  The protein solution 
was then stored at 4 
o
C in 3.2 M ammonium sulfate (0.5 g/l). 
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5.3 Results 
 
To determine if the protein expressed has activity as a leucyl aminopeptidase the 
following assay was performed with the substrate L-leucine-7-amido-4-methyl-
coumarin hydrochloride.  Substrate (0.005 mg/ml) was dissolved in a drop of 
dimethyl sulfoxide (DMSO), then in 10 mM HEPES buffer, pH 7.4.  To 1 ml of this 
was  added either 50 µl of distilled H2O (blank), protein solution, filtered washings 
from concentration process or cell free extract supernatant (stored just prior to 
purifying with nickel column).  These reactions were then incubated at 37 
o
C for 1 h 
before being viewed under exposure to ultraviolet light (Figure 5.12). 
 
 
Figure 5.12:  Leucyl aminopeptidase activity.  Tubes (from left to right); blank, protein, washings and 
cell free extract supernatant. 
 
Fluoresence showed enzyme activity against L-leucine-7-amido-4-methyl-coumarin 
hydrochloride in the purified protein sample and the cell free extract supernatant but 
none in the filtered washings from the concentration process.  From these results, it 
can be concluded that the process has successfully produced an active leucyl 
aminopeptidase. 
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5.4 Discussion 
 
Although time did not permit the synthesis or evaluation of any aminopeptidase 
susbstrates, the work done in this part of the study still had positive outcomes. 
An active recombinant leucyl aminopeptidase was produced and the expression 
vector produced during this work has been taken up by Prozomix Ltd. (a U.K. 
biotechnology company that develops, produces and supplies a large, diverse and 
rapidly expanding range of highly purified recombinant enzymes and proteins of 
known sequence with associated biochemical reagents) as part of their commercial 
academic partnering programme.  This programme offers royalty based 
commercialisation of enzyme and protein encoding recombinant plasmids from the 
global academic resource. 
Once the specific activity of this enzyme has been determined, it may be used to 
measure kinetics and evaluate newly synthesised substrates at a fraction of the cost of 
purchasing aminopeptidase from a commercial source, not to mention produce 
royalties. 
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CHAPTER SIX 
Conclusions and future work 
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6.1 Conclusions 
 
The aim of this study was to produce novel enzyme substrates and apply them to uses 
in biomedical science.  This has been achieved by synthesising a range of 
chromogenic and fluorogenic core compounds, then evaluating their suitability as 
chromophores, fluorophores and metal chelators.  It was then attempted to 
glycosidate the promising compounds leading to the successful substrates being 
selected for evaluation with respect to applications in biomedical science. 
Major findings include:- 
 Novel core compounds synthesised:- 
2-hydroxy-1-naphthaldehyde-4-nitrophenylhydrazone 
 4-acetoxy-3-methoxycinnamylidene-1,3-indandione 
 4-hydroxy-3-methoxycinnamylidene-3-phenyl-5-isoxazolone 
 3,4-dihydroxybenzylidene benzhydrazide 
 
 Substrates applied and evaluated:- 
alizarin-2-yl-β-D-galactoside, used to identify recombinant and non-
recombinant transformants in molecular biology 
 alizarin-2-octanoate, used to detect species such as Salmonella and 
 5-nitrosalicylaldehyde-β-D-galactoside used to identifiy Gram-negative 
 bacterial species in microbiology 
 3-hydroxyflavone-β-D-glucoside used as a fluorogenic and chromogenic
 substrate for isolated β-glucosidase enzyme and for microbial identification 
 of Listeria spp. 
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 The cloning and expression of a gene and the characterisation of its encoded 
product as an active recombinant leucyl aminopeptidase. 
  
 
6.2 Future work 
 
Apart from the uses already stated in this work, for example diagnostic 
microbiology, it may be possible to develop other roles for these chromogenic and 
fluorogenic substrates. 
They may be employed in the field of microbial systematics, the classification, 
nomenclature and identification of microorganisms.  If a range of substrates with 
different sugars was produced they could form the basis of a semi-automated rapid 
multiplate test, used to build taxonomic profiles.  Another use of this system would 
be a faster method of determining the correct nutrient (sugar) content when 
developing new selective media. 
Although highly specific, these substrates could be, for example, used as a more cost 
effective and less hazardous method of investigating bacterial cell wall development 
in pathogens such as Mycobacterium tuberculosis, with the hope of identifying new 
drug targets.  Current experimental research uses a 
14
C radiolabelled sugar, to 
monitor uptake and function in the cell wall and is visualised by thin layer 
chromatography and autoradiography (Birch et al., 2008).  A chromogenic substrate 
with the correct sugar moiety may be used instead of the radiolabelled sugar, 
reducing both the hazard and the amount of labour required to perform the method. 
 
The use of alizarin based substrates has so far been limited to the incorporation of 
iron and aluminium salts, but, in this study, a variety of other metal ions have been 
used and compared and some show additional potential.  Cobalt and zinc, for 
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example, gave a dark purple chelate, while magnesium gave a lighter purple 
coloration, and all of these precipitated to some degree. 
An alternative, although more involved, method of creation of alizarin substrates 
having varied colours with added metal ions, is to substitute other groupings in the 
anthraquinone skeleton.  Inspection of such works as the Handbook of the Society of 
Dyeists and Colourists describes various alizarinic molecules such as 3- and 4-
nitroalizarins (Figure 6.1) and their reduction products, i.e. the aminoalizarins.  The 
aminoalizarins, in particular, give rise to substantially different coloured metal 
complexes.   
 
OH
OH
O
O
N
+
O
-
O  
Figure 6.1:  Structure of 4-nitroalizarin. 
 
Furthermore, by subjecting the aminoalizarins to a Skraup reaction  such as is 
commonly encountered in the synthesis of quinolines (Li, 2006), cyclisation occurs 
giving rise to, e.g., ‘Alizarin Green’ (Figure 6.2).  This is reported to give a bright 
green metal complex with iron and could find value if derivatised as a glycoside. 
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Figure 6.2:  Possible cyclisation of 4-aminoalizarin to form alizarin green via the Skraup reaction. 
 
In addition to the octanoate, several other esters of alizarin were synthesised, e.g. 
alizarin-2-palmitate.  The disadvantage of such long chain esters is, however, the 
aqueous insolubility. One possible solution to the insolubility problems associated 
with the use of these alizarin esters would be to synthesise the corresponding 
Alizarin Red S compound (Figure 6.3).  This is a 3-sulphonic acid derivative of 
alizarin and the sulphonic acid group would confer a high measure of water solubility 
to the otherwise highly non-polar substrate. 
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Figure 6.3: Structure of alizarin Red S-2-octanoate. 
 
Regarding 5-nitrosalicylaldehyde subtrates, the chelation depends on an interaction 
between the phenolic hydroxyl group and the adjacent aldehyde, it is conceivable 
that an extension of this work could be to create a Schiff’s base or aldimine by 
reaction of either nitrosalicylaldehyde itself or the glycoside with an amine, e.g. 
aniline (Figure 6.4).  Formation of these aldimines is usually straightforward, 
involving reaction of the components in acidic ethanol. 
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Figure 6.4:  Possible synthesis of 5-nitrosalicylidene-aniline. 
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The chelation properties of such aldimines could be studied using appropriate metal 
ions and the glycosides evaluated accordingly (Figure 6.5). 
  
Fe
2+
NO
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O
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N O
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O
N
+
H
  
Figure 6.5:  Chelation of 5-nitrosalicylidene-aniline with Fe2+. 
 
The attempts at glycosidating the quinolone compounds did not give satisfactory 
results, probably because of their limited solubility.  One possible method of 
improving the situation with respect to solubility would be to react the fluorophenyl 
compound with a secondary amine such as diethylamine in dimethylformamide 
(Figure 6.6).  This is described in the previously mentioned paper.  The 4-
dialkylaminophenyl compounds produced could have greater solubility and be more 
readily glycosidated.    
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Figure 6.6:  Formation of 1-methyl-2(4’-diethylaminophenyl)-3-hydroxy-4(1H)-quinolone 
(Yushchenko et al., 2006a). 
 
 
Finally, with the production of a more cost effective supply of recombinant leucyl 
aminopeptidase it will be possible (once the specific activity of the enzyme has been 
determined) to test the effectiveness of any leucyl aminopeptidase substrates 
synthesised in the future. 
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8 Appendices 
 
8.1 Appendix A: Chemistry  
 
Active silver carbonate  
2AgNO3 + Na2CO3 →Ag2CO3 + 2NaNO3 
This reaction is light sensitive and was therefore performed in the dark or subdued 
lighting.  Distilled water (200 ml) was placed in a 1 litre beaker and silver nitrate (34 
g, 5 M) was added and stirred until dissolved.   
A slight excess of sodium carbonate (17 g, 6 M) was dissolved in distilled water (100 
ml) then slowly poured into the continually stirred silver nitrate solution. 
A white/yellow precipitate was formed.  If the precipitate was brown in colour more 
silver nitrate was added.  After 5 min stirring the suspension was allowed to settle 
then the water was decanted.  More distilled water (400 ml) was added to the solid 
material which was stirred for a further 5 min to dissolve any unreacted sodium 
carbonate and sodium nitrate.  The suspension was then filtered.  Distilled water (100 
ml) was filtered through the solid, then ethanol (100 ml), then diethyl ether (100 ml) 
to remove any unreacted material and to extract water to assist the drying process. 
The silver carbonate was dried in a vacuum desiccator (29 g yield). 
 
Brady’s reagent 
Dissolve 40 g of 2,4 dinitrophenylhydrazine in 80 ml concentrated sulphuric acid (80 
ml). Cool and add methanol (900 ml) and water (100ml).  Filter if necessary. 
Charring reagent 
Methanol (33 ml) was added to distilled water (33 ml) and stirred.  Concentrated 
sulphuric acid (33 ml) was then cautiously added and stirred. 
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Sodium methoxide 
200 mmol Sodium methoxide was prepared by adding freshly cut sodium metal (0.47 
g) to HPLC grade methanol (100 ml).  
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8.2 Appendix B: Biochemistry 
 
Synthesised compound spectrum scans 
 
Spectra are colour coded as pH: 3 5 7 9 11 13 
 
 
4-nitrovinyl-2-methoxyphenol
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.500
1.000
1.500
2.000
2.500
3.000
3.500
4.000
 
4-nitrovinyl-2-methoxy-6-bromophenol
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.500
1.000
1.500
2.000
2.500
3.000
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Spectra are colour coded as pH: 3 5 7 9 11 13 
1-nitrovinyl-2-naphthol
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.500
1.000
1.500
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3.000
3.500
4.000
4.500
 
2-hydroxy-1-naphthaldehyde
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.500
1.000
1.500
2.000
2.500
3.000
 
4-hydroxy-3-methoxybenzylidene-1,3-indandione
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.500
1.000
1.500
2.000
2.500
3.000
3.500
4.000
4.500
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Spectra are colour coded as pH: 3 5 7 9 11 13 
4-hydroxy-3-methoxycinnamylidene-1,3-indandione
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.200
0.400
0.600
0.800
1.000
1.200
1.400
1.600
 
4-acetoxy-3-methoxycinnamylidene-1,3-indandione
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.100
0.200
0.300
0.400
0.500
0.600
0.700
0.800
0.900
 
4-hydroxy-3-methoxycinnamylidene-3-phenyl-5-isoxazolone
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.500
1.000
1.500
2.000
2.500
3.000
3.500
4.000
4.500
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Spectra are colour coded as pH: 3 5 7 9 11 13 
2-hydroxy-1-naphthaldehyde-4-dinitrophenylhydrazone
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.500
1.000
1.500
2.000
2.500
 
2-hydroxy-1-naphthaldehyde-2,4-dinitrophenylhydrazone
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.200
0.400
0.600
0.800
1.000
1.200
1.400
1.600
1.800
2.000
2.200
 
naphthofluorescein
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.500
1.000
1.500
2.000
2.500
3.000
3.500
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Spectra are colour coded as pH: 3 5 7 9 11 13 
p-naphtholbenzein
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.200
0.400
0.600
0.800
1.000
1.200
1.400
1.600
 
2(3,4-dihydroxybenzylidene)indan-1,3-dione
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
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1.000
1.500
2.000
2.500
3.000
3.500
4.000
4.500
 
3,4-dihydroxybenzylidene benzhydrazide
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.500
1.000
1.500
2.000
2.500
3.000
3.500
4.000
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Spectra are colour coded as pH: 3 5 7 9 11 13 
3,4-dihydroxybenzylidene isonicotinic hydrazide
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.500
1.000
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2.500
3.000
3.500
 
7,8-dihydroxy-4-methylcoumarin
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
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3.500
 
1-methyl-2-phenyl-3-hydroxy-4(1H)-quinolone
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.200
0.400
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0.800
1.000
1.200
1.400
1.600
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Spectra are colour coded as pH: 3 5 7 9 11 13 
1-methyl-2-(4-fluorophenyl)-3-hydroxy-4(1H)-quinolone
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
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0.200
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0.700
0.800
0.900
1.000
 
5-nitrosalicylaldehyde
Wavelength (nm)
O
D
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3-hydroxyflavone
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.500
1.000
1.500
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2.500
3.000
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Spectra are colour coded as pH: 3 5 7 9 11 13 
5,7-dichloro-8-hydroxy-2-methylquinoline
Wavelength (nm)
O
D
300 350 400 450 500 550 600 650 700
0.000
0.200
0.400
0.600
0.800
1.000
1.200
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Enzyme kinetics of 4-methylumbelliferyl-β-D-glucopyranoside 
 
4-Methylumbelliferyl-β-D-glucopyranoside (MUD) (Figure B1) is a commercially 
available and well documented artificial fluorescence substrate (Grange and 
Mcintyre, 1979; Park et al., 1995; Villari et al., 1997).  The enzyme kinetics of MUD 
were investigated in order to have a point of reference when comparing the kinetics 
of the novel fluorescence glucosides synthesised in this study. 
0.3mmol of 4-methylumbelliferone (4-MU) (Sigma) was dissolved in one litre of 
distilled water.   The fluorescence maximum (λF) of this core compound was 
determined using a Biotek Synergy multi-detection microplate reader and found to be 
Ex 360, Em 460 nm (Figure B2). 
 
CH3
OH OO  
Figure B1:  Structure of 4-methylumbelliferone. 
   
       
 
Figure B2:  Fluorescence of 4-MU. 
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The glucoside of 4-MU (Sigma) was then reacted with β-glucosidase enzyme 
(Sigma) at varying pH using the following reaction mixture. 
200 μl 0.05M/L sodium acetate/acetic acid buffer containing:- 
0.3 mmol/L MUD 
5 μl 1.5 g/L β-glucosidase 
The reactions were monitored for 30 minutes, at 37 
o
C, at pH 5-9 and the rates of the 
reaction are shown (Figure B3). 
 
Figure B3:   Rate of reactions of MUD and β-glucosidase at pH 4-9. 
 
The pH optimum for this enzyme system was determined to be pH 6.5. 
Using the same reaction mixture at pH 6.5, the substrate concentration was varied 
(Figure B4). 
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Figure B4:  Rate of reactions of MUD and β-glucosidase at subrate concentrations 0.003-3 mmol/L. 
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To convert FU into concentrations (mmol/L) of 4-MU a standard curve was prepared 
and measured.  A linear relationship between FU and 4-MU concentration was found 
to exist up to 0.2 mmol/L (Figure B5). 
 
Figure B5:  Linear standard curve for 4-MU. 
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This, along with the results gained from varying the substrate concentration, was 
used to calculate the following kinetics data (Figure B6). 
 
 
Figure B6:  Lineweaver-Burk plot for MUD. 
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A linear trendline was plotted from the Lineweaver-Burk data.  Error bars represent 
the standard deviation from the mean.  The correlation coefficient (r
2
) between 
outcomes and their predicted values was calculated as 0.999 (where values 
approaching 1 are desirable), therefore the data was acceptable. 
Vmax = 25.32 μmoles of product released per minute, per μmole of enzyme. 
or 0.42 kcat (μmoles of product released per second, per μmole of enzyme). 
KM = 0.30 mmol/L. 
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8.3 Appendix C: Microbiology/molecular biology 
 
Protein sequence 
 
MEFSVKSGSPEKQRSACIVVGVFEPRRLSPIAEQLDKISDGYISALLRRGELEGKPGQTLLLHHVPNVLS 
ERILLIGCGKERELDERQYKQVIQKTINTLNDTGSMEAVCFLTELHVKGRNNYWKVRQAVETAKETLYSF 
DQLKTNKSEPRRPLRKMVFNVPTRRELTSGERAIQHGLAIAAGIKAAKDLGNMPPNICNAAYLASQARQL 
ADSYSKNVITRVIGEQQMKELGMHSYLAVGQGSQNESLMSVIEYKGNASEDARPIVLVGKGLTFDSGGIS 
IKPSEGMDEMKYDMCGAAAVYGVMRMVAELQLPINVIGVLAGCENMPGGRAYRPGDVLTTMSGQTVEVLN 
TDAEGRLVLCDVLTYVERFEPEAVIDVATLTGACVIALGHHITGLMANHNPLAHELIAASEQSGDRAWRL 
PLGDEYQEQLESNFADMANIGGRPGGAITAGCFLSRFTRKYNWAHLDIAGTAWRSGKAKGATGRPVALLA 
QFLLNRAGFNGEE 
 
Gene sequence 
ATGGAGTTTAGTGTAAAAAGCGGTAGCCCGGAGAAACAGCGGAGTGCCTGCATCGTCGTGGGCGTCTTCGAACCACGTCGCCTTT
CTCCGATTGCAGAACAGCTCGATAAAATCAGCGATGGGTACATCAGCGCCCTGCTACGTCGGGGCGAACTGGAAGGAAAACCGGG
GCAGACATTGTTGCTGCACCATGTTCCGAATGTACTTTCCGAGCGAATTCTCCTTATTGGTTGCGGCAAAGAACGTGAGCTGGAT
GAGCGTCAGTACAAGCAGGTTATTCAGAAAACCATTAATACGCTGAATGATACTGGCTCAATGGAAGCGGTCTGCTTTCTGACTG
AGCTGCACGTTAAAGGCCGTAACAACTACTGGAAAGTGCGTCAGGCTGTCGAGACGGCAAAAGAGACGCTCTACAGTTTCGATCA
GCTGAAAACGAACAAGAGCGAACCGCGTCGTCCGCTGCGTAAGATGGTGTTCAACGTGCCGACCCGCCGTGAACTGACCAGCGGT
GAGCGCGCGATCCAGCACGGTCTGGCGATTGCCGCCGGGATTAAAGCAGCAAAAGATCTCGGCAATATGCCGCCGAATATCTGTA
ACGCCGCTTACCTCGCTTCACAAGCGCGCCAGCTGGCTGACAGCTACAGCAAGAATGTCATCACCCGCGTTATCGGCGAACAGCA
GATGAAAGAGCTGGGGATGCATTCCTATCTGGCGGTCGGTCAGGGTTCGCAAAACGAATCGCTGATGTCGGTGATTGAGTACAAA
GGCAACGCGTCGGAAGATGCACGCCCAATCGTGCTGGTGGGTAAAGGTTTAACCTTCGACTCCGGCGGTATCTCGATCAAGCCTT
CAGAAGGCATGGATGAGATGAAGTACGATATGTGCGGTGCGGCAGCGGTTTACGGCGTGATGCGGATGGTCGCGGAGCTACAACT
GCCGATTAACGTTATCGGCGTGTTGGCAGGCTGCGAAAACATGCCTGGCGGACGAGCCTATCGTCCGGGCGATGTGTTAACCACC
ATGTCCGGTCAAACCGTTGAAGTGCTGAACACCGACGCTGAAGGCCGCCTGGTACTGTGCGACGTGTTAACTTACGTTGAGCGTT
TTGAGCCGGAAGCGGTGATTGACGTGGCGACGCTGACCGGTGCCTGCGTGATCGCGCTGGGTCATCATATTACTGGTCTGATGGC
GAACCATAATCCGCTGGCCCATGAACTGATTGCCGCGTCTGAACAATCCGGTGACCGCGCATGGCGCTTACCGCTGGGTGACGAG
TATCAGGAACAACTGGAGTCCAATTTTGCCGATATGGCGAACATTGGCGGTCGTCCTGGTGGGGCGATTACCGCAGGTTGCTTCC
TGTCACGCTTTACCCGTAAGTACAACTGGGCGCACCTGGATATCGCCGGTACCGCCTGGCGTTCTGGTAAAGCAAAAGGCGCCAC
CGGTCGTCCGGTAGCGTTGCTGGCACAGTTCCTGTTAAACCGCGCTGGGTTTAACGGCGAAGAGTAA 
MWG Oligo synthesis report 
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Qiagen DNeasy kit protocol 
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Agarose gel electrophoresis 
 
Agarose gels were prepared by heating agarose in 1 x TAE buffer until the solid had 
completely dissolved. All gels in this study were 1 % (w/v) agarose in a total volume 
of 50 ml. 
Once dissolved, the solution was allowed to cool to ~ 60 °C, 5 μl of 1 x Sybr® Safe 
(Invitrogen) was added, and the solution poured into a mini gel casting tray avoiding 
the introduction of air bubbles. The appropriate sized comb was then inserted into the 
solution (for analytical purposes, a 12-toothed comb able to hold 15 μl in each well 
was used) and the gel allowed to set for > 20 min. 
After the gel had set, the gel tray was placed horizontally in an agarose gel 
electrophoresis tank, submerged in 1 x TAE buffer. The comb was then carefully 
removed and samples were prepared by the addition of of sample buffer, and added 
to the wells. A 5 μl volume of Hyperladder 1 size standard was also added to an 
unoccupied well in order to determine the size of electrophorised DNA fragments. 
The samples were then electrophoresed at 120 mA (200 V) for approximately 45 min 
to ensure good separation of DNA fragments. 
 
Visualisation of DNA and photography of agarose gels 
After electrophoresis, the gel was visualised using a gel documentation system (Bio-
Rad Gel Doc 2000 using Quantity One™ software). Hard copies of the gel picture 
were produced using a Mitsubishi Video Copy Processor (Model P91 attached to the 
gel doc system), with Mitsubishi thermal paper (K65HM-CE / High density type, 110 
mm x 21 m). 
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TAE buffer (50 x stock)  
Per L  
Tris Base (ultra-pure) (MelforD)           242.0 g 
17.51 M Glacial acetic acid (Fisher)                      57.1 ml 
0.5 M EDTA pH 8.0 (Duchefa)         100.0 ml 
This buffer was diluted to 1 x by a 1:50 dilution prior to use in the preparation of 
agarose gels and use as reservoir buffer in gel tanks.  
 
Bromophenol blue (6 x) sample loading buffer 
Per 10 ml 
Bromophenol blue (BDH Laboratory Supplies)           0.025 g 
Glycerol (Fisher)                                     3.000 g 
This buffer was diluted to 1 x with the sample prior to loading on an agarose gel. 
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Size Standards 
Bioline Hyperladder I agarose gel size standard was diluted to a concentration of 1 
μg/12 μl prior to loading on a gel (Figure C1) 
 
 
Figure C1:  Agarose gel size standards. Bioline Hyperladder I. 
 
 
 
 
 
10 x KOD buffer  
 
1.2 M Tris-HCl; 100 mM KCl; 60 mM (NH4)2 SO4; 1% (v/v) Triton X-100; 0.01% 
(w/v) bovine serum albumin, pH 8.0. 
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QIAquick Gel Extraction Kit Protocol 
 
using a microcentrifuge 
 
This protocol is designed to extract and purify DNA of 70 bp to 10 kb from standard or 
low-melt agarose gels in TAE or TBE buffer. Up to 400 mg agarose can be processed per spin 
column. This kit can also be used for DNA cleanup from enzymatic reactions (see page 8). 
For DNA cleanup from enzymatic reactions using this protocol, add 3 volumes of Buffer 
QG and 1 volume of isopropanol to the reaction, mix, and proceed with step 6 of the 
protocol. Alternatively, use the MinElute Reaction Cleanup Kit. 
Important points before starting 
■ The yellow color of Buffer QG indicates a pH 7.5. 
■ Add ethanol (96–100%) to Buffer PE before use (see bottle label for volume). 
■ All centrifugation steps are carried out at 17,900 x g (13,000 rpm) in a conventional 
table-top microcentrifuge at room temperature. 
Procedure 
1. Excise the DNA fragment from the agarose gel with a clean, sharp scalpel. 
Minimize the size of the gel slice by removing extra agarose. 
2. Weigh the gel slice in a colorless tube. Add 3 volumes of Buffer QG to 1 volume of 
gel (100 mg ~ 100 μl). 
For example, add 300 μl of Buffer QG to each 100 mg of gel. For >2% agarose 
gels, add 6 volumes of Buffer QG. The maximum amount of gel slice per QIAquick 
column is 400 mg; for gel slices >400 mg use more than one QIAquick column. 
3. Incubate at 50°C for 10 min (or until the gel slice has completely dissolved). To help 
dissolve gel, mix by vortexing the tube every 2–3 min during the incubation. 
IMPORTANT: Solubilize agarose completely. For >2% gels, increase incubation time. 
4. After the gel slice has dissolved completely, check that the color of the mixture is 
yellow (similar to Buffer QG without dissolved agarose). 
If the color of the mixture is orange or violet, add 10 μl of 3 M sodium acetate, 
pH 5.0, and mix. The color of the mixture will turn to yellow. 
The adsorption of DNA to the QIAquick membrane is efficient only at pH 7.5. 
Buffer QG contains a pH indicator which is yellow at pH 7.5 and orange or violet at 
higher pH, allowing easy determination of the optimal pH for DNA binding. 
5. Add 1 gel volume of isopropanol to the sample and mix. 
For example, if the agarose gel slice is 100 mg, add 100 μl isopropanol. This step 
increases the yield of DNA fragments <500 bp and >4 kb. For DNA fragments 
between 500 bp and 4 kb, addition of isopropanol has no effect on yield. 
Do not centrifuge the sample at this stage. 
Gel Extraction 
Spin Protocol 
6. Place a QIAquick spin column in a provided 2 ml collection tube. 
7. To bind DNA, apply the sample to the QIAquick column, and centrifuge for 1 min. 
The maximum volume of the column reservoir is 800 μl. For sample volumes of more 
than 800 μl, simply load and spin again. 
8. Discard flow-through and place QIAquick column back in the same collection tube. 
Collection tubes are reused to reduce plastic waste. 
9. Recommended: Add 0.5 ml of Buffer QG to QIAquick column and centrifuge for 1 min. 
This step will remove all traces of agarose. It is only required when the DNA will 
subsequently be used for direct sequencing, in vitro transcription, or microinjection. 
10. To wash, add 0.75 ml of Buffer PE to QIAquick column and centrifuge for 1 min. 
Note: If the DNA will be used for salt-sensitive applications, such as blunt-end ligation 
and direct sequencing, let the column stand 2–5 min after addition of Buffer PE, 
before centrifuging. 
11. Discard the flow-through and centrifuge the QIAquick column for an additional 1 min 
at 17,900 x g (13,000 rpm). 
IMPORTANT: Residual ethanol from Buffer PE will not be completely removed unless 
the flow-through is discarded before this additional centrifugation. 
12. Place QIAquick column into a clean 1.5 ml microcentrifuge tube. 
13. To elute DNA, add 50 μl of Buffer EB (10 mM Tris·Cl, pH 8.5) or water (pH 7.0–8.5) to the 
center of the QIAquick membrane and centrifuge the column for 1 min. Alternatively, 
for increased DNA concentration, add 30 μl elution buffer to the center of the QIAquick 
membrane, let the column stand for 1 min, and then centrifuge for 1 min. 
IMPORTANT: Ensure that the elution buffer is dispensed directly onto the QIAquick 
membrane for complete elution of bound DNA. The average eluate volume is 48 μl 
252 
 
from 50 μl elution buffer volume, and 28 μl from 30 μl. 
Elution efficiency is dependent on pH. The maximum elution efficiency is achieved 
between pH 7.0 and 8.5. When using water, make sure that the pH value is within 
this range, and store DNA at –20°C as DNA may degrade in the absence of a 
buffering agent. The purified DNA can also be eluted in TE (10 mM Tris·Cl, 1 mM 
EDTA, pH 8.0), but the EDTA may inhibit subsequent enzymatic reactions. 
14. If the purified DNA is to be analyzed on a gel, add 1 volume of Loading Dye to 5 
volumes of purified DNA. Mix the solution by pipetting up and down before loading 
the gel. 
Loading dye contains 3 marker dyes (bromophenol blue, xylene cyanol, and orange 
G) that facilitate estimation of DNA migration distance and optimization of agarose 
gel run time. Refer to Table2 (page 15) to identify the dyes according to migration 
distance and agarose gel percentage and type. 
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pET-28a vector map 
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Construction of pET-YSBLIC vector 
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10 x T4pol buffer 
 
500 mM Tris-HCl pH 7.5, 100 mM MgCl2, 100 mM DTT, 10 mM ATP, 250 g/ml 
BSA. 
 
 
Preparation of chemically competent cells 
 
For all strains of E. coli, chemically competent cells were freshly prepared using the 
procedure described below and was essentially by the method of (Cohen et al., 
1972). Firstly, an agar plate of the glycerol stock of the required cell type was 
prepared and incubated overnight at 37 
o
C. After overnight growth, 50 ml of 
prewarmed LB media in a 500 ml conical flask was inoculated using a wire loop. 
The culture was then allowed to grow at 37 °C with shaking at 200 rpm up to an 
optical density at 600 nm of 0.35~0.4. At this point the culture was placed on ice for 
30 min. After incubation on ice, the culture was centrifuged at 4000 x g for 10 min at 
4 °C and the supernatant discarded. The cell pellet was then re-suspended (by gentle 
vortex never more than 3 sec at a time off ice) in 15 ml of ice-cold 80 mM MgCl2, 20 
mM CaCl2 solution, and the cells were then re-centrifuged at 4000 x g for 10 min at 
4 °C and the supernatant removed. The cell pellet was re-suspended (by gentle vortex 
never more than 3 sec at a time off ice) in 1 ml of ice- cold 100 mM CaCl2. The cells 
were then retained on ice for 1 h and were then used immediately or snap frozen (in 
liquid N2) and stored at -85 
o
C subsequent to the addition of 50 % (v/v) glycerol to a 
final concentration of 15 % (v/v).  
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QIAprep spin miniprep kit 
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10 x digest buffer 2 
 
500 mM NaCl; 100 mM Tris-HCl; 100 mM MgCl2; 10 mM Dithiothreitol, pH 7.9  
 
 
 
 
MDG media 
 
MDG non-induction media for growing glycerol stocks and starter cultures 
 
Inoculate starter cultures directly from glycerol stocks (by scraping up a small 
amount of frozen glycerol stock with a sterile plastic tip without thawing the rest of 
the stock and inoculating into MDG) 
  10 mL total 
- Water  9.55 mL  
- 1M MgSO4  20 µL  
- 1000 x metals (for metal containing protein) 2 µL  
- 40 % glucose  125 µL  
- 25 % aspartate  100 µL  
- 50 x M  200 µL  
- antibiotic  
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Stock solutions 
 
- 1M MgSO4 (100mL) (autoclave and reautoclave everytime it is used) 
    
 
- 40 % (w/v) glucose (20 mL) (autoclave and reautoclave everytime it is used, 
make up fresh when it caramelizes)     
 
- 50 x M (100 mL) (autoclave)     
o dissolve sequentially in water 
o 3.6 g Na2SO4 anhydrous 
o 13.4 g NH4Cl anhydrous 
o 17.0 g KH2PO4 anhydrous 
o 17.7 g Na2HPO4 anhydrous 
 
- 1000 x metal (100mL) (autoclave separate solutions and mix aseptically)  
o 36 mL water 
o 50 mL 0.1M FeCl3-6H2O (dissolved in 100-fold dilution of HCl, 
~0.12 M HCl and filter sterilize using 0.2 µm filters) 
o 2 mL 1M CaCl2 anhydrous 
o 1 mL 1M MnCl2-4H2O 
o 1 mL 1M ZnSO4-7H2O 
o 1 mL 0.2M CoCl2-6H2O 
o 2 mL 0.1M CuCl2-2H2O 
o 1 mL 0.2M NiCl2-6H2O 
o 2 mL 0.1M Na2MoO4-5H2O 
o 2 mL 0.1M Na2SeO3-5H2O 
o 2 mL 0.1M H3BO3 anhydrous 
 
- 25 % (w/v) aspartate (20 ml) (check pH is 7, if not neutralise with NaOH) 
(autoclave) 
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ZYM media 
 
ZYM-5052 auto-induction media 
Inoculate from MDG starter culture 
 
 10 mL total 1 L total 
  (max vol for 2 L baffled flask) 
 
- ZY 9.77 mL 947 mL 
- 1M MgSO4 20 µL 2 mL 
- 1000 x metals  
- (for metal containing protein) 10 µL 1 mL 
- 50 x 5052 200 µL 20 mL 
- 50 x M 200 µL 20 mL 
- antibiotic  
 
Stock solutions 
 
- 1M MgSO4 (100mL) (autoclave and reautoclave everytime it is used) 
    
 
- 50 x 5052 (100 mL) (autoclave and reautoclave everytime it is used) 
    
o dissolve sequentially in water 
o 25 g glycerol 
o 2.5 g glucose 
o 10 g -lactose 
 
- 50 x M (100 mL) (autoclave and reautoclave everytime it is used)  
   
o dissolve sequentially in water 
o 3.6 g Na2SO4 anhydrous 
o 13.4 g NH4Cl anhydrous 
o 17.0 g KH2PO4 anhydrous 
o 17.7 g Na2HPO4 anhydrous 
 
- ZY (1 L) (autoclave)     
o dissolve sequentially in water 
o 10 g Tryptone 
o 5 g Yeast extract 
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- 1000 x metal (100mL) (autoclave separate solutions and mix aseptically)  
o 36 mL water 
o 50 mL 0.1M FeCl3-6H2O (dissolved in 100-fold dilution of HCl, 
~0.12 M HCl and filter sterilize using 0.2 µm filters) 
o 2 mL 1M CaCl2 anhydrous 
o 1 mL 1M MnCl2-4H2O 
o 1 mL 1M ZnSO4-7H2O 
o 1 mL 0.2M CoCl2-6H2O 
o 2 mL 0.1M CuCl2-2H2O 
o 1 mL 0.2M NiCl2-6H2O 
o 2 mL 0.1M Na2MoO4-5H2O 
o 2 mL 0.1M Na2SeO3-5H2O 
o 2 mL 0.1M H3BO3 anhydrous 
 
 
 
SDS-PAGE chemicals 
 
12 % (w/v) Acrylamide resolving gel components 
40 % (w/v) solution (37.5:1 acrylamide: bisacrylamide) (Fisher)    3.0 ml   
Solution B*                 2.5 ml 
18.2 M /cm H2O                4.5 ml 
10 % (w/v) Ammonium persulphate (Fisher)            50.0 μl 
Tetramethylethylenediamine (TEMED) (Fisher)          10.0 μl 
 
*Solution B  
Per 100 ml 
2 M Tris Base (Melford) pH 8.8             75.0 ml 
10 % (w/v) Sodium dodecyl sulphate (SDS) (Melford)           4.0 ml 
 
262 
 
4% (w/v) Acrylamide stacking gel components 
40 % (w/v) solution (37.5:1 acrylamide: bisacrylamide) (Fisher)    0.5 ml   
Solution C*                 1.0 ml 
18.2 M /cm H2O                2.5 ml 
10 % (w/v) Ammonium persulphate (Fisher)             30.0 μl 
TEMED (Fisher)                 10.0 μl 
 
*Solution C  
Per 100 ml 
1 M Tris Base (Melford) pH 6.8                                   50.0 ml 
10 % (w/v) SDS (Melford)                                     4.0 ml 
 
SDS-PAGE running buffer 10 x (Stock) 
Running buffer was made up at 10 x stock concentration and diluted 1:10 before use. 
Per L 
Tris Base (Melford)    30.3 g     
Glycine (Melford)  144.0 g 
SDS (Melford)    10.0 g 
The pH of the Tris Base and glycine was adjusted to 8.8 in a volume of ~900 ml 
prior to the addition of SDS. 
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SDS-PAGE sample buffer 
Per 10 ml 
60 mM Tris Base (Melford) pH 6.8   0.6 ml 
50 % (v/v) Glycerol (Fisher)    5.0 ml 
10 % (w/v) SDS (Melford)    2.0 ml 
14.4 mM β-Mercaptoethanol (Sigma)   0.5 ml 
1 % (w/v) Bromophenol blue (BDH)   1.0 ml 
 
Stored at –20 °C in 0.5 ml aliquots. 
 
Solublising SDS-PAGE sample buffer 
Per 10 ml 
SDS - PAGE sample buffer    7.6 ml 
Urea (Melford)     2.4 g 
Stored at 4 °C. 
 
Protein size standard 
High molecular weight range (M.W. 36, 45, 55, 66, 84, 97, 116 and 205 kDa) 
Low molecular weight range (M.W. 20, 24, 29, 36, 45 and 66 kDa) 
Lyophilised standards were reconstituted with 100 μl of 18.2 M  H2O to give a final 
concentration of ~2.0-3.5 mg/ml, which was aliquoted into 4 μl amounts and stored 
at –20 °C. 
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Coomassie blue gel stain solution 
Per L 
Coomassie Blue R-250 (Fisher)      1.0 g 
Glacial Acetic acid (Fisher)        100.0 ml 
Methanol (Fisher)    450.0 ml 
Coomassie blue gel stain solution is recycled for re-use by filtering through filter 
paper to remove any small pieces of gel.  
 
Coomassie gel destain solution 
Per L 
Glacial Acetic acid (Fisher)  100.0 ml 
Methanol (Fisher)   100.0 ml 
Coomassie gel destain solution is recycled for re-use by filtering through activated 
charcoal on a filter paper funnel to remove the Coomassie blue stain. 
 
 
 
MIDAS® PlasimidSpin™ miniprep Protocol 
 
1. Inoculate 5 ml LB/ampicillin (50 μg/ml) medium placed in a 10-20 ml culture tube 
with E. coli carrying desired plasmid and grow at 37°C with agitation for 12-16 h.  It 
is strongly recommended that an endA negative strain of E. coli be used for routine 
plasmid isolation.  
 
2. Pellet 1.5-5 ml bacteria by centrifugation at 10,000 x g for 1 min at room 
temperature. 
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3. Decant or aspirate medium and discard.  To the bacterial pellet add 250 μl 
Solution I/RNase A.   Resuspend cells completely by vortexing. Complete 
resuspension of cell pellet is vital for obtaining good yields. 
 
4. Add 250 μl Solution II and gently mix by inverting and rotating tube 4-6 times to 
obtain a cleared lysate.  A 2 min incubation at room temperature may be necessary. 
Avoid vigorous mixing as this will shear chromosomal DNA and lower plasmid 
purity. (Store Solution II tightly capped when not in use.) 
 
5. Add 350 μl Solution III and gently mix by inverting several times until a 
flocculent white 
precipitate forms. Centrifuge at 10,000 x g for 10 minutes at room temperature. 
 
6. CAREFULLY aspirate and add the clear supernatant to a clean BioBind™ mini 
column (blue) assembled in a 2 ml collection tube (provided). Ensure that the pellet 
is not disturbed and that no cellular debris is carried over into the column. Centrifuge 
1 min at 10,000 x g at room temperature to completely pass lysate through column. 
 
7. Discard liquid and wash column with 500 μl Buffer HB and Centrifuge 1 min at 
10,000 x g. This step ensures that residual protein contamination is removed and 
must be included for downstream applications requiring high quality DNA. This step 
can be skipped if the downstream applications don’t require high quality plasmid, 
such as enzyme digestion or other screening methods. 
 
8 Discard flow-through liquid and wash the column by adding 750 μl of Wash Buffer 
diluted with ethanol. Centrifuge 1 min at 10,000 x g as above and discard flow-
through. 
Note: Wash Buffer Concentrate must be diluted with absolute ethanol before use. See 
label for directions. If refrigerated, Wash Buffer must be brought to room 
temperature before use. 
 
9. Optional step: repeat wash step with another 750 μl Wash Buffer. 
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10 Centrifuge the empty column for 1 min at 10,000 x g to dry the column matrix. 
Do not skip this step - it is critical for removing ethanol from the column. 
 
11. Place column into a clean 1.5 ml microcentrifuge tube. Add 50 μl to 100 μl 
(depending on desired concentration of final product) sterile deionised water (or TE 
buffer) directly onto the column matrix and centrifuge 1 min at 10,000 x g to elute 
DNA. This represents approximately 75-80% of bound DNA. Further, optional, 
elutions will yield any residual DNA, though at a lower concentrations. 
 
 
Chemical Transformation 
 
1. Equilibrate a water bath or heat block to 42
o
C.  Remove the appropriate number of 
tubes of frozen XL1 Blue chemically competent cells (50 μl each) and thaw on ice. 
2. Add 1 μl of each ligation reaction (if the cell competency is <1 x 108 cfu/μg, you 
may need to use more of the ligation mixture) to a separate tube of competent cells.  
Mix gently with the pipette tip.  DO NOT PIPETTE UP AND DOWN.  Repeat for 
all ligations. 
3. For control reactions, add 1μl (10ng) of each supercoiled plasmid (e.g. pUC18 to a 
separate tube of cells. 
4. Incubate all tubes on ice 20 minutes. 
5. Transfer all tubes to 42
o
C heat block or water bath and incubate for 1 minute, then 
place on ice for 1 minute. 
6. Add 450 μl of room temperature NZY+ medium to each tube and shake at 225 
rpm for 60 minutes at 37
o
C. Place on ice. 
7. Plate 25 and 100 μl of each transformation mix on LB/ampicilin agar plates.  (If 
the cell competency is <1 x 10
8
 cfu/μg, you may need to plate more of each 
transformation mix).  Let all the liquid absorb, invert, and incubate at 37
o
C, 18-24 
hours.   
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LB broth 
10 g Tryptone 
5 g Yeast extract 
10 g NaCl 
in 1 L distilled H2O and adjusted to pH 7.4. 
